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ZUSAMMENFASSUNG
Streptococcus pyogenes ist ein bedeutender Krankheitserreger des Menschen,
welcher den Oropharynx und verschiedene Epithelien inklusive der Haut besiedeln kann und
dadurch ein Spektrum an verschiedenen Krankheiten verursacht. Die Eigenschaft des
Bakteriums verschiedene Gewebe zu infizieren beruht auf dessen Fähigkeit verschiedene,
vom Wirt induzierte Stresskonditionen zu ertragen. Die Mechanismen, die zu dieser enormen
Anpassungsfähigkeit beitragen sind jedoch noch nicht vollständig verstanden. Eine Strategie,
die in diesem Zusammenhang eine Rolle zu spielen scheint, sind Toxin-Antitoxin (TA)
Systeme. Typ II TA Systeme sind genetische Module, die für zwei Proteine kodieren, ein Toxin
und ein Antitoxin. Beide Proteine bilden einen stabilen TA Komplex, der das bakterielle
Wachstum nicht beeinträchtigt. Verschlechtern sich jedoch die Wachstumsbedingungen
durch äußere Einflüsse, kann das Antitoxin proteolytisch abgebaut werden, wodurch das
freigesetzte Toxin essentielle zelluläre Prozesse des Bakteriums beeinflussen oder inhibieren
kann. TA Systeme haben Einfluss auf Vorgänge wie post-segregational killing (PSK), abortive
infection (Abi) und bakterielle Persistenz, welche das pathogene Potenzial eines Erregers
steigern können. In dieser Studie charakterisierte ich zwei chromosomal kodierte TA Systeme
der ParDE Proteinfamilie des humanpathogenen Bakteriums S. pyogenes. Beide Systeme
sind hochkonserviert in verschiedenen Serotypen. Die Hauptziele meiner Untersuchungen
bestanden in: 1) der funktionellen Validierung der Eigenschaften des putativen Toxins und
Antitoxins, 2) der Charakterisierung des molekularen Targets des Toxins, 3) Untersuchungen
zur Rolle beider TA Systeme in unserem Modellorganismus und 4) der Erforschung von
Regulationsmechanismen der TA Systeme.
Beide Systeme (parDEF1 und parDE2) zeigten bona fide Charakteristika von TA
Systemen, aber auch spezifische Eigenschaften, die in der ParDE TA Familie noch nicht
beschrieben wurden. Ähnlich zu anderen Systemen werden das Toxin und das Antitoxin co-
transkribiert und werden durch Stresseinwirkung wie Ethanolbehandlung und
Aminosäuremangel induziert. Wenn S. pyogenes einem Aminosäuremangel ausgesetzt war,
konnte ich zudem die Prozessierung der parDE2 mRNA beobachten, was auf eine putative
posttranskriptionelle Regulation unter Stressbedingungen hindeutet.  Zusätzlich konnte in
beiden Systemen der Abbau des Antitoxins durch die Protease ClpXP in vivo nachgewiesen
werden. Dies ist ein bedeutender Faktor zur Kontrolle von TA Systemen.
Die extrachromosomale Expression der Toxine ParE1 und ParE2 führten in S.
pyogenes und Escherichia coli zum Zelltod, wobei die Co-expression der entsprechenden
Antitoxine ParD1 und ParD2 die Toxizität deutlich minderte. Zusätzlich zu der Fähigkeit die
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Toxizität von ParE1 und ParE2 zu vermindern zeigte auch eine Überexpression der Antitoxine
allein einen negativen Effekt auf das Zellwachstum. ParD1 hemmte die Zellteilung in E. coli,
wobei der N-Terminus des Proteins entscheidend für diesen Effekt zu sein schien. Diese
Ergebnisse deuten auf einen neuen TA Mechanismus hin, bei dem beide Proteine, das Toxin
und das Antitoxin, präsent sein müssen, um das Zellwachstum nicht zu blockieren.
Neben der verminderten Überlebensrate bei Expression der Toxine, konnte ich zeigen,
dass ParE1 und ParE2 die normale DNA Topologie der Zelle schädigen und dadurch zu einem
deutlichen Phänotyp führten. Wir haben die molekularen Targets beider Toxine identifiziert
und konnten dadurch die erstaunliche Plastizität der Toxine verdeutlichen, da sowohl die
Funktion des Enzyms Gyrase, als auch Topoisomerase IV durch die Toxine beeinträchtigt
wurden. Beide Enzyme gehören zur Gruppe der essentiellen Topoisomerasen, welche die
korrekte DNA Topologie in der Zelle aufrechterhalten und zudem bei Behandlung von
Infektionen als Ziele für Antibiotika dienen können. Die Fähigkeit von ParE beide
Topoisomerasen zu inhibieren, impliziert eine höhere Effizienz bei der Modulierung des
bakteriellen Wachstums im Vergleich zu bekannten Toxinen wie CcdB, welche nur die Gyrase
hemmen.
Zusammengefasst erweitern die Ergebnisse dieser Arbeit unser Verständnis von ParE
Toxinen, derer molekularen Targets und verdeutlichen außerdem die diversen Mechanismen,
welcher sich TA Systeme bedienen, um die bakterielle Physiologie zu beeinflussen. Zusätzlich
gibt diese Arbeit einen Einblick in mögliche Mechanismen, die S. pyogenes implementiert, um
Stresskonditionen im Wirt zu überdauern und dadurch effizienter Krankheiten bedingt.
IV
ABSTRACT
Streptococcus pyogenes is an important human pathogen that colonizes the oropharynx
and epithelium including the skin and causes a wide spectrum of diseases worldwide. Its
remarkable ability to colonize different tissues relies on the capacity to endure diverse host-
induced stress conditions through mechanisms that have yet to be fully understood. One
strategy employed by bacteria to cope with changing and potentially stressful environments
are toxin-antitoxin (TA) systems. Type II TA systems are genetic modules encoding two
proteins that permit growth when forming a tight antitoxin-toxin complex. Under non-ideal
conditions, the antitoxin is subject to proteolysis and thus the freed toxin can target crucial
pathways in the cell modulating bacterial growth. TAs have been connected to some important
cellular functions such as post-segregational killing (PSK), abortive infection (Abi) and
bacterial persistence, all of which can support the pathogenic potential of bacteria. In this
study, I characterized two chromosomally encoded ParDE-like TA systems from the human
pathogen S. pyogenes, both of which are well conserved in different serotypes. In this context,
I aim to, 1) validate the function of the putative toxin and antitoxin molecules, 2) characterize
the toxins’ molecular targets, 3) elucidate the role of the respective TA systems in our model
organism and, 4) investigate the putative TA regulation.
I found that both parDEF1 and parDE2 presented commonly described bona fide TA
characteristics, but also some particular features that have not been described for this TA
family. Like other TA systems, the antitoxin-toxin genes are co-transcribed and triggered by
ethanol treatment and amino acid starvation conditions. I detected parDE2 mRNA processing
which may suggest a putative post-transcriptional regulation under amino acid starvation,
implying an additional layer of TA regulation upon stress exposure. Additionally, both systems
are controlled by ClpXP antitoxin-protein degradation in vivo, an important factor for TA
triggering.
Moreover, plasmid-based expression of the toxins ParE1 and ParE2 resulted in cell death
in our model organism S. pyogenes and in the heterologous system Escherichia coli. Most
importantly, the antitoxin molecules ParD1 and ParD2 were able to prevent ParE1 and ParE2
toxicity, respectively. In addition to their capacity to prevent the ParE1 and ParE2 toxic effect,
unlike canonical antitoxins, both ParD1 and ParD2 molecules displayed a deleterious effect
when over-expressed in S. pyogenes. Furthermore, ParD1 arrested E. coli cell division, and
its activity seemed to be exclusive and related with its N-terminus domain potentially involved
Vin DNA-interaction. These findings might suggest a new TA mechanism where the two
molecules – antitoxin and toxin – need to co-exist to permit bacterial growth.
Besides decreasing cell viability upon expression, ParE1 and ParE2 toxins induced DNA
topology damage and an altered phenotype. We identified the toxin molecular targets and
interestingly the ParE toxins presented remarkable plasticity, able to harm not only gyrase but
also topoisomerase IV. Both topoisomerases belong to the group of essential enzymes, which
are involved in the maintenance of DNA topology and constitute interesting targets to treat
bacterial infections. The ParE ability to target both proteins implies more efficacy to modulate
bacterial growth in comparison with for instance the well-known CcdB toxin that only targets
gyrase.
Overall, the results of this thesis expand the view on the molecular targets of ParE
toxins and highlight the diverse mechanisms TAs employ to modulate bacterial physiology. In
particular, this thesis provides more insights into possible mechanisms that S. pyogenes
employs to endure stress in the host and efficiently cause disease.
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1 INTRODUCTION
Regulation of cell growth and death is essential for all living organisms, especially in
eukaryotic cells processes such as senescence, apoptosis, necrosis, or autophagy are
important for maintaining normal homeostasis (Galluzzi et al., 2018). All these processes are
triggered under specific conditions. For example, in eukaryotic cells, the pathway of apoptosis
is initiated by a variety of external signals related to stressful conditions such as nutrient
deprivation or infection (Galluzzi et al., 2018). Similarly, in bacteria, analogous processes of
regulated cell growth and death exist to provide an advantage in response to environmental
stimuli (Tanouchi et al., 2013). Toxin-antitoxin (TAs) systems are ubiquitous molecular
switches genetically encoded, that control bacterial growth and in some cases their cellular
effect may cause cell death in an apoptotic-like fashion. It has been hypothesized that the TA
capacity to kill its bacterial host might have come from a maladaptive trait resulting from a
process that would provide fitness; e.g. some TAs control gene expression under non-ideal
conditions rather than killing (Tanouchi et al., 2013). Another possibility is that cell death
induced by TAs might represent an altruistic trait since the sacrifice of some cells in a
population can benefit survivors by the provisioning of some nutrients which active cells can
benefit (Tanouchi et al., 2013). The study of cell growth and/or death modulation by TA
systems in bacteria involves a more complex network of not only one genetic TA copy, but
normally several TA copies encoded within the same genome. In addition, numerous features
make TA modules versatile systems: they come in six different types, they have different
modes of genetic regulation, diverse cellular targets to modulate bacterial growth and/or cell
death and a variety of roles that will be summarized in the following section.
1.1 TOXIN-ANTITOXIN SYSTEMS IN BACTERIA
TA systems are abundant genetic elements composed of two molecules: a normally stable
protein toxin that modulates bacterial growth by interfering with vital functions and a
comparatively unstable non-coding RNA or protein antitoxin that counteracts the toxin’s effect.
The toxin molecules modulate bacterial growth by targeting important elements that are
essential to fulfill successful DNA replication, transcription or translation. They can also affect
for example the function of the inner cell membrane homeostasis, peptidoglycan synthesis or
cytoskeleton conformation (reviewed by Unterholzner et al., 2013).
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TAs are classified into six major types (I- VI) based on the nature and mechanism by which
the antitoxin molecule counteracts the toxic effect (Unterholzner et al., 2013). In TA type I and
III the antitoxin is an RNA molecule while in type II, IV, V and VI the antitoxin is a protein. The
main features of the different TA types are summarized in Figure I, and the specific toxin
targets of each type will be described in detail later in this section. Moreover, the most studied
TA type II system will be described in greater detail in section 1.2.
Figure I. TAs are divided in VI types
The figure summarizes the modes by which the antitoxin (blue) control the toxin (red) in the different
TA types. Promoters are shown with black arrows and terminators with a black bubble. Curly lines
represent RNAs and a protease is shown in grey and yellow for the type VI. The antitoxin is a sRNA
in type I and II and a protein in type II, IV,V and VI. Type I: the antisense sRNA antitoxin counteracts
the toxin activity by binding to the mRNA encoding toxin molecule avoiding its translation. Type II:
the less stable antitoxin protein counteracts toxicity by forming a complex with the more stable toxin
molecule. Type III: The sRNA antitoxin directly interacts with the active side of the toxin protein
molecule. Type IV: AT-T do not interact, the antitoxin protein has the capacity to stabilize the toxin
target that will disassemble in the presence of the toxin molecule. Type V: The antitoxin is a RNase
that degrades the mRNA encoding the toxin. Type VI: The antitoxin protein is an adaptor that
interacts with both the toxin and the ClpX ATPase stimulating the toxin proteolytic degradation by the
ClpXP protease.
TAs were first discovered as addiction molecules that play a role in plasmid maintenance
by post-segregational killing (PSK) of plasmid-free daughter cells (Ogura and Hiraga, 1983).
Intriguingly, beside such plasmid-located TA systems, several bacterial chromosomes contain
multiple TA copies that belong to the same or distinct types or families displaying different
roles (reviewed by Harms et al., 2018). E. coli K-12 for instance encodes 19 type I TA systems
and 13 type IV TA loci as well as many other putative (reviewed by Harms et al., 2018). The
human pathogen Mycobacterium tuberculosis has been also highlighted due to the abundant
and redundant TA modules encoded in the chromosome (79 in total), which may contribute to
its pathogenesis and persistence (Ramage et al., 2009; Sala et al., 2014). Similarly,
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Salmonella enteritica serovar Typhimurium encodes 6 type I TAs and 21 type II TAs in its
genome, highlighting redundancy that might lead to different biological outcomes under
diverse conditions (Lobato-Márquez et al., 2015).
1.1.1 BIOLOGICAL FUNCTIONS OF TA MODULES
Different functions have been attributed to TA modules, some of which are still
controversial and some others are well supported by experimental data (Magnuson, 2007;
Van Melderen, 2010). The stabilization of mobile genetic elements through PSK constitutes
one of the best-described TA functions, not only important for plasmidic TA copies but also for
chromosomally encoded TA modules, e.g. within pro-phage encoded regions. The abrogation
of bacteriophage infections - abortive infection (Abi) - through altruistic suicide of phage-
infected cells constitutes another important trait of some chromosomally encoded TAs
(Fineran et al., 2009). Finally, the formation of dormant cells – antibiotic tolerant cells – known
as persisters, represents the most controversial proposed function of TA systems (Helaine et
al., 2014). The three concepts are depicted in Figure II and will be discussed in the following
sections.
Figure II. Biological functions of TA modules
The main TA biological functions are depicted; plasmids and chromosomes are represented by a
small circle and by a black spiral, respectably. Light blue cells are alive while light grey cells are dead.
A. Post-segregational killing (PSK) by TA system encoded in a plasmid (or in the chromosome).
Plasmid-free cells (light grey cell) loss the TA genes and therefore cannot supply antitoxin molecules
to counteract the toxin. The already present antitoxin is rapidly degraded and thus the toxin is
released. B. Abortive infection (Abi) by TA system encoded in a plasmid (or in the chromosome) gets
triggered upon phage infection, the free toxin kills the cells before the phage can replicate. C.
Persistent cell formation, less than 1% of the whole population stochastically enters into a dormant
stage where they are tolerant to environmental insults (e.g. antibiotic treatment). The dormant cells
can resume growth in ideal conditions.
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1.1.1.1 Post-segregational Killing
Type I and type II TAs were the first ones implicated in PSK, but this function is also
attributed to some type IV TAs (reviewed by Harms et al., 2018). These “addiction modules”
prevent the loss of plasmid but can also use this mechanism to maintain the genomic mobile
regions in which they are encoded, throughout bacterial generations (Szekeres et al., 2007;
Wozniak and Waldor, 2009). PSK relies on the different stability of the two TA molecules
wherein the antitoxin is less stable than the toxin. Upon cell division, the locus encoding the
TA module needs to be inherited to the offspring so that the antitoxin molecule continues being
produced to keep the toxin in check. Conversely, if upon cell division the offspring loses the
TA module, the antitoxin remaining molecule will be rapidly degraded, while the toxin molecule
will target specific cellular functions leading to cell death. As a consequence, this mechanism
ensures that the TA-free cells die (Gerdes et al., 1986; Jensen and Gerdes, 1995; Ogura and
Hiraga, 1983).
The first characterized TA system was the ccdAB operon (couple cell division) involved in
the maintenance of the F plasmid (Ogura and Hiraga, 1983). This TA system operates by
coupling host cell division to plasmid proliferation, since cell host division is inhibited when the
copy number of a plasmid carrying the ccdAB segment decreases (Ogura and Hiraga, 1983).
Notably, Partition Systems (PS) also promote stability of plasmids during cell division,
but the mechanism of PS is not related to TA systems. PS direct segregation of plasmids into
the daughter cells with a nucleoside triphosphatase (NTPase) and a centromere binding
protein (CBP) which binds the DNA par sites forming a partition complex (Pilla and Tang,
2018). Based on this function, another crucial element for the RK2 plasmid maintenance, was
first named parDE, from “partition system” due to induction of a similar phenotype compared
with PSs (Roberts and Helinski, 1992). Now it is known that parDE constitutes a type II TA
system and is not associated with the partition mechanism of a cognate PS (Roberts et al.,
1994a).
1.1.1.2 Abortive Infection
Although bacteria are the most abundant organisms on earth, then times more phages
(predator) exist per bacterial cell (prey) (Chibani-Chennoufi et al., 2004; Lima-Mendez et al.,
2007). This predator-prey relationship has caused bacteria to evolve multiple strategies of
protection such as: 1) surface alterations to avoid phage absorption, 2) prevention of phage
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DNA injection, 3) restriction of incoming DNA, via both innate (restriction enzymes) and
adaptive mechanisms by clustered regularly interspaced short palindromic repeats system
(CRISPR) (Sorek et al., 2008), and 4) abortive infection (Abi) (Petty et al., 2007). Abi systems
encoded in plasmids and chromosomes provide population protection by promoting “altruistic
suicide” of infected cells (Forde and Fitzgerald, 1999). One of the main characteristics of Abi
systems is that they harbor a highly effective toxin that when activated, targets a crucial cellular
function to inhibit phage DNA replication, transcription and translation (Chopin et al., 2005).
TA modules that constitute Abi systems encoded for a toxin that interfere with
processes such as DNA replication and translation or with the inner membrane homeostasis.
The TA type II rnlAB which is a chromosomally encoded in E. coli, has been shown to abort
bacteriophage T4 infection, wherein the toxin RnlA degrades mRNA (Koga et al., 2011). The
MazEF (type II) and hok/sok (type I) were also shown to abort T4 infection, by degrading
mRNA in the case of the MazF toxin or by damaging the bacterial inner membrane in the case
of the Hok toxin (Alawneh et al., 2016; Pecota and Wood, 1996). The type III TA modules, e.g.
toxIN and tenpIN, wherein the toxins interfere with the bacterial membrane, were also
described to protect a wide range of bacteria from bacteriophage infection (Goeders et al.,
2016)
Regarding the bacteriophage’s resistance to Abi systems, several interference
mechanism have been studied. Interestingly, one of these mechanisms constitutes an
antitoxin-like molecule (Dmd “the master key”) encoded in the T4 phage that can counter the
effect of several toxins from the LsoA and RnlA family by direct interaction (Otsuka and
Yonesaki, 2012). Moreover, the protein Alt from the T4 bacteriophage, ADP-ribosyltates the
MazF toxin in a specific position rendering the toxin inactive. Some bacteriophages (e.g. T7)
also encoded protease inhibitors, since proteases are important for the depletion of the
antitoxin protein molecules (TA type II and IV) to release the toxins. However, cellular
proteases are also responsible for many important function in the cell (e.g. protein quality
control), thus phage protease inhibitors not only impair abortive infection by TAs but can also
interfere with essential bacteria cellular processes (Sberro et al., 2013).
1.1.1.3 Bacterial Persistence
Persistent bacterial infections (or recurrent infections) are commonly due to difficult to
eradicate pathogens that have not evolved classical resistance (genetically-encoded) but
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antibiotic tolerance (Lewis, 2010; Mulcahy et al., 2010). This antibiotic tolerance is
stochastically induced in less than 1% of a clonal bacterial population that enters in a “dormant
stage” called persistence where molecular antibiotic targets are inactive and therefore
unaffected (Balaban, 2004).
Studies in E. coli allowed the identification of the first bona fide persister gene hipA
(high persistence) from the type II TA system HipAB (Moyed and Bertrand, 1983). HipA is a
protein-serine kinase toxin that phosphorylates glutamyl-tranfer RNA synthase in the absence
of its cognate antitoxin HipB (Germain et al., 2013; Korch and Hill, 2006). Thus, HipA inhibits
protein synthesis, which induces cell dormancy. Another example highlights the importance
of the toxin TisB (TA Type I) induced upon DNA damage. TisB affects the bacterial cell
membrane by forming channels that disrupt the proton motive force resulting in a drop in ATP
levels (Dörr et al., 2010). Importantly, the activity of many antibiotics is typically ATP-
dependent; therefore a decrease in cellular energy leads to increased drug-tolerance (Conlon
et al., 2016; Shan et al., 2017). A recent finding from the group of Kim Lewis suggested that
low ATP levels lead to persister formation and that this might be an important aspect of this
bacterial trait (Shan et al., 2017). However, a drop in cellular ATP can be also due to other
factors not related to TA systems (Shan et al., 2017).
The stress-induced expression of mRNAase toxins from 10 type II TA loci was claimed
to have major contribution to persister formation in E. coli (retracted Maisonneuve et al., 2013).
This process involved the alarmone ppGpp, the PPK phosphatase and the Lon proteases.
Careful reexamination of E. coli mutants lacking either 10 TAs (Δ10 TAs), Lon (Δlon ΔsulA) or
the polyphosphate operon  (Δppx Δppk), did not reproduce the persister phenotype, disproving
the model (Chowdhury et al., 2016; Harms et al., 2017; Shan et al., 2017). The misleading
findings arose as a result of a cryptic prophage contaminant (Harms et al., 2017). Moreover,
a controversial more recent publication confirmed that the 10 TA copies from E. coli are not
essential for persister cell formation (Goormaghtigh et al., 2018a).
David Holden (Imperial College-London) has recently published his opinion and
highlighted three important points with regard to TA modules and persister formation (Holden
and Errington, 2018): 1) The relevance of TA systems on persister cell formation should be
addressed under different physiological conditions – e.g. biofilm formation (Harrison et al.,
2009) - and not only in optimal growth conditions where the TA systems might not be active.
2)  The involvement of TAs in persistence should be considered during infection. There have
been evidences in pathogenic bacteria that support the involvement of TAs in persister cell
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formation; in favor to this idea, one report suggested that the YefM-YoeB,  YbaJ-Hha and
PasTI TAs are important for niche-specific colonization of uropathogenic E. coli using a murine
infection model (Norton and Mulvey, 2012). Another study highlighted the involvement of TAs
in Burkholderia cenocepacia persistence during biofilm formation, wherein expression of these
TAs relied on the mode of growth and antibiotic used (Van Acker et al., 2014). In addition,
recent publications have demonstrated that the persister cell formation of Salmonella in
macrophages depends on TAs, specifically three tRNAs acetyltransferase toxins (Cheverton
et al., 2016; Helaine et al., 2014; Rycroft et al., 2018). 3) The role of single TA copies in
persistence should be highlighted. The naturally acquired hipA7 mutant (toxin from TA type II
hipAB), was the first hint of TAs implicated in this process (Moyed and Bertrand, 1983),
afterwards RelE (Keren et al., 2004) and MazF (Tripathi et al., 2014) toxin expression was
shown to significantly increase persister cells in a population. However, experiments relying
on artificial overexpression of a toxin or gain-of-function alleles of TA systems do not present
enough evidence for TA being causative agents of a phenotype, and the information of those
experiment should be carefully analyzed (Goormaghtigh et al., 2018b).
 Overall, these information present enough evidence to conclude that TAs are
somehow involved in the persistence stage (Holden and Errington, 2018). However,
persistence is a phenomenon that involves several factors among which TA systems might be
only one.
1.1.1.4 Other Functions
Besides Abi, PSK and persister cell formation, TAs have been implicated in biofilm
formation, a trait that is still under debate. One report showed in E. coli, five TAs modulating
biofilm formation due to the induction of the gene yjgK, potentially involved in adherence (Kim
et al., 2009). Moreover, a clearer phenotype was observed also in E. coli where five TAs were
compared for the capacity to mediate cell death in both planktonic and sessile cells; it was
observed that mazEF was activated under both conditions, whereas dinJ-yafQ  was shown to
play a role only during biofilm formation (Kolodkin-Gal et al., 2009). As mentioned before some
papers have also suggested the involvement of TAs in persister cell formation only under
biofilm formation conditions (Sun et al., 2017; Van Acker et al., 2014).
Interestingly, a recent publication concluded that the toxin ParE (from the type II TA
parDE) protects Pseudomonas aeruginosa under antibiotic treatment with fluoroquinolones
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that target the same molecule targeted by ParE, the DNA gyrase. In this model the toxin will
compete with the antibiotic to bind gyrase thereby protecting it. In addition, this mechanism
depends on the ParE/ParD ratio that in excess of the toxin with respect the antitoxin will lead
to cell death (Muthuramalingam et al., 2018).
Many reports have shown that some TA systems are up-regulated under stress
conditions (Christensen et al., 2001a, 2003; Christensen-Dalsgaard et al., 2010; Wang et al.,
2011). In some cases TA systems modulate growth under non-ideal conditions by reducing
the rate of cell division in a reversible manner, while in some other cases TA elements might
lead to cell death as an altruistic mechanism by which a subpopulation die to provide nutrients
to the remaining cells (Erental et al., 2012; Tanouchi et al., 2013).
Finally, TAs might also play a regulatory role in the cell, e.g. some of them specifically
degrade mRNA thereby modulating translation. MazF for instance is an endoribonuclease (of
the MazEF type II TA), that cleaves multiples sites in most mRNAs while blocking ribosome
biogenesis by targeting ribosomal-protein transcripts and ribosomal RNA (rRNA) precursors.
In addition, MazF generally cleaves mRNAs in a sequence specific manner, which might
inhibit growth, but also modulate the translation of its targets (Culviner and Laub, 2018).
1.1.2 TYPE I TA SYSTEMS
The type I TA systems is constituted by an unstable antisense sRNA antitoxin (AT)
molecule that base-pairs with the mRNA toxin (T) molecule thereby down-regulating its
expression (Brantl, 2012). The genes are normally arranged in the same genetic locus where
the AT can be a cis-encoded antisense RNA or a trans-encoded sRNA with respect to the
toxin ORF. The sRNA AT-mRNA T complex blocks the T mRNA ribosome binding side
sequence Shine-Dalgarno (SD) sequence, by binding the T mRNA translational start side
(TSS) or binding to the open reading frame (ORF), thereby arresting translation of the T
molecule (Fozo et al., 2008a). However, formation of this sRNA AT-mRNA T complex can also
promote mRNA T degradation. Thus, the regulation of type I TAs often involves RNases
providing an additional layer of control (Reviewed by Brantl, 2012). Some examples are
described in Table 1.
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Table 1: Representative type I TA modules
Antitoxin Toxin Organism Regulation Reference
symR symE E. coli symE expression by LexA (SOS
induced)
SymE degradation by Lon
(Fernández de
Henestrosa et al.,
2002; Kawano et
al., 2007)
istR-1 tisB E. coli Transcription of the T controlled by
LexA (SOS induced).
Inhibitory 5’ UTR structure masks the
RSS preventing translation of TisB,
relive by a processing event.
Binding of the AT istR-1 to tisB
triggers cleavage by RNase III
(Berghoff et al.,
2017; Wagner
and Unoson,
2012)
ibs sib E. coli Transcription of the T controlled by
LexA (SOS induced)
(Fozo, 2012)
sok hok Plasmid R1 E. coli.
Genomes of
several
entorebacteria.
Five copies in the
E. coli K12
genome.
Processing by RNase II to allow
translation and biding of sok.
mRNA mok overlaps with mRNA hok.
sok preventing transcription therefore
no hok is translated.
hok mRNA/sok-RNA is degraded by
RNaseIII
(Franch et al.,
1997; Gerdes et
al., 1992;
Pedersen and
Gerdes, 1999;
Thisted and
Gerdes, 1992)
txpA ratA
B. subtillis
AT RNA binds SD of T mRNA.
The complex is degraded by RNase III
(Durand et al.,
2012a)
sr4 bsrG (Jahn et al., 2012)
as-yonT yonT (Durand et al.,
2012a)
tisA tisB E. coli AT RNA binds SD of T mRNA. (Gurnev et al.,
2012)
agrB dinQ E. coli Transcription of the T controlled by
LexA (SOS induced).
Translation of DinQ depends on
mRNA processing.
AT agrB binds to dinQ mRNA
sequestering the SD sequence.
(Berghoff et al.,
2017; Weel-
Sneve et al.,
2013)
orzO zorO E. coli O157:H7 Antisense encoded antitoxin
orzO binds the mRNA zorO.
(Wen et al., 2014,
2017)
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zorO mRNA processing in response
to nutrient shift.
ohsC shoB E. coli shoB mRNA processing.
ohsC binds the mRNA shoB
(Fozo et al.,
2008b; Kawano,
2005)
Hok/Sok is one of the most studied and complex members of the type I TA family
(Reviewed by Berghoff et al., 2017). Its regulatory mechanism has been studied in detail and
is summarized in Figure III. Translation of the hok (host killing) T depends on a third
component mok (modulation of killing) that together with hok forms a single translationally
inert transcript (mok-hok). RNase II and the polyribonucleotide nucleotidyltransferase
(PNPase) process and remove 39nt (nucleotides) respectively from the 3’ end of the mok-hok
transcript thereby inducing structural rearrangements of the mRNA that lead to translation of
hok. Moreover, the sok (suppressor of killing) AT is able to bind to the hok transcript thereby
blocking its translation (Berghoff and Wagner, 2017). Interestingly a second regulatory event
involves the RNase III, which cleaves the sok-hok RNA heteroduplex to decay the transcript
(reviewed by Gerdes and Wagner, 2007)
Figure III. Translation of the Hok toxin is controlled by several regulatory RNA elements
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The sok-hok locus is depicted in colors where the toxin hok (red) gene overlaps the sequence of the
regulatory element mok (grey). The antitoxin sok (blue) RNA is transcribed in cis. The mok-hok RNA
is processed by RNase II (orange) and PNPase (brown) allowing the antitoxin sRNA sok to bind the
mRNA of hok. RNase III (scissors) processes the double stranded sok-hok sRNA-mRNA complex to
deplete the toxin transcript. In the absence of sRNA sok, the Hok protein is translated (modified from
Berghoff and Wagner, 2017).
Except for SymE, all type I toxins are hydrophobic proteins with a putative transmembrane
domain,  similar to phages holins and are therefore able to introduce pores into cell
membranes (Reviewed by Brantl, 2012). Thereby, membrane depolarization can occur and
ATP synthesis can become impaired resulting in the inhibition of vital functions such as,
replication, transcription and translation leading to cell death.
Type I TA systems are known to interfere with phage propagation by affecting the bacterial
cell membranes or preventing the maturation of phage particles (Kawano, 2012). The toxins
SymE and TisB (regulated by the LexA repressor) have been shown to recycle damaged
mRNAs which are produced under SOS stress conditions or to prevent infection by RNA
phages (Kawano, 2012). Other type I toxins affect the maintenance of prophages within
bacterial chromosome, e.g. TxpA, BsrG, YonT (Durand et al., 2012b), in a manner which
resembles the PSK plasmidic-TA function. Some of the TAs type I have been reported to be
bacteriostatic and are induced under oxygen or glucose limitation conditions (Durand et al.,
2012b). Moreover, type I TAs have been also related with persister cell formation since
deletion of tisAB abrogates persistence and over-expression of the toxin TisB increased the
level of persister cells (Dörr et al., 2010). This is due to the cellular effect of TisB which
destabilizes membrane integrity leading to a decrease in ATP levels shutting down antibiotic
targets resulting in multidrug tolerance (Reviewed by Brantl, 2012).
1.1.3 TYPE III TA SYSTEMS
Similar to type I TA systems, in type III TA systems the antitoxin is a small RNA, but
instead of interacting with the toxin mRNA, the antitoxin sRNA forms pseudoknots that bind
directly to the active side of the toxin protein molecule. Recently, a classification of TA type III
have been proposed according to the amino acid sequence similarities consisting of: ToxIN,
CptIN and TenpIN (reviewed by Goeders et al., 2016). The most studied member of TAs type
III is the ToxIN module discovered on a cryptic plasmid from Pectobacterium atrosepticum
(Erwinia carotovora subsp. atroseptica), also present in Bacillus thuringiensis (plasmid
pAW63), Histophilus somni 129PT and within the chromosome of many Firmicutes and
proteobacteria (Blower et al., 2012; Fineran et al., 2009). The toxNI distribution implies
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horizontal gene transfer as the plasmid pAW63 from B. thuringiensis is conjugal (Short et al.,
2015). The toxNI operon is co-transcribed from a single promoter wherein the toxin toxN gene
is preceded by the toxI, a short palindromic repeat and a tandem array of nucleotide repeats.
The ToxN toxin is an RNase that cleaves the toxIN transcript to activate the sRNA toxI antitoxin
transcripts that fold into an RNA pseudoknot, and three ToxI monomers bind three ToxN
proteins in a trimeric ToxI/ToxN complex to inhibit toxicity of ToxN. Interestingly, most of the
TA transcripts end right after the antitoxin toxI, leaving on average only 10% of read-through
into the toxN sequence, thus the presence of the toxI terminator ensures an appropriate
ToxI:ToxN stoichiometry (Fineran et al., 2009).
The ToxN toxin has endoRNase activity and cleaves other mRNAs to inhibit growth in
a bacteriostatic and reversible manner, highlighting its important regulatory function in the cell
(Brantl and Jahn, 2015). ToxIN provides viral resistance against multiple phages (Fineran et
al., 2009). In a similar fashion, the second TA type III described abiQ/AntiQ is required for
promoting cell death and limit phage replication where the AbiQ (abortive phage infection)
toxin also acts as an RNase (Samson et al., 2013). It has been reported that plasmidic TA
types III also play a role in PSK (Short et al., 2015). Finally, the cptIN TA module is the only
chromosomally encoded TA type III that has been reported to date, and a physiological
function has not been described.
1.1.4 TYPE IV TA SYSTEMS
The antitoxin and toxin elements of the type IV TA systems never interact. In this group
the toxin molecule prevents growth by binding and inhibiting the polymerization of the bacterial
cytoskeletal proteins MreB and FtsZ (Brown and Shaw, 2003; Masuda et al., 2012). MreB is
the actin-homolog in bacteria, it is important for maintaining cell shape and polarity and is also
involved in chromosome segregation. FtsZ is the tubulin-like protein that serves as scaffold
during assembly of the divisome (Shih and Rothfield, 2006). Maintaining the homeostasis of
these molecules constitute an important step during cell division. The antitoxin prevents the
toxic effect by stabilizing the same molecules and therefore promoting the bundling of the
MreB and FtsZ filaments. The YeeU-YeeV (CbtA for cytoskeletal bundling-toxic) encoded in
the chromosome of E. coli is the main representative of this type where both molecules bind
to the MreB and FtsZ proteins (Masuda et al., 2012). The CbtA toxin was found to have a
profound effect in cell morphology and division (Tan et al., 2011), while the YeeU antitoxin not
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only neutralized the CbtA toxicity but also the effect of other MreB and FtsZ inhibitors, such
as A22 [S-(3, 4-dichlorobenzyl) isothiourea], SulA or DicB (Masuda et al., 2012).
In order to respond to environmental insults, bacteria need to rapidly modulate the
bundling of filaments; the direct manipulation of these dynamics by type IV TA systems may
allow bacteria to quickly change their physiology under unfavorable conditions. Moreover, the
yeeU-cbtA operon is part of a prophage sequence (CP4-44) that might give to the host a
potential selective advantage to easily manipulate cell division (Masuda et al., 2012).
1.1.5 TYPE V TA SYSTEMS
In the only known type V TA system in E. coli and Shigella spp, the antitoxin GhoS (YjdK)
is an RNase that cleaves the toxin ghoT (yjdO) mRNA. Under stress condition the antitoxin
ghoS mRNA is degraded by the type II toxin MqsR (from the mqsRA “motility quorum sensing
regulator” TA type II) resulting in translation of GhoT (Wang et al., 2011, 2012) (Figure IV).
Moreover, the antitoxin GhoS is stable during stress (not proteolytically degraded) and does
not bind the promoter-DNA to regulate its own transcription, like a typical type II antitoxin.
Interestingly, its structure resembles the CRISPR-associated-2 (CAS2) sequence-specific
endo-RNase, indicating a putative evolutionary of post-translational regulation for serving
several purposes in the cell, from controlling cell growth to preventing phage attack (Wang et
al., 2012).
The toxin GhoT (toxin producing ghost cells) is an inner membrane lytic peptide, known to
function similar to the type I toxins, which targets the integrity of the cell membrane leading to
membrane depolarization and cellular ATP depletion (Figure III) (Wang et al., 2012).
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Figure IV. The antitoxin GhoS is an RNase that degrades the GhoT toxin mRNA
The ghoST locus is depicted in colors; the toxin ghoT (red) mRNA is degraded by the antitoxin protein
GhoS (blue). Under stress conditions the toxin MqsR (light red) (form the MqsAR TA type II, light
blue and red) enriches the GhoT toxin by degrading the ghoS antitoxin mRNA leading to the toxin
accumulation that targets the inner membrane (modified from Wang et al., 2013).
It has been suggested that GhoS-GhoT plays a role in persister cell formation since
GhoT not only kills the cells but can also to a certain extent reduce cell growth. Remarkably,
the toxin GhoT has been shown to also prevent cell elongation upon the addition of low levels
of ampicillin (Wang et al., 2013). Furthermore, GhoT increases early biofilm formation and
swimming motility (Wang et al., 2013).
1.1.6 TYPE VI TA SYSTEMS
SocAB is the only TA type VI systems representative known up to date, encoded in a
bisistronic operon within the Caulobacter crescentus chromosome (Aakre et al., 2013). Unlike
canonical TA systems the atypical toxin SocB is unstable and degraded by the ClpXP
proteolytic complex via the adaptor SocA antitoxin molecule. The SocA antitoxin is therefore
able to bind both the toxin SocB and the N-terminal domain of ClpX. In the absence of SocA,
the toxin SocB blocks the replication elongation through direct interaction with the essential
sliding clamp (DnaN) important for DNA replication, leading to replication fork collapse (Figure
V). This effect leads to induction of the SOS response and eventually cell death.  The SocB
toxin might accumulate and compete for binding to the clamp with polymerase III (Pol III) and
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other important replication factors such as DNA repair proteins, Pol IV and Pol V (translesion
synthesis), MutS and MutL (DNA mismatch repair) and Had (regulation of initiation) that are
also able to bind DnaN (Aakre et al., 2013).
The socAB operon is induced by the DNA-damaging agent mitomycin C (MMC),
suggesting that it may play a regulatory role during the DNA-damage response. Aakre and
coworkers suggested that DNA damage or other stress conditions might lead to accumulation
of SocB to regulate the rate at which DNA replication occurs (Aakre et al., 2013).
Figure V. SocAB mode of regulation
A. Under normal growth conditions, the antitoxin SocA binds and delivers the SocB toxin protein for
degradation by the ClpXP proteolytic complex, leading to normal DNA replication. B. In the absence
of ClpXP or SocA, the toxin SocB accumulates and reaches the DNA β clamp thereby collapsing the
replication forks. SocB abolish the interaction of important protein such as the Pol III to the clamp
inducing the RecA-mediated SOS response (modified from Aakre et al., 2013a).
1.2 TYPE II TA SYSTEMS
Type II TA systems is the best-studied class. They are composed of two proteins, an
unstable antitoxin and a stable toxin. In this type, the antitoxin forms a tight complex with the
toxin resulting in its neutralization (Wang et al., 2011). The TA type II genes are typically
encoded in a small operon where the upstream gene encodes the antitoxin that overlaps with
the beginning of the toxin-encoding gene. However, there are some exceptions to the typical
AT-T operon configuration, e.g. the operon higBA harbors the opposite operon organization
where the toxin higB is the first gene followed by the antitoxin higA gene (Tian et al., 2001),
however the implication of this genetic organization have not been characterized. The
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regulation of TAs type II occurs at two different levels, i) transcriptional repression by the
antitoxin molecule alone or in complex with the toxin and ii) posttranslational degradation of
the unstable antitoxin protein. Both mechanisms are important for triggering the system -
summarized in the Figure VI - and will be discussed in the next sections.
Figure VI. TA type II mode or regulation
The AT-T operon is composed of two genes, one encoding the antitoxin unstable protein (blue), and
the second gene encoding the stable toxin molecule (red). The antitoxin or antitoxin-toxin complex
can bind to the TA promoter to block its own transcription. The unstable antitoxin molecule can be
degraded by cellular proteases, which leads to TA transcription and toxin release. The freed toxin
molecule accumulates and therefore modulates bacteria growth by targeting vital functions. In the
absence of the antitoxin the toxin will kill the cells.
1.2.1 Transcriptional Regulation
In type II TA systems the antitoxins molecules normally have three important features: one
domain that binds DNA, a second region that binds the cognate toxin and a segment that is
recognized by a proteolytic machinery. The domain that directly interacts with DNA is normally
located at the N-terminal end of the protein and specifically recognizes its own promoter DNA
sequence. Thus, at the transcriptional level, the expression of type II TA systems is tightly
regulated by presence of the antitoxin, which has the ability to repress expression of its own
operon, either alone or in complex with the cognate toxin. The formation of the AT-T complex
will then result in a more potent transcriptional repression that might be due to the toxin
capacity to stabilize the antitoxin by binding to the same region recognized for its proteolysis,
located at the C-terminus of the protein. Thus, a more stable antitoxin will efficiently reach and
bind its promoter (reviewed by Page and Peti, 2016).
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Interestingly, an excess of the toxin molecule will also drive transcription but in the opposite
direction; one of the first reports about TA transcriptional autoregulation was characterized in
the Doc/Phd TA system, where the excess of toxin activated rather than repressed
transcription (Magnuson and Yarmolinsky, 1998). Therefore, the level of transcriptional auto-
regulation depends on the formation of TA complexes with different stoichiometries and
distinct affinities for their own operator (Afif et al., 2001; Garcia-Pino et al., 2016a; Tsuchimoto
and Ohtsubo, 1993). The toxin enhances cooperative auto-repression at low T:A ratios in
steady state conditions, whereas it acts as activator at high T:A ratios, thereby stimulating TA
transcription (reviewed by Harms et al., 2018). This phenomenon has been named conditional
cooperativity (Garcia-Pino et al., 2010) and has been reported for other type II systems such
as ccdBA (Afif et al., 2001), parDE (Johnson et al., 1996), relBE  (Overgaard et al., 2008),
kid/kis (Monti et al., 2007) and vapBC (Dienemann et al., 2011). Nevertheless, some TA type
II copies do not regulate transcription by conditional cooperativity, e.g. MqsRA, where the
MqsR toxin does not enhance MqsA antitoxin binding to the promoter but instead destabilize
it (Brown et al., 2013).
Some other TAs type II operons are composed of three molecules where the third gene
might also play a role in the TA transcriptional regulation. As an example, the TA module ω-
ε-ζ, encoded within the pSM19035 plasmid from Streptococcus pyogenes constitutes of a
three-component system. In this model the ε antitoxin dimer counteract the ζ toxin effect by
forming a heterotetramer complex while ω plays a regulatory role by binding to the TA
promoter (Camacho et al., 2002; Meinhart et al., 2003; Zielenkiewicz et al., 2009). The TA
locus parR-paaA-parE in E. coli 0157:H7 is also composed by the AT-T elements and a
regulatory protein, ParR which is necessary for the TA transcriptional control (Hallez et al.,
2010). In addition, both the PaaA antitoxin and the PaaA-ParE AT-T complex can bind to its
own promoter and regulate transcription of the TA operon (Hallez et al., 2010). Moreover,
other examples of tripartite TA subtypes exist where the third molecule does not play a role in
transcription, e.g pasA-pasB-pasC encoded in the plasmid pTF-FC2 from Thiobacillus
ferrooxidans, where the third component PasC enhances AT-T complex formation, helping to
control the toxin (Smith and Rawlings, 1997).
Another mechanism of post-transcriptional regulation has been recently suggested in
which the TA mRNA transcripts can be processed by RNases (Altuvia et al., 2018; Lybecker
et al., 2014). These studies, reported cleavages in the transcripts of the antitoxins hipB
(hipA/hipB), and dinJ (yafQ/dinJ) from type II TAs and ghoS (ghoS/ghoT) from the type V TA
systems, but interestingly also in the transcripts encoding the toxins cptA (cptA/sdhE) and
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yafO (yafO/yafN) (Altuvia et al., 2018; Lybecker et al., 2014). These results imply a putative
additional layer of regulation at the TA mRNA level, which needs to be explored.
1.2.2 Post-translational Regulation
Bacterial proteases are important for general protein quality control and also play a role in
the regulation of various cellular processes such as cell cycle, cellular development and
adaptation by controlling the stability of a regulatory protein (Lehnherr and Yarmolinsky, 1995;
Melderen et al., 1994; Tsuchimoto et al., 1992). They are responsible for the proteolytic
degradation of misfolded or aggregated proteins and are normally composed of two parts the
ATPase or unfoldase and the peptidase. Hsp100/Clp proteins from the AAA+ ATPase
(ATPase associated with diverse cellular activities) unfold and translocate the substrates into
the proteolytic chamber of a peptidase such as ClpP (caseinolytic protease) which is in charge
of the substrate hydrolysis (reviewed by Kirstein et al., 2009). In both Gram-positive and Gram-
negative bacteria, the ATPase ClpX is an example of an hexamer that interacts with the ClpP
14-mer to form the proteolytic complex; ClpXP (Figure VII). Alternatively, in Gram-negative
and to a lesser extent in Gram-positive bacteria, the protease Lon harbors both the ATPase
or unfoldase and the peptidase functions on the single polypeptide (reviewed by Kirstein et
al., 2009).
Figure VII. Bacterial AAA+ proteases mechanism of assembly with the peptidase.
The formation of the protease complex is depicted, where single monomers of the ATPase (grey)
form a hexamer upon ATP hydrolysis. The ATPase hexamer then assembles with the 14-mer
peptidase complex (yellow). The substrate (green) is recognized by the ATPase and subsequently
unfold and driven through the peptidase channel for its hydrolysis in a process that is ATP dependent
(adapted from Kirstein et al., 2009).
Antitoxin degradation has been reported to be mediated by ATP-dependent proteases
such as, Lon, ClpCP, ClpXP and ClpAP (reviewed by Muthuramalingam et al., 2016). In some
cases degradation of the antitoxin is the key process that leads to the release and thus
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activation of the toxin (Wang et al., 2011). As mentioned before, the mechanism by which the
system is activated relies on the different stability of the two molecules. Upon stress exposure,
binding of the AT-T complex is disrupted. This causes the loosely structured C-terminal
domains of the AT, which are most commonly associated with binding the T molecule, to
become sterically available to cellular proteases. Thus, the AT molecules may be rapidly
degraded, whereas the unpaired T molecules are generally more resistant to protease-
degradation, leading to an accumulation of catalytically active toxins (Ruangprasert et al.,
2017)
CcdA constitutes an example of an antitoxin with an intrinsically unstructured C-terminal
domain, which explains its high susceptibility to proteolysis by the Lon protease in E. coli
(Figure VIII) (Madl et al., 2006). CcdA can form a tight complex with its cognate toxin
molecule, similar to the PhD antitoxin (Phd/Doc) (Garcia-Pino et al., 2016b) and this complex
formation protect it from degradation. On the other hand, the ParD antitoxin (parDE) from the
RK2 plasmid in E. coli, is a protein with an unstructured C-terminal domain, in the absence of
its cognate binding partner ParE (Figure VIII) (Oberer et al., 2007), similar to HipB (Hansen
et al., 2012). Conversely, the DinJ (from the dinJ/yafQ TA system) (Figure VIII)  is an antitoxin
degraded by both, the ClpXP and Lon protease in E. coli, which contains a structured C-
terminus in the absence of the toxin molecule, similar to YefM (Kumar et al., 2008) and MqsA
(Brown et al., 2009), leading to a higher stability. This antitoxin structural diversity suggests
its stability alone might not be the only factor that determines antitoxin recognition for
degradation.
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Figure VIII. Antitoxin lability alone may not fully explain susceptibility to proteolysis.
Three different antitoxins type II structures are shown: CcdA (Madl et al., 2006) harbors an
intrinsically disorder C-terminal region similar to the PhD antitoxin. ParD (Oberer et al., 2007) have a
flexible but not completely deserter C-terminus similar to HipB. DinJ (Ruangprasert et al., 2017)
contains a structured C-terminal region that renders the protein more stable, similar to the YefM and
MqsA antitoxins.
Bacterial proteases are not only able to recognize unstructured or aggregated protein but
also specific domain or proteolytic tags. The ClpXP protease recognizes flexible domains but
also structured peptide tags within protein substrates (reviewed by Baker and Sauer, 2012)
(Figure IX). The protease direct recognition of a substrate involves binding to short
unstructured peptide sequences called degradation tags or degrons at the end of the N-
terminus or C-terminus of a substrate (Baker and Sauer, 2012; Jana et al., 2016).
Nevertheless, to date there are no reports that suggest a specific antitoxin domain or
sequence that will lead to proteolysis. The ClpXP protease can also recognize substrates after
endo-proteolytic event (Flynn, 2004; Neher, 2003) a process that has not been described for
antitoxins. Adaptor molecules can also mediate proteolysis since they recognize and enhance
the substrate recognition by the unfoldase (Levchenko et al., 2000). Interestingly, protein
adaptors such as TrfA, but also chaperones such as SecB, have been reported to enhance or
assist antitoxin degradation (Bordes et al., 2016; Donegan et al., 2014). Finally, free
substrates with solvent expose domain as described for the antitoxin DinJ can be also
recognized for proteolysis by the ClpXP protease (Ruangprasert et al., 2017).
Figure IX. Mechanism of ClpX substrate recognition
In the left part of the figure, C-terminal or N-terminal sequence degrons in the substrates (green) can
be recognized by ClpXP (ClpX ATPase in grey and ClpP peptidase in yellow) for degradation, the
amino acid sequence and representative proteins containing this tags are shown (Baker and Sauer,
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2012; Jana et al., 2016). Right part of the figure: ClpXP can also recognize substrates after proteolytic
events e.g. LexA and RseA (Flynn, 2004; Neher, 2003), the substrate recognition can be enhance
by adaptor molecules (orange) (Levchenko et al., 2000), and free substrates with solvent exposes
domains such as DinJ can be also targeted for degradation (Ruangprasert et al., 2017).
Finally, a recent report has suggested that a DNA molecule can stimulate antitoxin
degradation (Dubiel et al., 2018). In Pseudomonas aeruginosa, the ClpAP protease is in
charge of ParD recognition, which is enhanced in the presence of DNA as ClpA interaction
with DNA enhances its ATPase activity and thus substrate proteolysis (Dubiel et al., 2018).
1.2.3 Molecular Toxin Type II Targets
Toxins from the type II TA systems have a broad variety of targets; the majority that
have been studied are mRNA endonucleases or kinases that phosphorylate proteins
implicated in ribosome function and therefore reversibly interfere with protein translation (i.e.,
RelE, HipA) (Christensen and Gerdes, 2003a; Germain et al., 2013). Another group of type II
toxins interfere with DNA replication by interacting with and thereby inactivating essential
molecules, such the DNA gyrase (Yuan et al., 2010) (Figure X).
Figure X. Toxins type II affect either DNA replication or translation
Two main functions are targeted by toxins type II: the protein translation by degradation of free
mRNA, mRNA within the ribosome or tRNAs or the DNA replication by for instance inhibiting the DNA
gyrase.
Toxins that arrest translation comprise ribosome-dependent mRNA endonucleases
such as RelE (Christensen and Gerdes, 2003b), ribosome-independent mRNA
endonucleases of the MazF family (Culviner and Laub, 2018) or toxins that cleave tRNAs or
rRNAs like the VapC toxin (Winther and Gerdes, 2011) (Figure X). Other toxins modify their
targets post-transcriptionally by introducing a modification. Remarkably, TacT is a toxin that
also targets tRNAs, but instead of cleaving tRNA, TacT is an acetyltransferase that blocks the
Introduction
22
primary amine group of amino acids on the already charged tRNA molecules. This effect also
inhibits translation and is known to promote persister cell formation in Samonella (Cheverton
et al., 2016).
Toxic kinases are examples of toxins that modify their targets post-translationally, such
as the Doc toxin that phosphorylates the translation elongation factor EF-tu. This
phosphorylation renders EF-Tu unable to bind aminoacylated tRNAs, thereby arresting
translation (Castro-Roa et al., 2013). HipA is another kinase toxin, which phosphorylates the
glutamyl-tRNA synthetase GltX that inhibits aminoacylation. This leads to the generation of
so-called “hungry codons” at the ribosomal A site that trigger the synthesis of the second
messenger (p)ppGpp, leading to a persistent phenotype (Germain et al., 2013). Interestingly,
the ζ zeta toxins (from the epsilon/zeta ε-ζ family) is also a kinase, which does not target
cellular factors involved in translation. Instead, the ζ toxin phosphorylates the peptidoglycan
precursor uridine diphosphate-N-acetylglucosamine (UNAG) impairing cell wall synthesis,
thus displaying a bacteriotoxic effect in Gram-positive bacteria (Mutschler et al., 2011).
Recently, another report has suggested that the ζ toxin displays a broader substrate
specificity. This kinase can phosphorylates multiple UDP-activated sugars that are not only
precursors of peptidoglycan but also required for lipopolysaccharide synthesis in the Gram-
negative bacteria Neisseria gonorrhoeae (Rocker et al., 2018).
Other type II toxin arrest DNA replication, e.g. a recent report has shown that the toxin
DarT (darTG) from M. tuberculosis, ADP-ribosylates thymidines on ssDNA in a reversible and
sequence-specific manner. The DarT activity leads to induction of the SOS response, a
cellular stress response triggered upon DNA damage, thus having important implications at
the level of DNA maintenance (Jankevicius et al., 2016).
Importantly, they are many reports about toxin proteins targeting the DNA gyrase as
poisons that lead to stronger cellular effects in comparison with RNase or kinases (Figure XI).
The DNA gyrase, a type II topoisomerases together with topoisomerase IV (topo IV) are
important for cellular survival as they relieve DNA-topological stress. Gyrase is essential
during initiation, elongation, and termination of DNA replication, while topo IV mainly
influences chromosomal stabilization during cell division. Both enzymes act via double strand
breakage and re-joining process in an energy-dependent manner (reviewed by Sissi and
Palumbo, 2010). Type II toxin inhibitors such as the acetyltransferase FicT (ficAT) abrogates
the function of both gyrase and topo IV in a reversible manner (Harms et al., 2015) (Figure
XI). In contrast, toxins such as CcdB (from the CcdAB system) and most of the ParE-like toxins
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(from the ParDE-family) have been reported to target the gyrase resealing capacity of the
transient double strand DNA breaks resulting in a bactericidal effect (Bernard and Couturier,
1992; Jiang et al., 2002) (Figure XI). Conversely, the MtbParE toxin from M. tuberculosis
leads to a bacteriostatic effect (Gupta et al., 2016) by interacting with a different gyrase domain
(Figure XI). Moreover, some short-ParE synthetic peptides, designed based on the E. coli
ParE plasmidic toxin, displayed the capacity to inhibit both gyrase and topo IV in vitro (Barbosa
et al., 2012). However, the broader spectrum of targets has not been studied for native ParE-
like toxins. Since gyrase, and to a lesser extent topo IV, are present in prokaryotes – and
some eukaryotes – but absent in humans, they represent interesting cellular drug targets
(Forterre et al., 2007). Due to the importance of topoisomerase IIA as toxins type II targets,
they will be discuss in the next section.
Figure XI. Toxins type II that affect DNA replication
Four toxins ParE, MtbParE, FicT, and CcdB (depicted in red), encoded in chromosomes (Chr) or in
plasmid (Pla) of different bacteria, have been predicted to arrest DNA replication by interacting with
topoisomerase IIA: topoisomerase IV (TE-TC) or gyrase (GB-GA).
1.3 Bacterial DNA Topoisomerases
The normal biological function of DNA and processes related to this molecule - RNA
transcription and DNA replication - will not occur, happen very slowly, or will be aberrant if the
DNA lacks the proper super-helical tension. A geometric property of the DNA is that the
number of times one strand wraps around the other cannot be altered without first cleaving at
least one of its polynucleotides. Topoisomerases (classified in type I and II) have a remarkable
role of changing the topological state of circular DNA by introducing DNA breaks and re-
sealing them without changing its covalent structure, thus keeping the molecule accessible
but in correct shape (Sissi and Palumbo, 2010).
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Type I topoisomerases play an important role in creating transient single strand breaks
in DNA and are further classified in type IA and type IB topoisomerases based on their amino
acid sequences and catalytic mechanism. They are in charge of catalyzing the relaxation of
supercoils in DNA by single turns until the supercoil is entirely relaxed. Type IA
topoisomerases are present in all living cells and relax only negatively supercoiled DNA,
reversibly catenate two single-stranded circles or unwinds duplex DNA by one turn.
Conversely, type IB topoisomerases are present in many prokaryotes but not in E. coli, and
eukaryotes. They can relax both negatively and positively coiled DNA. As of this writing, there
have been no previous reports of toxins from TA modules affecting type I topoisomerases in
bacteria.
In contrast, they are several reports about toxins type II that target type II
topoisomerases (Figure XI) (Barbosa et al., 2012; Bernard and Couturier, 1992; Fiebig et al.,
2010; Gupta et al., 2016; Hallez et al., 2010; Harms et al., 2015; Jiang et al., 2002). Type II
topoisomerases, are complex enzymes that act by transiently cutting both strands of a duplex,
passing the duplex through the break and resealing it. The main representatives are the
gyrase and topoisomerase IV. They help to remove the torsion in the DNA and remove positive
supercoils ahead of the DNA polymerase.
While eukaryotic type II topoisomerases are single subunit enzymes that are active as
homodimers, prokaryotic topoisomerases type II are composed by two subunits. DNA gyrase
is a hetero-tetramer of approximately 375 kD A2B2, where the subunit GyrA wraps the DNA
and GyrB is in charge of ATP hydrolysis. Importantly, gyrase catalyzes the stepwise negative
supercoiling of DNA with the concomitant hydrolysis of an ATP molecule to ADP + P. Gyrase
prepares the negatively supercoiled template for DnaA to initiate replication. Another function
of gyrase is to remove the positive supercoils that form ahead of the growing fork during
elongation of the growing strands. It can also catenate and decatenate double-stranded circles
as well as tie knots in them, while the topoisomerase I antagonizes the action of the DNA
gyrase. In addition, the gyrase can complement the function of the topoisomerase IV but the
topo IV cannot complement the activity of Gyrase. The gyrase is therefore vital, important
during initiation elongation and termination of the DNA replication, chromosome segregation,
DNA decatenation prior to cellular division (Sissi and Palumbo, 2010).
Topoisomerase IV (Topo IV ) is also a hetero-tetramer composed of two molecules
topo C (ParC) that share a 46% sequence homology to GyrA and contains the active site
tyrosine residue and topo E (ParE), that is 40% similar to gyrB and contains the ATPase
Introduction
25
domain. Despite the strong sequence similarity between gyrase and topo IV, the C-termini of
the A subunits are not well conserved. This domain of the protein is involved in topology
recognition and allows gyrase, but not topo IV, to generate supercoils in DNA. Topo IV activity
is important in chromosome partitioning, decatenation and relaxation of DNA, it decatenates
during replication more than the gyrase and therefore plays an important role in passive
separation of the chromosomes during cell elongation. Topo IV might be associated with the
replication complex (DnaE) and is a membrane-associated enzyme (Sissi and Palumbo,
2010).
Topoisomerases type II can be inhibited by a variety of substances such as novocin
(NOV) and quinolones such as ciprofloxacin (CPX). NOV associates with GyrB thereby
inhibiting the enzyme, whereas CPX associates with GyrA and poisons the enzyme (Aldred
et al., 2014). Thus, bacterial NOV treatment results in the arrest of DNA replication and RNA
transcription, while CPX treatment enhances the rate at which gyrase cleaves double stranded
DNA and reduces the rate at which it reseals these breaks. Upon gyrase poisoning, there are
higher level of transient protein-bridges breaks in the DNA that are easily ruptured by the
passage of the replication machinery, thereby rendering the breaks permanent. Although all
cells possess, extensive enzymatic machinery to repair damaged DNA, a high level of DNA
damage can result in cell death (Aldred et al., 2014). Interestingly, one of the quinolones
target-mediated resistance is cause by specific mutations that weaken the interactions
between quinolones and these enzymes, highlighting the importance of finding new drugs.
1.4 Streptococcus pyogenes
Group A Streptococcus (GAS; Streptococcus pyogenes) is a non-motile bacterium that
grows in chains and belongs to the Firmicutes phylum, the Bacilli class and the Lactobacillales
order. S. pyogenes colonizes the oropharynx, epithelium, skin of humans and causes a wide
spectrum of diseases worldwide (Cunningham, 2000). Although GAS is a frequent agent of
mild infections like pharyngitis and uncomplicated impetigo infections, penetration of GAS into
deeper tissues can lead to devastating invasive infections, such as necrotising fascilitis,
myonecrosis or “flesh-eating” syndrome or lead to severe systemic complications such as,
sepsis or streptococcal toxic shock syndrome (STSS), as well as sequelae of rheumatic fever
and acute poststreptococcal glomerunophritis (Stevens et al., 2014; Tsatsaronis et al., 2014;
Walker et al., 2014).
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The complex surface of S. pyogenes includes conventional globular proteins,
polysaccharides and the M protein, which has specifically evolved to enable survival in
different host tissues (Cunningham, 2000). The M protein, in particular, has developed to allow
this bacterium to persist while avoiding the human immune response, specifically
phagocytosis. Thus, the M protein is considered the archetypical surface molecule. At the
moment of this writing there are more than 200 different serotypes based on the M protein,
one of the most studied streptococcal proteins (Lancefield, 1962). S. pyogenes also harbors
a pili structure that plays important roles during pathogenesis by mediating bacterial adhesion
to host tissues and biofilm formation (Bessen and Kalia, 2002; Mora et al., 2005). The capsule
is produced by most of the group A streptococci, and also plays an important role for
pathogenicity. It is associated with the cell surface during exponential growth and shed during
stationary phase and is mainly composed of hyaluronic acid (linear polymer of N-
acetylgrucosamine and glucuronic acid)(Wilson, 1959).
Among the virulence related transcriptional regulators, S. pyogenes harbors 13 two-
component regulatory systems and at least 30 transcriptional regulators known. The most
important master regulators are CovR/S (Gryllos et al., 2003) and RofA-like proteins  (RALPs)
that control the activity of multiple virulence regulators (Granok et al., 2000). Some other
regulators are relevant for sensing environmental conditions and response to stress e.g.
CcpA, Mga that response to carbohydrates (Deutscher et al., 2006) or Rsh, CodY that
response to different nitrogen sources (Steiner and Malke, 2001). Regulators such as VicR/S,
MtsR, CiaH/R influences the expression of metabolism-related genes. Moreover, PerR is also
an important regulator that response to oxidative stress, Rgg2/3 is involved in quorum sensing,
and SalK/R response to environmental signals from the host (Le Breton et al., 2015).
S. pyogenes has also a wide variety of extracellular virulence factors which include:
streptokinase, proteinases, esterases, DNAase, CAMP factor, hyaluronidases, complement
inhibitor, superoxide dismutase, immunoglobulin degrading enzymes, and the hemolysins
SLO and SLS (reviewed by Ferretti et al, 2016). All these secreted factors provide to S.
pyogenes different abilities to cope with the host response and can vary between different
serotype. Interestingly, some of the most studied are SLO and NADase that can destroy cell
tissues, red blood and immune cells, SLS lyses a variety of host cell types and SpeB that
degrades tissues and immune response molecules. Importantly, Ska converts host
plasminogen into plasmid and SodA converts oxygen radical into hydrogen peroxide. All of
these virulent factors among many others, make GAS an efficient  pathogen (reviewed by
Hynes and Sloan, 2016).
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While the mechanism by which GAS evades elements of the innate immune response
have been the focus of extensive research, less attention has been paid to the molecular
mechanisms that facilitate its remarkable ability to persist. Certain conditions might lead to
asymptomatic carriage of GAS causing common recurrent episodes of pharyngitis (Osterlund
and Engstrand, 1997). There are a few reports about S. pyogenes antibiotic tolerant cells, an
in vitro study has reproduce a persistent behavior (Wood et al., 2005), but the basis of this
phenotype is not yet elucidated.
Finally, the TA type II module ω- ε -ζ encoded in the streptococcal plasmid pSM19035
is the only reported TA system in our model organism (Zielenkiewicz et al., 2009), and its
implications in virulence have not been described. Nevertheless, bioinformatic predictions
have revealed the presence of four hypothetical type II TA copies within the chromosome of
S. pyogenes, which are still uncharacterized (Figure XII).
Figure XII: Type II TA copies predicted within the chromosome of S. pyogenes M1 GAS
TA type II systems predicted by TADB (Y. Xie et al., 2018). The purple circle represents the bacterial
chromosome. In blue the predicted antitoxins and in red the predicted toxins. Grey and green genes
represent hypothetical ORFs non-predicted as TA elements. 4 genes compose the hypothetical Xre-
Bro TA system: SPy_2126, SPy_2127, SPy_2128 and SPy_2129. Two genes typically compose the
putative MazEF TA system: SPy_0938, SPy_0939. Two hypothetical RelBE/ParDE-like TA systems
are predicted, the first one composed by three genes SPy_0550, SPy_0552 and SPy_0553 and the
second one compose by two genes: SPy_1926 and SPy_2127.
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1.5 AIMS OF THE STUDY
Four type II TA systems are predicted to occur in the chromosome of the human pathogen
S. pyogenes and two of these loci are putative ParDE-like TA modules (Xie et al., 2018). The
ParDE-like TA family was first described as an addiction molecule within the RK2 plasmid,
playing a role in PSK. Chromosomal ParDE-like TA systems have been predicted in several
bacterial genomes (Sevin and Barloy-Hubler, 2007; Xie et al., 2018), but are poorly studied or
not completely characterized. In Caulobacter crescentus, a set of four functional parDE
modules were reported, which are differentially expressed under certain stress conditions
(Fiebig et al., 2010). E. coli 0157:H7 encodes for a typical ParDE TA system as well as two
tripartite homologs for which the physiological role is currently unknown (Hallez et al., 2010),
and three ParDE homologs in the Vibrio cholerae superintegron were reported to be required
for the inheritance of chromosome II (Yuan et al., 2011). Moreover, in Mycobacterium
tuberculosis H37Rv two bacteriostatic ParDE-like copies were reported to be expressed upon
oxidative stress (Gupta et al., 2016; Ramage et al., 2009). All ParE-like toxins described in
Gram-negative bacteria and M. tuberculosis are known to influence DNA replication, stability
and maintenance by targeting the gyrase. Interestingly, ParDE-like TA systems located on the
chromosome of Firmicutes have not been characterized.
Characterization of hypothetical genes helps us to understand the mechanism that
pathogens use to endure diverse conditions within the host and cause diseases. In this work,
I used the Firmicute S. pyogenes as a model organism to shed light on the features that render
two chromosomally encoded ParDE-like TA systems functional and relevant for this human
pathogen. In this context, I specifically aimed to:
1) Functionally validate the putative ParDE-like TA systems.
2) Characterize the ParE-like toxin molecular target.
3) Elucidate the role of these ParDE-like modules in S. pyogenes.
4) Investigate their regulatory mechanism.
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2 MATERIALS AND METHODS
2.1 Bioinformatic and statistical analysis
The genome of S. pyogenes M1 GAS NC_002737.2 (Ferretti et al., 2001) was used as
a reference of our study (SPy_0550: parD1, SPy_0552: parE1, SPy_0553: parF1, SPy_1926:
parD1, SPy_1927: parE1). To determine the subfamily of the predicted ParE-like toxins or
ParD-like antitoxins, non-redundant ParE/RelE or PhD, RelB, PaaA and ParD proteins were
retrieved from the TADB database (Xie et al., 2018) and global alignments were computed
using Mafft V.7 with default parameters (Katoh et al., 2002). Principal component analysis
based on protein sequence similarity was performed in Jalview V2.8 (Waterhouse et al., 2009)
using the substitution matrix BLOSUM62. Phylogenetic analysis was inferred by the GGDC
web server (Meier-Kolthoff et al., 2013) available at http://ggdc.dsmz.de/. A multiple sequence
alignment was created with MUSCLE (Edgar, 2004). Maximum likelihood (ML) and maximum
parsimony (MP) trees were inferred from the alignment with RAxML (Stamatakis, 2014) with
a 1000 bootstrapping replicates.
The TA conservation and synteny among the distinct S. pyogenes M serotypes was
performed with SyntTax web tool (Oberto, 2013) using the ParE-like nucleotide sequence as
a reference to map the locus of interest and further analyzing a 15 Kb genomic window. The
genomic percentage of guanine/cytosine content (GC%) was calculated in R package
Biostrings.  The identification of the parDEF1 transcription start site (TSS) and confirmation of
operon architecture was assessed using previously published RNAseq data from our model
organism (Le Rhun et al., 2017), the operon image was captured from Integrative Genomics
Viewer (Robinson et al., 2011; Thorvaldsdottir et al., 2013) and the Rho-independent
terminator (TransTermHP v2.07) prediction was downloaded from
http://transterm.cbcb.umd.edu/tt/Streptococcus_pyogenes_M1_GAS.tt.
Protein sequences were analyzed in Pfam (Finn et al., 2016) and secondary structure
predictions were performed using SWISS-MODEL (Waterhouse et al., 2018) and Phyres2
(Kelley et al., 2015) websites tools. Protein alignments and oligonucleotide design were
performed in Geneious 10.2.6 software (https://www.geneious.com). Statistical analyses were
performed using R v3.5.1 (2018-07-02). For all experiments at least 3 biological replicates
were done each with 3 technical replicates. For T tests, p values < 0.05 were considered as
significant.
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2.2 Bacterial strains and growth conditions
Bacterial strains and - restriction or Gibson mediated cloned - vectors and their usages
are listed in Table 2 in the appendix. E. coli MG1655 was used for growth rescue and killing
assays and E. coli TOP 10 was used for cloning. E. coli strains were grown under standard
conditions (37°C, 180 rpm) in LB media (Becton Dickinson) supplemented with antibiotics if
required at the following concentrations: 50 μg ml-1 kanamycin (Sigma-Aldrich), 30 μg ml-1
chloramphenicol (Sigma-Aldrich) or 100 μg ml-1 carbenicillin (Roth). Heat-shock competent
cells (0.1 M CaCl2 method) were used for transforming vectors following standard procedures
(Sambrook and Russell, 2001).
S. pyogenes SF370 (M1 GAS) and isogenic derivatives (Table 2) were cultivated at
37°C, 5 % CO2, without shaking in THY medium (Todd Hewitt Broth THB, Bacto, Becton
Dickinson) supplemented with 0.2% yeast extract (Servabacter) and TSA (tryticase soy agar,
BD Difco) supplemented with 3% sheep blood (defibrinated; Oxoid). Antibiotics were added
when required at the following concentrations: 300 μg ml-1 kanamycin (Sigma-Aldrich), 3 μg
ml-1 erythromycin (Sigma-Aldrich) or 100 μg ml-1 spectinomycin (Sigma-Aldrich).  Pre-cultures
were always diluted 1:100 in fresh THY medium and grown at 37°C, 5% CO2 until mid-
exponential phase at OD620nm 0.25 (plate reader; BioTekTM Cytation 3) or OD620nm 0.6 (cuvette
reader Eppendorf BioSpectrometer® basic) for the antitoxin stability assays, or until early
logarithmic phase at OD620nm 0.1 (plate reader; BioTekTM Cytation 3) or OD620nm 0.4 (cuvette
reader Eppendorf BioSpectrometer® basic) for the stress response experiments.
S. pyogenes electrocompetent cells were prepared following the ice-cold method
(Caparon and Scott, 1991). Briefly, the cells were grown in THY medium until mid-exponential
phase of growth (OD620nm 0.25; plate reader BioTekTM Cytation 3). The cells were washed
twice with ice-cold water and suspended in 20% glycerol and kept at –80 °C or immediately
used. Transformation of S. pyogenes was performed as previously described (Caparon and
Scott, 1991) by electroporation (1.8 kV, 25 μF and 400 Ω; Gene Pulse Xcell Biorad), followed
by a recovery step in 3 ml of THY pre-warm media incubating for 3 hours at 37°C, 5% CO2
before spreading on the appropriate selection TSA blood plates.
2.3 DNA and RNA manipulation
S. pyogenes SF370 (M1 GAS) (NC_002737.1; Ferretti et al., 2001) was used as a
reference for oligo design. Vectors and oligonucleotide primers (Sigma-Aldrich and Biomers)
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used in this study are listed in the Table 2 and Table 3 respectively. Plasmid extraction
(QIAprep Spin MiniPrep Kit), polymerase chain reaction (PCR) (Phusion High-Fidelity DNA
Polymerase, and Q5® High-Fidelity DNA Polymerase, New England Biolabs), DNA digestion
(fast digest restriction enzymes, Fermentas), DNA ligation (T4 DNA ligase, Fermentas), DNA
purification (QIAquick PCR and gel Purification Kit, Qiagen) were done according to the
standard techniques (Sambrook and Russell, 2001). For cloning PCR fragments into vectors
two strategies were used: restriction (Fastdigest restriction enzymes; Thermo Scientific) and
ligation (T4 DNA ligase, Thermo Scientific) mediated cloning for pBAD33Para, pZE12Plac,
pUC19 and pEC85Ptet plasmids, and Gibson mediated cloning for pAH160Prha and pEC85Ptet
(refer to appendix Table 3).
RNA extractions were performed following protocols pre-set by our lab (Fonfara et al.,
2014); a minimum of 20 ml of growing bacterial were mixed with an equal volume of ice-cold
acetone/ethanol (1:1) solution and harvested (1500 x g, 4°C, 10 minutes) for RNA extraction
using TRIzol (Life Technologies)/chloroform (Sigma-Aldrich) and precipitated with isopropanol
(Sigma-Aldrich). RNA concentrations were measured (NanoDrop, Thermo Scientific) and
RNA integrity was determined by electrophoresis in agarose gel (1.8% agarose in 1X TBE
(Tris-borate-EDTA pH 8) and ethidium bromide (Merck) staining. S. pyogenes DNA
extractions were performed from exponentially growing cells (OD620nm 0.25; plate reader
BioTekTM Cytation 3) following the instructions from the kit (NucleoSpin® Microbial DNA;
Macherey-Nagel).
The DNA from Escherichia coli Serotype O157:H7 (Migula 1895); was obtained from
the DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, DSM No:
17076). The DNA from Mycobacterium tuberculosis was share by Prof. Kaufman laboratory
at the Max Planck Institute for Infection Biology. Vectors harboring the Vibrio cholearae and
Vibrio fischeri TA systems were share by the Prof. Waldor laboratory at the Brigham and
Women’s Hospital- Boston MA (Yuan et al., 2010).
2.4 S. pyogenes methods
2.4.1 Construction of S. pyogenes mutants
Chromosomal deletion of the complete parDE1 and parDE2 TA operons, the clpP
peptidase, clpX, clpE and clpC ATPase were generated using the Cre-Lox system (Lambert
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et al., 2007). Oligonucleotides were designed to delete the complete genes except for clpX
(Δ60-1161bp) where 60 bp were maintained at the beginning of the ORF to avoid polar effects,
and ensure translation of the second gene yihA in frame.
Around 1 Kb of the upstream and downstream regions of each gene of interest were
PCR amplified from the wild type genomic DNA using primers described in Table 2. The
fragments were then PCR ligated (LongAmp Taq DNA-polymerase; NEB) with the lox71-
ermAM/B-lox66 PCR fragment (amplified from the plasmid pEC454). The resulting 3 Kb
fragments were gel purified (QIAGEN Gel Extraction Kit) and cloned either by restriction-
ligation into pUC19 (suicide vector for S. pyogenes) or by poly A mediated ligation into TOPO
XL PCR cloning vector (Thermo Fisher), following the manufacturers instructions. Plasmid
preparations were performed according to manufacturer’s protocols (Plasmid Miniprep Kit
QUIAGEN), and vectors were linearized using NcoI (Thermo Fisher) restriction enzyme that
cleaves the kanamycin resistance cassette in the vector. The gel purified linear plasmids (up
to 1 μg) were transformed into freshly prepared S. pyogenes electro-competent cells and after
the recovering time (3ml THY, 37°C, 5% CO2) the cells were spread on TSA blood plates
supplemented with 3 μg ml-1 erythromycin.
Erythromycin-resistant growing clones were collected and genomic DNA was extracted
following the instructions from the kit (NucleoSpin® Microbial DNA; Macherey-Nagel) to
perform PCRs and DNA sequencing (Microsynth, Switzerland) of the region of interest in order
to confirm the insertion of the fragments in the correct position (SEQ mutant or
Upstream/Downstream oligonucleotides Table 3 Mutants construction). Positives clones were
transformed with pEC455 encoding the Cre recombinase (Laboratory collection) to remove
the DNA between the lox sites (replaced with a lox72 site). Moreover, blue colonies were
selected in TSA blood supplemented with 80 μg ml-1 XGal (5-Brom-4-chlor-3-indoxyl-β-D-
galactopyranosid; Sigma-Aldrich) and 300 μg ml-1 kanamycin. Kanamycin-resistant and
erythromycin-sensitive mutants should have excised the DNA between the two lox sites and
have replaced the cassette with the lox72 site. Finally, mutants were grown in TSA medium
without antibiotics until they lost the pEC455 plasmid. The integrity of the generated mutant
strains was confirmed by PCR and DNA sequencing (Microsynth, Switzerland) (SEQ mutant
or Upstream/Downstream oligonucleotides Table 3 Mutants construction).
Materials and Methods
33
2.4.2 Growth curves and biofilm formation
Overnight cultures of S. pyogenes wild type, ΔparDE1 and ΔparDE2 mutant
backgrounds were used (1/100) to inoculate 50ml of fresh THY media to follow growth.
Samples were taken 60, 120, 180,140, 300 and 360 minutes after inoculation, serial diluted
((10-1 to 10-6), spotted on TSA blood plates and incubated overnight (37°C, 5% CO2). 4
biological replicates each with 3 technical replicates were considered to plot the log10 CFU ml-
1 versus the time course.
To perform the biofilm formation assays, overnight cultures were normalized to OD620nm
0.2 (plate reader BioTekTM Cytation 3), and 1.5 ml of each sample was inoculated in triplicates
in a 24 well plate for cell culture (Tissue culture 24-well plate (Flat bottom) for adherent cells;
Hain life science). After 24 hours of incubation at 25°C or 37°C (5% CO2), the media was
gently removed by flipping the plate upside down on a disposal container followed by three
washing steps with distilled water (gently addition and removal with a plastic 25 ml pipette).
The plates were kept under the hood for 30 minutes to dry and then 200 μl of 0.2% Crystal
violet (C.I. 42555; Roth) was added per well and the plates were incubated for 10 minutes at
room temperature. The Crystal violet was gently removed in a disposal container and plates
were washed three times as described before and air-dried out for 10 minutes. To elute the
biofilm Crystal violet- stained 1 ml of 1% SDS (sodium dodecyl sulfate; Applichem) solution
was used and transferred into a plastic cuvette to measure the absorbance at OD540nm (cuvette
reader Eppendorf BioSpectrometer® basic).
2.4.3 S. pyogenes stress induction, survival measurement
S. pyogenes growing cultures in THY (500 ml) were divided in early-logarithmic phase
(OD620nm 0.1, plate reader  BioTekTM Cytation 3 measured) into 5 different flasks, 100 ml of the
culture was used as a control and 100 ml was treated independently with each of the stress
inductors: 4 mM H2O2, 1.25 M NaCl, 3 μg ml-1 mitomycin or 8% ethanol (10% ethanol when
stated). Cell growth was monitored at OD620nm and samples were serial diluted and spotted in
TSA blood plates to register the CFU ml-1. Samples were taken (20 ml) at time zero, 5, 15, 30,
45 and 60 minutes upon ethanol treatment, and at zero, 10, 20 and 30 minutes upon SHX
treatment (DL-Serine hydroxamate; Sigma-Aldrich) to induce amino acid starvation, mixed
with an equal volume of ice-cold acetone/ethanol (1:1) solution and harvested (1500 x g, 4°C,
10 minutes) for RNA extraction (as described in the section 2.3 DNA and RNA manipulation).
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2.4.4 Killing assay in S. pyogenes
S. pyogenes was transformed with the low copy empty vector pEC85 (control) or
pEC85Ptet harboring the either parE1, parD1, parD1-parF1, parE2, parD2 or parD2-parE2
genes under the control of the anhydrotetracycline (AHT) promoter (Ptet from Bugrysheva and
Scott, 2010). Single colonies were used to start overnight cultures in 3 ml of THY medium
supplemented with 300 μg ml-1 kanamycin. The day after the optical density at OD620nm was
normalized to 0.2 (plate reader BioTekTM Cytation 3 measured) and serial dilutions were
prepared (10-1 to 10-6) and spotted on TSA media plates supplemented with 3% sheep blood,
300 μg ml-1 kanamycin without inductor (control conditions) or with 50 μg ml-1 of AHT to
induced the toxin expression (experimental conditions). After 16 hours of incubation, the
grown plates were scanned (CanoScan LiDE 700F).
To evaluate the toxicity of ParE2* L48A (start codon ATG versus TTG variants) OD-
standardized overnight pre-inoculums (1/100) were used to inoculate 3 ml of THY fresh media
with two different concentrations of the inductor (either 25 μg ml-1 or 50 μg ml-1 AHT) to
evaluate growth after 16h of incubation under the same conditions. Finally, to prepare samples
for phenotypic analysis by microscopy (refer to methods below), 50 ml of cultures were
inoculated as described above with 25 μg ml-1 AHT and samples were collected at mid
exponential growth phase (OD620nm 0.25; plate reader BioTekTM Cytation 3).
2.4.5 Antitoxin stability and western blot experiments
S. pyogenes wild type, ΔclpP, ΔclpX, ΔclpC and ΔclpE mutant strains were
transformed with the pEC85Ptet empty vector or harboring either the N-terminal FLAG-tagged
parD1 (pEC1487: pEC85PtetΩN-FLAGtaqSPy_ParD1) or the N-terminal FLAG-tagged parD2
(pEC1488: pEC85PtetΩN-FLAGtaqSPy_ParD2) gene under the control of the Ptet promoter.
Overnight cultures (1/100 dilution) were sub-cultured in fresh THY medium supplemented with
300 μg ml-1 kanamycin and 25 μg ml-1 of the inductor AHT. At exponential growth phase
(OD620nm 0.6, cuvette reader Eppendorf BioSpectrometer® basic, t = 0) translation was
inhibited by adding 100 μg ml-1 spectinomycin and 15 ml of each sample was collected every
20 minutes for 2 hours. After centrifugation (4000 rpm, 4°C, 10 minutes) pellets were washed
twice with 1X PBS pH 7.4 and lysed by bead beating with 0.1 mm glass beads (BioSpec) in a
FastPrep instruments (MP Biomedicals™ FastPrep-24™ 5G) using 500 µl of disruption buffer
(50 mM Tris-HCl pH 7.5, 10 mM EDTA, 150 mM NaCl, 0.1% Triton X-100) to extract
cytoplasmic proteins. The suspension was then centrifuged (21000 x g, 4°C, 10 minutes), the
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supernatant was collected and total protein concentration was determined using the Bradford
method. Normalized protein samples at 10 μg were separated on a 15% SDS-PAGE gel
(sodium dodecyl sulphate – polyacrylamide gel electrophoresis; 180 V for 1 hour) blotted via
wet transfer (at 60 V for 1 hour in transfer buffer, 39 mM glycine, 48 mM Tris, 0.037% SDS
and 20% methanol) on a Nitrocellulose membrane (Protran BA83, pore size 0,2µm,
30x300cm; GE Healthcare) for western blot (WB) analysis. Membrane blocking was
performed by incubating overnight at 4°C in 5% Skim Milk (Sigma) in 1X TBST (TBST 10X:
100 mM Tris, 1.5 M NaCl, 0.5% Tween 20), pH 8). After the incubation time the membrane
was incubated for at least 1 hour at 4°C with mouse monoclonal ANTI-FLAG® M2 antibody
(1/5000 dilution) in 1X TBST 5% Skim Milk (Sigma-Aldrich Chemie GmbH), then washed 3
times for 5 minutes in the same buffer and incubated with the anti-mouse (ECL Mouse IgG,
HRP-Linked Whole Ab from sheep; GE Healthcare, 1/10000) in 1X TBST for 1 hour at 4°C.
The HtrA-protein (Rabbit Polyclonal, 1/1000 dilution; secondary antibody Amersham ECL
Rabbit IgG, HRP-linked whole Ab from donkey; GE Healthcare, 1/10000) was used as loading
control measured on the same membrane (antibody provided by Prof. Jeffrey Weiser; New
York University School of Medicine). The WB was developed (Clarity Western ECL Substrate;
Bio-Rad) and signals were registered in the Molecular Imager Gel-Doc system (Bio-rad) and
analyzed in ImageJ (Schneider et al., 2012).
2.4.6 Antitoxin pull-down experiments
Exponentially growing S. pyogenes cells harboring either the N-terminal FLAG-tagged
parD1 (pEC1487: pEC85PtetΩN-FLAGtaqSPy_ParD1) or the N-terminal FLAG-tagged parD2
(pEC1488: pEC85PtetΩN-FLAGtaqSPy_ParD2) gene under the control of the Ptet promoter
were grown and induced as described for the antitoxin stability experiments. A total of 50 ml
of culture was collected on ice, centrifuge (4000 rpm, 4°C for 10 minutes) and lysed using 800
µl of disruption buffer (50 mM Tris-HCl pH 7.5, 10 mM EDTA, 150 mM NaCl, 0.1% Triton X-
100) and prepared as described above (section 2.4.5 antitoxin stability experiments). The
antitoxin pull-down was performed while incubating the samples at 4°C with gently rotation
the total protein extract with the ANTI-FLAG M1 agarose affinity gel following the
manufactures instructions (Sigma Aldrich) overnight. After 3 washing steps with 0.5 ml of TBS
(Tris-buffered saline: 150 mM NaCl, 50 mM Tris-HCl, pH 7.6; 8200 x g for 30 seconds each),
the elution was performed by mixing the samples with SDS-page loading dye without β–
mercaptoethanol and boiled at 95°C for 15 minutes. Samples were then centrifuged (8200 x
g, 30 seconds, 4°C) and the supernatant was resolved on a 15% SDS-PAGE gel (sodium
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dodecyl sulfate – polyacrylamide gel electrophoresis) and visualized with Coomassie Brilliant
Blue (Sigma-Aldrich) staining and imaged using CanoScan LiDE 700F. Different fractions
were gel-extracted and sent for mass spectrometry analysis (see below).
2.5 RNA assays
2.5.1 RT-PCR analysis
For quantitative RT-PCR (qRT-PCR), a total of 100 ng μl-1 of each RNA sample was
treated twice with DNase I at 37°C for 1 hour following the manufacturer protocols (1 unit/µl,
RNase-free, Thermo Fisher). DNA-free RNA samples were measured (NanoDrop, Thermo
Scientific) and normalized to 50 ng μl-1 to perform retro-transcription following the
manufacturer instructions (High-Capacity cDNA Reverse Transcription Kit; Applied
Biosystems). To test the operon architecture, PCRs were performed using DNA copy (cDNA)
as a template and the oligonucleotides listed in Table 3.  PCR samples were separated in a
1.5% agarose gel (1X TBE) and bands were visualized by staining with ethidium bromide,
imaged with a Molecular Imager Gel-Doc system (Bio-Rad) and analyzed in Image Lab (Bio-
Rad).
qRT-PCRs to assess the level of mRNA transcripts were performed by monitoring the
cDNA amplification rate by real time PCR (SensiFAST™ SYBR® No-ROX Kit, Bioline),
targeting the genes of interest using the oligos listed in Table 3, in a Lightcycler 480
instruments (Roche). The crossing point values (CP) were analyzed relative to the CPs
obtained with the housekeeping gene tufA, using the Pfaffl formula (Pfaffl, 2001) and the log10
relative fold change was plotted versus the time. At least three biological replicates were
considered in the analysis.
2.5.2 Polyacrylamide Northern blots analysis
The qRT-PCR results were confirmed by polyacrylamide Northern blot analysis
following standard protocols as described in (Fonfara et al., 2014). Briefly, a total of 15 μg of
RNA per sample was separated on a 5% polyacrylamide gels (Tris-base buffer containing 8M
urea) at 100 V for 90 minutes and transferred onto a nylon membranes (HybrondTM N+, GE
healthcare; Trans-Blot SD semi-dry transfer apparatus, Biorad; 1X TBE, 90 minutes, 20 V),
followed by crosslinking using EDC ((1-Ethyl-3-3-dimethylaminopropyl) carbodiimide
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hydrochloride; Sigma-Aldrich) (Pall and Hamilton, 2008) at 60 °C for 1 hour, and pre-
hybridization using Rapid-hyb buffer (GE healthcare), 1 h at 42°C, in glass tubes. Probes (40
pmol) listed in Table 3 targeting the parE1 or parE2 mRNA transcript and the 16S rRNA as
loading control (Table 3) were radioactively labeled with gamma-32P ATP (0.75 MBq;
Hartmann Analytics) using T4 Polynucleotide Kinase (T4-PNK, Fermentas) and purified over
G-25 columns following the manufactures protocols (GE Healthcare) as previously described
in (Le Rhun et al., 2016). The hybridization in Rapid-hyb buffer with the purified
32
P labeled
probes was performed over night at 42°C. After the incubation time, membranes were washed
with 5x SSC, 0.1 % SDS and 1x SSC, 0.1 % SDS (20 X SSC; NaCl 350.6 g, sodium citrate
177.4 g, ddH2O water for 2 L, pH 7) for 15 minutes each and the exposure was performed for
1 week (phosphorimager screen). Visualization of the radioactive signal was possible using
FLA-9000 (Fujifilm) and pictures were analyzed using ImageJ software.
2.6 In vitro topoisomerase assays
In vitro translation was performed to produce and purify the ParE-like proteins of
interest following the manufacturer instructions (PURExpress® In Vitro Protein Synthesis Kit,
NEB), using PCR products as templates (100ng μl-1each) that included the T7 promoter and
T7 terminator (Table 3). In vitro topoisomerase assays were performed with recombinant DNA
gyrase and topo IV from E. coli (TopoGEN) or S. pneumoniae (Inspiralis) following the
manufacturer instructions. In brief, relaxed plasmid DNA (provided in the kits) was used as a
substrate to assess the gyrase supercoiling activity, while supercoiled DNA and kDNA
(TopoGEN or Inspiralis) were used as substrates to test the topo IV relaxation and
decatenation activities. The antibiotics Ciprofloxacin (5 µg ml-1) and Novobiocin (5 µg ml-1)
were used as positive controls. Upon 1 hour of incubation at 37°C the reactions were
quenched by adding 2% of SDS and 1 mg ml-1 of proteinase K followed by 30 minutes of
incubation at 37°C. Chloroform: isoamyl alcohol (24:1) organic extractions were done for the
relaxation and supercoiling assays. Topoisomers were analyzed by electrophoresis (50 V for
3 hours) in 1% agarose gels and visualized by ethidium bromide staining. Images were
acquired with a Molecular Imager Gel-Doc system (Bio-Rad) and analyzed in the Image Lab
software (Bio-Rad).
2.7 Experiments involving E. coli as host
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2.7.1 Killing assay
The effect of the different ParE proteins on bacterial viability was investigated in E. coli
MG1655 using the low copy plasmid pBAD33Para harboring each of the ParE-like toxins under
the control of the arabinose promoter (Para). An additionally strategy was applied for depleting
the toxin expression to allow successful cloning by decreasing the distance between the
Shine-Dalgarno sequence and the start codon to 6nt (Ringquist et al., 1992a), maintaining the
same ribosome binding side sequence for all toxins tested (Table 2). Cells harboring the toxins
were grown taking 1/100 dilution of an overnight culture in LB media supplemented with 30 μg
ml-1 chloramphenicol. Exponentially growing cultures (OD600nm 0.5, cuvette reader Eppendorf
BioSpectrometer® basic, t = 0) were divided in two; one half was treated with glucose 0.2%
(control conditions), while the toxin was induced in the second half by adding 0.2% of
arabinose (experimental conditions). Samples were taken every 30 minutes for two hours to
perform serial dilutions (10-1 to 10-6) and which were spotted on LB agar plates supplemented
with 30 μg ml-1 chloramphenicol and 1% glucose for CFU ml-1 counting.
The effect of ParD1 or ParD1-ParF1 on bacterial viability was investigated by cloning
either the parD1 gene alone or together with parF1 in the high copy plasmid pAH160Prha,
under the control of the rhamnose promoter (Prha), provided by Prof. Dr. Christoph Dehio
(Harms et al., 2015). The experiments were performed by growing the cells in LB media
supplemented with 50 μg ml-1 kanamycin. Exponentially growing cultures (OD600nm 0.5, cuvette
reader Eppendorf BioSpectrometer® basic, t = 0) were divided in two; one half was treated
with glucose 0.2% (control conditions), while the toxin was induced in the second half by
adding 0.2% of rhamnose (experimental conditions). Samples were collected, prepared and
spotted on LB agar plates supplemented with 50 μg ml-1 kanamycin and 1% glucose for CFU
ml-1 counting. The parD1 titration of expression was performed by growing the cells in a bigger
amount of LB media and dividing the exponentially growing culture into 6 different flasks. One
flask served as a control and the others were treated independently with different
concentrations of rhamnose (0.001, 0.005, 0.01, 0.05 and 0.2%). To assess the viability,
samples were taken, diluted and spotted following the same protocol described above.
2.7.2 SOS response
The E. coli MG1655 AT15 strain (λatt::PsulA-gfp) was used to evaluate the SOS-
response where the promoter of the gene sulA has been fused to the GFP-encoding gene
(McCool et al., 2004). Cells were transformed with the empty pBAD33Para vector or harboring
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each of the ParE-like toxins or the pAH160Prha empty vector or harboring the parD1 or parD1-
parF1 and experiments were performed as described for the killing assays. After 2 hours of
expression 1 ml of each culture was washed twice and suspended in 1X PBS; then 200 μl
were placed in a 96 well plate (microplates, 96 well, clear, flat bottom with lid; Sarstedt) and
the GFP signal was measured (Cytation3, BioTek Instriments Inc; Excitation: 475, Emission:
509, Optics: Bottom, Gain: 70). The data was normalized to the OD600nm measurements.
2.7.3 Death prevention experiments
The capacity of the antitoxin to prevent the toxic effect was performed in E. coli MG1655
using a two plasmids system. For the characterization of the parDEF1 locus the toxin was
cloned in the pBAD33Para as previously stated for the killing assays and the antitoxin parD1
or the hypothetical gene parF1 in the low copy vector pZE12Plac under the control of the
isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible promoter. An overnight culture (1/100
dilution) was use to inoculate 100ml of LB media supplemented with 30 μg ml-1
chloramphenicol and 100 μg ml-1 carbenicillin. Exponentially growing cultures (OD600nm 0.5,
cuvette reader Eppendorf BioSpectrometer® basic, t = 0) were divided in two: half of the
culture was supplemented with 0.2 % arabinose to induce the toxin, while the second half was
supplemented with both 0,5 mM IPTG and 0.2% arabinose to induce both the antitoxin and
toxin. Samples were taken every 30 minutes for 2 hours to perform serial dilutions (10-1 to 10-
6) that were spotted on LB agar supplemented with 30 μg ml-1 chloramphenicol, 100 μg ml -1
carbenicillin and 1% D-glucose for CFU ml-1 counting.
To assess the putative ParE targets each toxin in the pBAD33Para vector was co-induced
with each of the putative targets: gyrA, gyrB, gyrase, topo IV E, topo IV C or topo IV, cloned
in the high copy vector pAH160Prha, (Harms et al., 2015) (Table 2). Cells were grown taking
1/100 dilution of an overnight culture in 100ml of LB media supplemented with 50 μg ml-1,
kanamycin, 30 μg ml-1 chloramphenicol and 0.2 % rhamnose to pre-induce the expression of
the target. At mid-exponential growth phase (OD600nm 0.5, cuvette reader Eppendorf
BioSpectrometer® basic, t = 0) the grown culture was split in two flasks (control and
experimental conditions). The toxin was induced by adding 0.2% of arabinose in one of the
flasks. Samples were taken every 30 minutes for 2 hours after expression of the toxin and
serial dilutions (10-1 to 10-6) from each time-point were plated on LB media supplemented with
1 % D-glucose, 50 μg ml-1 kanamycin and 30 μg ml-1 chloramphenicol to quantify the CFU ml-
1. For the characterization of the parDE2 operon, to further study the dual ParD1-ParE1 TA
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system and to assess the TA cross talk, the same set of vectors was used (pBAD33Para toxins,
pAH160Prha antitoxins) (Table 2), following the protocol described above, unless otherwise
stated.
2.7.4 Growth rescue experiments
To assess the ParD1 capacity to rescue the ParE1 effect and vice versa, E. coli MG1655
cells were transformed with two plasmids: the pBAD33Para harboring the parE1 (start codon
TTG-SD6) gene (pEC1484) and pAH160Prha harboring the parD1 gene (pEC2189). Bacteria
cells were grown in LB media (50 ml) supplemented with 30 μg ml-1 chloramphenicol, 50 μg
ml-1 kanamycin and 0.2% D-glucose to repress both Para and Prha until mid-exponential phase
of growth (OD600nm 0.5, cuvette reader Eppendorf BioSpectrometer® basic, t = 0). At this point,
the culture was divided in two and washed twice with fresh LB media (25°C, 1500 xg, 10
minutes), and re-suspended in LB supplemented with the same antibiotics and either 0.2%
arabinose to firstly induce parE1 expression (experiment 1) or 0.2% rhamnose to induce
parD1 expression (experiment 2). After one hour, cells were washed again twice as previously
described and re-suspended in fresh LB media supplemented with the same antibiotics and
the opposite sugar to induce the second molecule (parD1 for experiment 1 and parE1 for
experiment 2). Samples were taken from time zero every 30 minutes for 3 hours and serial
dilutions were spotted on LB agar plates supplemented with 30 μg ml-1 chloramphenicol, 50
μgml-1 kanamycin and 1% D-glucose for CFU ml-1 counts. Subcultures were only one of the
molecules was induced were used as controls.
2.8 Microscopy
Sample preparation for fluorescence microscopy was performed by collecting 1 ml of
grown cultures from the killing (section 2.7.1) or SOS response (section 2.7.2) assays in E.
coli or 1ml from the killing assays (section 2.4.4) in S. pyogenes. After 2 washes with the same
volume of 1X PBS (centrifugations at 21000 x g, 4°C, 10 minutes) the pellets were re-
suspended in 1 ml of a membrane dye (2.5 mg/ml FM4-64 in 1X PBS, Molecular Probes) and
incubated at room temperature in the dark for 30 minutes. Afterward, cells were centrifuged
and pellets were fixed with 1ml of 4% paraformaldehyde (Sigma) for at least 1 hour at 4°C.
Subsequently a second step of washes as described before was performed and cells were re-
suspended in a DNA stain solution (5 mg/ml Hoechst in 1X PBS, Sigma-Aldrich), incubated at
room temperature in the dark for 30 minutes and 4 µl were transferred onto microscopy slides
Materials and Methods
41
coated with 1X PBS 1.5 % agarose pads. Images were acquired with an Inverted Microscope
(Leica DMi8, DFC9000 GT VSC-D6212 camera), and a 100X phase contracts objective (HC
LP APO 100X/1.40 oil). Filter sets were as follows: excitation, 390/18; emission 435/48 for
Hoechst; and excitation, 542/27; emission, 594/45 for FM4-64. The images were further
analyzed in ImageJ (Schneider et al., 2012).
S. pyogenes samples for electron microscopy were prepared by re-suspending the
pellet of 20 ml (centrifugation step at 1500 x g, 25°C and 10 min) of grown cultures in 0.1 M of
HEPES buffer pH 6.9 (HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 0.09 M
sucrose, 10 mM CaCl2, 10 mM MgCl2) containing 5% formaldehyde and 2% glutaraldehyde
(refer to section 2.8.2).
2.8.1 Image processing
To calculate the overall E. coli DNA content per cell, ImageJ to filter (Gaussian Blur)
was used (threshold (Otsu) the original images of both fluorescent dyes). Small non-specific
outliers were removed and a mask with the information of both channels was created. The
overall DNA content was calculated: area (mask DAPI) / area ((mask DAPI) * (mask FM4-64)).
The cell size /length was determined manually. At least 80 cells from the controls and 51 cells
from the toxin-induced conditions were taken into account for performing the analysis.
2.8.2 Field emission scanning electron microscopy
Bacteria were fixed overnight with 5% formaldehyde and 2% glutaraldehyde at 4° C.
After washing with HEPES buffer, an aliquot of 50 µl of the bacterial solution was placed on
poly-l-lysine coated coverslips and allowed to settle for 10 min. After fixation with 1%
glutaraldehyde in TE buffer (20 mM Tris-HCl, 1 mM EDTA, pH 6.9) for 10 min at room
temperature, the coverslips were washed with TE buffer before dehydrating in a graded series
of acetone (10, 30, 50, 70, 90, and 100%) on ice, each step for 10 minutes. Samples in 100%
acetone were allowed to reach room temperature (exchange with fresh, room temperature
100% acetone after 10 min) before critical point drying with liquid CO2 (CPD 30, Balzers,
Liechtenstein). Dried samples were covered with a palladium–gold film by sputter coating
(SCD 500, Bal-Tec, Liechtenstein). The samples were examined with a field emission
scanning electron microscope (Merlin, Zeiss, Germany) using the HESE2 Everhart Thornley
SE detector and the in-lens SE detector in a 25:75 ratio at an acceleration voltage of 5 kV.
The SEM analysis was performed in collaboration with the Central Facility for Microscopy, at
The Helmholtz Centre for Infection Research, Braunschweig, Germany.
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2.8.3 Transmission electron microscopy
The fixed samples (refer to section 2.8.2) were further exposed to osmium tetroxide
(1% in HEPES buffer) for 1 h at room temperature. After washing with HEPES buffer, samples
were dehydrated in a graded series of ethanol on ice interrupted by an overnight incubation
with 2 % uranyl acetate (UAc) at 4 °C (10, 30, 50, 70 +UAc, 70, 90, 100%). Samples were
allowed to reach room temperature and subsequently infiltrated with the aromatic acrylic resin
LRWhite (1:1, 2:1, 100%). After polymerization for 2 days at 50 °C, ultrathin sections were cut
with a diamond knife (approx. 50-70 nm), collected onto butvar-coated 300 mesh grids, and
counterstained with 4% aqueous uranyl acetate for 3 min and lead citrate for 30 seconds. The
samples were examined with the transmission electron microscopes TEM 910 and Libra 120
Plus (Zeiss, Germany) with an acceleration voltage of 80 kV, respectively 120 kV and at
calibrated magnifications. Contrast and brightness was adjusted using the WinTEM software.
The TEM analysis was performed in collaboration with the Central Facility for Microscopy, at
The Helmholtz Centre for Infection Research, Braunschweig, Germany.
2.9 Mass spectrometry analysis
The SDS-PAGE gel fragments of interest were excised and transferred into 0,5 ml
Eppendorf tubes. For de-staining the gel bands were incubated with 500 µL of 200mM
ammonium bicarbonate (ABC) and 50% acetonitrile (ACN) for 30 min at 37°C, followed by
incubation with 500 µl of 50mM ABC, 5% ACN for 30 min at 37 °C. Gel pieces were then dried
at 37°C for 30 min. Protein digestion was performed overnight at 37°C with 0,1-0,2 µg modified
trypsin (Promega V5111) per 25 µl 50mM ABC, 5% ACN. The supernatant was transferred
into an Eppendorf tubes and peptides were extracted by first applying 25 µL of 60% ACN,
0.5% Trifluoroacetic acid (TFA) for 10 min, followed by 25 µL of 100% ACN for 10 min. All
supernatants were combined and dried in an Eppendorf Concentrator at 45°C. For desalting
the samples were solubilized with 15 µl 0,1% TFA and bound to ZipTips (Millipore) according
to the manufacturer’s instructions. The peptides were eluted with 5 mg/ml α-Cyano-4-
hydroxycinnamic acid in 60% ACN, 0.5% TFA onto the MALDI template.
Mass spectra were acquired with a 4700 Proteomics Analyzer (AB Sciex) MALDI-
TOF/TOF instrument. The MS mass range was set to 800-4000 Da and MS/MS precursor
selection for the 5 most intensive peptides was performed automatically; using the 4000 Series
Explorer Software. Proteins were identified using Mascot 2.6.2 (Matrix Science) allowing a
mass tolerance of 50 ppm for peptides and 0,3 Da for fragment masses. The search
parameters for the MSMS ion search were a maximum of one missed cleavage, oxidation of
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methionine, N-terminal acetylation of the protein, propionamide at cysteine residues and N-
terminal pyroglutamic acid formation. The data were searched against a manually created
database containing ParD1, ParE1, ParF1, ParD2 and ParE2 and the UniRef100 (133853533
sequences; 49656227882 residues) database. A protein was accepted as identified when the
Mascot protein score was significant (p <0,05) and the sequence coverage was > 30% or at
least two peptides were confirmed by MSMS. The mass-spectrometry analysis was performed
in collaboration with Monica Schmid at the Max Planck Institute for Infection Biology.
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3 RESULTS
3.1 ParDEF1 is a bona-fide Toxin-Antitoxin System from S. pyogenes
This chapter describes the characterization of the parDEF1 operon, an atypical TA
system from the human pathogen Streptococcus pyogenes. The results demonstrated that
parDEF1 is a bona-fide TA system: 1.) The toxin-antitoxin- genes are co-transcribed 2.)
Ectopic expression of the toxin ParE1 resulted in cell death and 3.) Co-expression of the toxin
together with its cognate antitoxin prevented but did not reverse ParE1 toxicity. Unlike
canonical antitoxins and in addition to its capacity to prevent ParE1 toxicity, ParD1 expression
had a reversible effect in growth. This activity appeared to be exclusive for S. pyogenes ParD1
compared to previously characterized ParD-like proteins. The experimental results indicated
that ParD1 impairs cell division and that the phenotype can be rescued by the presence of
ParE1. These findings advocate a new type of TA system where both molecules target
important cellular processes and their coexistence permits bacterial growth. Collectively, this
chapter expands the knowledge about TAs and the diversity of mechanisms employed by
these elements to modulate bacterial behavior.
The parDEF1 locus is an operon conserved among different S. pyogenes serotypes
 Five different type II TA systems encoded in the chromosome of S. pyogenes were
predicted (Xie et al., 2018). Among them, two loci are hypothesized to encode ParDE-like TA
modules. In this chapter, I focused on the parDEF1 locus which is an operon composed of
three genes (Figure 1.1A). The operon architecture was validated by RT-PCR (Figure 1.1B).
SPy_0550 is the first gene of the operon encoding the putative ParD1 antitoxin protein. As in
other TA modules, one nucleotide of the stop codon from the antitoxin gene overlaps the first
nucleotide of the toxin gene-encoding region. SPy_0552 encodes the putative ParE1 toxin
molecule, while the last gene of the operon SPy_0553 encodes a hypothetical protein named
ParF1. With the aim to identify the transcription start site (TSS) and confirm the operon
architecture, we used previously reported transcriptome data of our model organism (Le Rhun
et al., 2017). The analysis showed that the parDEF1 operon is expressed at mid-exponential
growth phase and that the parD1 TSS differs from the predicted start site; therefore we have
accordingly re-annotated the parD1 start codon (coordinate 448386) (Figure 1.1A).
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The parDEF1 operon is highly conserved among S. pyogenes serotypes (Figure
1.1C). However, in some genomes the parF1 gene is truncated leading to a potentially non-
functional peptide (Figure 1.1D). The genomic context of the parDEF1 locus is also well
conserved among most of the serotypes. Namely, it is located in a region encoding three
hypothetical prophage proteins: a phage terminase, a phage portal protein and a transposase-
encoding gene. In addition, putative cell division and multidrug resistance elements are
encoded close to the parDEF1 operon (Figure 1.1C). The GC content of these features differs
from the rest of the genome, suggesting that this operon may be located in a hypothetical
prophage-like area (Figure 1.1E). These findings could highlight the origin and/or role of the
parDEF1 locus in our model organism; if the putative prophage region is prone to excision,
this TA module could stabilize the chromosomal DNA region surrounding it under certain
conditions.
Figure 1.1: parDEF1 is an operon highly conserved among S. pyogenes serotypes.
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A. The parDEF1 locus was shown to be co-transcribed in the S. pyogenes M1 GAS RNAseq analysis
(expression signal depicted in purple). The coverage of reads and the coverage of the 5’ and 3’ ends
are given into brackets (image captured from Integrative Genomics Viewer) (Robinson et al., 2011;
Thorvaldsdottir et al., 2013). The parD1 start codon was re-annotated based on the genome
NC_002737.2 at the coordinate 448386 (green colored ATG sequence). The red box indicates the
predicted Rho-independent terminator (TransTermHP v2.07 prediction downloaded from Le Rhun et
al., 2017). Analysis performed in collaboration with Dr. Anaïs Le Rhun from the Max Planck Unit for
the Science of Pathogens. B. The parDEF1 operon architecture is depicted: parD1 antitoxin in blue,
parE1 toxin in red and the hypothetical parF1 gene in green. An adenine, indicated by an “A” overlaps
the antitoxin and toxin sequences. Gene sizes are shown above the open reading frames (ORFs)
and lines with arrows below the ORFs represent RT-PCRs performed to confirm the operon
conformation. parD1, parE1 and parF1 formed a three-gene operon (positive PCR line 2 and 3 and
negative PCR line 1 and 4 from cDNA). Positive (DNA) and negative (water) controls are shown. C.
The parDEF1 operon is conserved among different S. pyogenes serotypes and the genomic context
includes putative pro-phage and antibiotic resistant genes depicted in colors. A BLAST-base analysis
was performed using SyntTax web server (http://archaea.u-psud.fr/synttax). D. The parF1 gene is
truncated and/or non-annotated in some serotypes shown. E. Guanine/cytosine (GC) content
analysis shown that the parDEF1 operon is located in a genomic region with low GC-content. The
zoomed panel indicates a window of 15Kb (pink squared, antitoxin in blue and toxin in red). The
genomic GC% content was calculated in R, package Biostrings using a genome window of 1000bp.
The parDEF1 operon encodes a bona-fide TA system
I next aimed to evaluate whether the predicted TA system is functional. For this
purpose I first examined whether ParE1 has a toxic effect in the heterologous host E. coli.
Multiple cloning strategies applied to express the wild-type parE1 gene from the low copy
plasmid pBAD33Para under the control of the arabinose promoter failed due to the acquisition
of random mutations that led to the recovery of non-toxic variants. To reduce the expression
level of parE1 the start codon was changed from ATG to TTG and 6 nucleotides between the
ribosome binding site and the methionine-encoding triplet were left, as previously described
to reduce the expression level in E. coli (Ringquist et al., 1992b). Growth rescue experiments
revealed killing of E. coli cells upon overexpression of the ParE1 toxin (Figure 1.2A and 1.2B).
Whereas, expression of the ParE1*L47A variant with a randomly acquired mutation during
cloning allowed growth, displaying the importance of the L47 residue for toxicity or protein
stability (Figure 1.2A). Next, I wanted to evaluate the phenotype of E. coli cells overexpressing
ParE1. Two hours of ParE1 expression caused strong cell elongation, absence of septum and
nucleoid condensation compared to the non-induced conditions (Figure 1.2C). Moreover, by
live and dead staining we could determine that ParE1 expression indeed resulted in cell killing,
since the elongated cells were dead (Figure 1.2C).
To determine whether parDEF1 is a typical TA module I assessed the antitoxin
capacity by cloning parD1 in the low copy vector pZE12Plac. Co-expression of ParD1 efficiently
counteracted the toxicity of its cognate toxin ParE1, but also in the absence of the inducer.
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This is most likely due to the leakiness of the isopropyl β-D-1-thiogalactopyranoside (IPTG)-
inducible promoter that controls antitoxin expression (Figure 1.2D). Repeated attempts to
clone the wild type parD1 gene also lead to various suppressor mutations. Some of these
ParD1 variants showed reduced antitoxin capacity. For instance, the ParD1* F49L variant
partially counteracted ParE1 toxicity in comparison with the non-induced conditions,
highlighting the potential importance of the F49 residue for the interaction of ParD1 with its
toxin or for ParD1 stability (Figure 1.2D). The highly toxic phenotype upon ParE1 expression
and the growth prevention upon co-expression of the two molecules suggest that parDE1 is a
bona-fide TA system.
Furthermore, I have also investigated the function of the third gene of the operon.
ParF1 did not show any antitoxin capacity when co-expressed with the ParE1 toxin, nor toxicity
when solely express in E. coli (Figure 1.2E). Finally, I have assessed the interaction of the TA
components in the natural host S. pyogenes. For this purpose, I cloned extra-chromosomally
the N-terminal FLAG-tagged ParD1 variant which retained its antitoxin function (Figure 1.2F)
into S. pyogenes. In vivo pull downs from total cell extracts of cells expressing this ParD1
variant, followed by mass spectrometry analysis, have revealed the presence of ParE1
(Figure 1.2G), suggesting that indeed ParD1 and ParE1 can interact in vivo. Conversely, in
the same analysis ParF1 was not detected in any of the fractions, possibly due to a weaker or
absent interaction with ParD1 under the conditions tested, or an interaction with ParE1 that
we have not studied yet.
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Figure 1.2: parDEF1 is a bona fide TA system encoding the ParE1 toxin that induces cell
elongation and nucleoid condensation in E. coli.
A. Exponentially growing E. coli cells harboring the toxin parE1 (TTG-SD6) under the control of the
arabinose promoter (Para) were divided in two (time zero); one half was treated with 0.2% D-glucose
to repress Para (black) while 0.2% of arabinose was added to the second half (red) to induce toxin
expression. Colony-forming units (CFU ml-1) were counted every 30 min during 2 hours. Expression
of the ParE1 toxin resulted E. coli cell death while the toxin variant ParE* L47A did not have an effect
in growth. Error bars represent the standard deviation of at least three biological replicates. B.
Exponentially growing E. coli cells harboring parE1 (TTG-SD6) under the Para control and the
pZE12Plac empty vector were divided in two (time zero): i) half of the culture was treated with 0.2%
arabinose to induced the toxin (red dotted line), ii) the second half was treated with 0.2% arabinose
and IPTG 0.5 mM to induced the Plac. (black dotted line). ParE1 expression led to killing while the
empty pZE12Plac vector did not rescue ParE1 toxicity. Error bars denote standard deviation of at least
three biological replicates. C. E. coli cells from A, 120 minutes after ParE1 (TTG-SD6) expression
were prepared for dead (cell depicted in red)/live (cell depicted in green) analysis, as well as stained
with FM4-64 (membranes; red) and Hoechst (DNA; blue) and observed by fluorescence and phase
contrast (Ph) microscopy. The toxin ParE1 led to cell death, induced cell elongation and nucleoid
condensation indicating that DNA-topology and cell division is strongly affected. Representative
images are shown. D. The death prevention experiment in exponentially growing E. coli cells
harboring parE1 (TTG-SD6) under the Para control and parD1 under the control of the lactose
promoter (Plac), was performed as described in B. At mid-exponential phase the culture was divided
in half: i) the toxin was induced by adding 0.2% of arabinose (red), ii) both the toxin and the antitoxin
were induced by adding IPTG 0.5 mM and 0.2% of arabinose (blue). ParD1 effectively prevent ParE1
toxicity even in absence of the inductor while the ParD1* F49L variant partially prevent death. Error
bars represent the standard deviation of at least three biological replicates. E. Death prevention
experiment in E. coli cells harboring parF1 under the Plac promoter and either the toxin parE1 (TTG-
SD6) under the Para promoter or the empty pBAD33Para vector. The experiment was performed as
described in D. ParF1 was not toxic (dotted orange and brown lines) and ParF1 did not shown
antitoxin activity since expression of only the toxin ParE1 (orange line) as well as both ParF1 and
ParE1 (brown line) led to killing. F. Death prevention experiment in exponentially growing E. coli cells
harboring parE1 (TTG-SD6) under the Para control and the N-terminal FLAG-tagged parD1 variant
under the control of the lactose promoter (Plac), performed as described in B. The FLAG-tagged
parD1 variant efficiently prevent ParE1 toxicity (blue), even in absence of the inductor (red). G.
Exponentially growing S. pyogenes cells expressing extra-chromosomally the N-terminal FLAG-
tagged ParD1 protein under the control of the AHT promoter (Ptet) were grown until mid-exponential
phase to perform antitoxin pull-downs (Anti-FLAG M2 agarose beads) where ParE1 was detected.
Samples were run in a 15% polyacrylamide gel and different fractions were analyzed by Mass-
spectrometry. ParD1 was detected in three fractions: a putative dimer at 22 kDa, a monomer at 11
kDa and a potential degradation product below 10 kDa. A putative ParE1 dimer was detected at
around 19 kDa. The mass-spectrometry analysis was performed in collaboration with Monica Schmid
at the Max Planck Institute for Infection Biology.
Both ParD1 and ParE1 cause cell division halt in S. pyogenes
To ascertain the ParDEF1 TA function in the natural host S. pyogenes, I studied the
phenotype of the wild type and ΔparDE1 mutant strain upon extra-chromosomal expression
of each TA component. Multiple attempts to clone independently the wild type toxin gene in
the low copy plasmid pEC85Ptet under the control of the tetracycline promoter failed. Still, while
the mutation ParE1*L47A (start codon TTG) leads to a non-toxic variant in E. coli (Figure
1.2A), ParE1* L47A (start codon ATG) reduced growth in the wild type S. pyogenes strain
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when compared with the empty vector control (Figure 1.3A). The phenotype was stronger in
the ΔparDE1 mutant, which we attributed to the absence of ParD1 (Figure 1.3B), thus
implying that ParD1 is the antitoxin that neutralizes ParE1 toxicity.
Next, I assessed the phenotype upon antitoxin expression. As for ParE1, multiple
attempts to clone the antitoxin in the same vector were unsuccessful. Therefore, I used the N-
terminal FLAG-tagged ParD1 variant that was previously shown to counteract ParE1 toxicity
and interact with the cognate toxin (Figure 1.2F and 1.2G). Strikingly, expression of the ParD1
variant caused growth defects in the S. pyogenes wild type strain (Figure 1.3A). This
phenotype was stronger in the ΔparDE1 mutant strain where the reduction in CFU ml-1 was
also evident under non-induced conditions (Figure 1.3B). This result could suggest that ParD1
is unexpectedly toxic and that ParE1 is also acting as the cognate antitoxin. In addition,
multiple attempts to delete only parE1 on the chromosome failed, suggesting a potential
ParD1-mediated deleterious outcome that leads to unviable cell. The ParE1 molecule could
possibly counter this effect and therefore the two TA components need to co-exist.
I was also interested in confirming the ParD1 antitoxin phenotype upon ParE1 co-
expression in S. pyogenes. Molecular tools to ectopically co-express different genes under
distinct promoters are not available for S. pyogenes M1 GAS. In order to validate the TA
function in its natural host, we attempted to clone the parD-parE1 genes or the complete
parDEF1 operon in the same vector. Unfortunately, we were not able to obtain a clone using
the pEC85Ptet backbone for S. pyogenes or by using a different set of vectors for E. coli. This
inability to evaluate antitoxin: toxin ratios in S. pyogenes prohibits us from confidently
concluding whether these two molecules act as a dual TA system. Nevertheless, it could
suggest that the 1:1 antitoxin: toxin ratio is not enough to lead to viable cells when attempting
to clone the two components under the control of the same promoter. Furthermore, since
ParF1 showed neither antitoxin nor toxin activity in E. coli (Figure 1.2E), we assessed the
effect of ParF1 when expressed with ParD1. Cloning and co-expression of ParD1 and ParF1
was possible. Nevertheless, the phenotype is similar to the solely ParD1 expression condition
in both the wild type and the ΔparDE1 mutant strain (Figure 1.3A and 1.3B), suggesting that
ParF1 does not act as an antitoxin of ParD1.
These experiments also indicated that the ParE1 toxin arrests DNA replication since I
observed prominent cell elongation and nucleoid condensation when ParE1 was expressed
in the heterologous system E. coli (Figure 1.2C). I was interested in describing the phenotype
in the natural host where defects at the level of DNA replication via TA systems have not been
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characterized. Furthermore, having seen impaired of growth upon ParD1 overexpression, I
also wanted to elucidate the basis of this intriguing outcome. For this purpose, I grew in liquid
medium wild type S. pyogenes cells overexpressing either ParE1 or ParD1 and prepared the
samples for DNA-labeled fluorescence microscopy (FL), scanning (SEM) and transmission
electron microscopy (TEM). As depicted in Figure 1.3C S. pyogenes cells harboring the
pEC85 empty vector showed a normal DNA staining pattern (FL). In addition, chains were well
defined and cell sizes were homogeneously distributed (FL, SEM). Finally, by TEM we could
see the septum positioned in the middle of the cells undergoing cell division (Figure 1.3C).
When ParE1 was expressed the DNA staining pattern appeared weaker (FL), some cells were
swollen in size (SEM) and the septum was displaced and multi-positioned (TEM) (Figure
1.3D). Surprisingly, expression of ParD1 also had a clear impact on the cells (Figure 1.3E);
namely it caused cell elongation and a single clump of DNA was positioned at the cell poles
(FL). In addition, elongated cells seemed to have started cell division (SEM), while the
misplaced septum appeared to be incomplete (TEM). Taken together, I hypothesized that the
ParD1 antitoxin is also toxic when overexpressed in S. pyogenes.
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Figure 1.3: Both ParE1 and ParD1 are toxic in S. pyogenes
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A-B. S. pyogenes overnight cultures of cells harboring the pEC85Ptet empty vector or harboring either
parE1* (ATG L47A), N-terminal FLAG-tagged parD1 or N-terminal FLAG-tagged parD1-parF1 under
the control of the tetracycline promoter (Ptet), were normalized to the same optical density (OD620nm
0.2), and serial dilutions (10-1 to 10-5) were spotted in TSA-blood agar plates with and without the
inductor (AHT 50 ng ml-1). Expression of all of the three constructs led to a small reduction of viable
S. pyogenes wild type cells (A) a stronger effect in the ΔparDE1 mutant background (B).
Representative pictures of at least 6 biological replicates are shown. C-D-E. Exponentially wild type
growing S. pyogenes cells with the constructs described in A were induced for 2 hours (AHT 25 ng
ml-1) and subjected to fluorescence (DNA stained with Hoechst; blue), phase contrast (Ph), scanning
(SEM) and transmission (TEM) electron microscopy. C. The DNA molecule was spread in the cells,
a typical cocci shape was evident and the septum was right positioned. D. The DNA staining pattern
looked weaker than when the empty vector was induced and nucleus seemed to be condensed, cells
were swollen and the septum was misallocated upon ParE1 expression. E. The DNA molecule is
highly condensed, cells are swollen, elongated, and the septum is uneven positioned. Representative
pictures of at least three biological replicates are shown. SEM and TEM analysis were performed in
collaboration with the Central Facility for Microscopy, at The Helmholtz Centre for Infection Research,
Braunschweig, Germany.
ParD1 is a novel antitoxin that has a deleterious effect in E. coli
The results demonstrated that ParD1 is an antitoxin in E. coli (Figure 1.2D) and in S.
pyogenes (Figure 1.3B). Furthermore, experiments in S. pyogenes support the idea that
ParD1 and ParE1 may be toxins that cancel their effect when coexisting in an unknown ratio
(Figure 1.3A and 1.3B). To further characterize ParD1 I analyzed the protein features in silico.
According to this analysis, ParD1 typically harbors two important domains with distinct
functions (Figure 1.4A). The N-terminal domain adopts a ribbon-helix-helix (RHH) fold that
harbors a DNA-binding domain (DNA-BD) and allows the interaction of ParD-like proteins with
the parDE promoter sequence, thus regulating the transcription of the whole operon (Oberer
et al., 2002). On the other hand, the C-terminal domain of ParD-like proteins encoded in
plasmids harbors the toxin-neutralization domain (TND), an intrinsically unstructured region
prompt to be recognized for degradation by the bacterial protein quality machinery (Oberer et
al., 2007). Interestingly, the ParD1 C-terminus appears to be rather structured with two well-
defined α-helical shapes (Figure 1.4A), which could lead to a more stable protein as
previously described for other chromosomally encoded ParD antitoxins (Dalton and Crosson,
2010). Besides these features, there are no other obvious characteristics that would allow me
to predict the nature of ParD1 toxicity. However, I cannot exclude the possibility that the N-
terminal domain could nonspecifically bind nucleotide sequences in the genome that could
lead to deleterious effects.
We assessed the toxicity of ParD1 using killing experiments by overexpressing ParD1 in
E. coli from the pAH160 high copy vector. As expected, ParD1 expression led to a 105-fold
decrease in CFU ml-1 compare to the non-induced conditions, confirming its deleterious effect.
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Intriguingly, the N-terminal tag appeared to reduce ParD1 toxicity in E. coli, as it showed only
101-fold decrease in CFU ml-1 in comparison with the non-induced conditions (Figure 1.4B).
Since multiple cloning attempts led to different mutations in the ParD1 protein, we also studied
the toxicity of some of these variants including a C-terminal FLAG-tagged ParD1 protein; all
of these ParD1 variants retained their antitoxin capacity (Figure 1.4C). The C-terminal tag did
not have an influence on ParD1 toxicity as this variant has shown a 104-fold decrease in CFU
ml-1 in comparison with the non-induced conditions, similar to the wild type ParD1 protein
(Figure 1.4D). Conversely, mutations in the amino acid at position 8 (N8I) and position 3 (K3A)
led to non-toxic ParD1 protein variants. Next, we designed mutations in different N-terminal
residues to further understand their implications and found that a mutation in the position 5
(G5A) lead to a stronger phenotype in E. coli when compared with the wild type ParD1 (Figure
1.4D). These results suggest that the ParD1 N-terminus could potentially carry the features
that render the protein toxic.
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Figure 1.4: ParD1 has a deleterious effect in E. coli and its N-terminus might be implicated in
toxicity.
A. The ParD1 secondary structure prediction (Waterhouse et al., 2018), showed a b-sheet (b1:
orange arrow) and two a-helix (a1, a2: orange spirals) on the hypothetical DNA-binding (DNA-BD)
domain located at the N-terminus while two a-helix (a3, a4: orange spirals) on the putative toxin
neutralization domain (TND) at the C-terminus of the protein. Three arrows at the N-terminus
represent hypothetical key residues for its toxicity (2 blue arrows, K3 and N8 and one red arrow G5).
B. E. coli exponentially growing cultures harboring either parD1 or N-terminal FLAG-tagged parD1
under the Prha control, where divided in two (time zero) to perform the killing assays: half of the culture
was treated with 0.2% D-glucose to repress the Prha expression (dotted blue and black lines), while
the second half was treated with 0.2% rhamnose to induced expression of either parD1 (blue line) or
the FLAG-tagged parD1 variant (black line) and the CFU ml-1 were followed for two hours. ParD1 led
to a growth reduction while the FLAG-tagged ParD1 had a mild impact in E. coli growth. C. E. coli
cells harboring either parD1 C-terminus FLAG-tagged, parD1* N8I, parD1* K3A or parD1* G5A
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variants under the Prha control with the ParE1 (TTG-SD6) toxin under the Para control, were grown
inducing expression of parD1 variants (0.2% rhamnose) until mid-exponential phase (time zero), and
then divide in two to perform the death prevention experiment: half of the culture served as a control
(blue line) while the second half was treated with 0.2% arabinose to co-induce expression of the toxin
(purple line). All ParD1 variants prevent ParE1 toxicity. D. Killing assays (as described in B) of E. coli
cells harboring each of the different ParD1 variants tested in C displayed that the ParD1 C-terminal
FLAG-tagged variant led to a reduction of CFU ml-1 similar to the wild type parD1 (B), while the
mutations N8I and K3A led to less toxicity and G5A to stronger killing compared to the native ParD1
(B).
Deleterious effects of antitoxins have never been reported. In fact, parD1 might be a new
type of antitoxin/toxin gene assigned to the incorrect family of antitoxins. In addition, toxins
belonging to a given superfamily can be associated to antitoxins that belong to different
superfamilies (Leplae et al., 2011). A typical ParE-like toxin could potentially be associated to
at least four different superfamilies: PhD, RelB, PaaA (Hallez et al., 2010) and ParD1-like
antitoxins. With the aim to find antitoxins closely related to ParD1 and test their possible
toxicity, we retrieved all antitoxins belonging to the ParD, PhD, RelB and PaaA superfamilies
from the TADB database (Xie et al., 2018) and performed a sequence-base comparison.
Principal component analysis has revealed 4 different clusters grouped by the antitoxin
superfamilies included in the test and not by phylum (Figure 1.5A). As expected, ParD1 forms
a cluster with typical ParD proteins; nevertheless, phylogenetic analysis of the ParD cluster
revealed that ParD1 branches only with a hypothetical antitoxin from another strain of S.
pyogenes (Figure 1.5B). These analyses support assigning ParD1 to a new, uncharacterized
type of antitoxins that share some sequence features with the ParD1 superfamily.
Moreover, we were interested in comparing the effect of ParD1 with other proteins
assigned to this superfamily of antitoxins. Thus, we have performed growth arrest experiments
upon expression of ParDEDL933 from E. coli 0175H7 (EcoParD3) (Hallez et al., 2010) and ParD2
from M. tuberculosis H37Rv (MtbParE3) (Gupta et al., 2016). Interestingly, only ParD1 from
S. pyogenes showed a 105-fold decrease in CFU ml-1 in comparison to the non-induced
conditions (Figure 1.5C). These data suggest that ParD1 toxicity in E. coli is an intrinsic
characteristic of this protein and not a feature more widely extended to its ParD homologs.
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Figure 1.5: The toxic phenotype is exclusive from ParD1.
A. Principal component analysis of the PhD, RelB, PaaA and ParD family members that have been
reported to interact with ParE-like toxins, retrieved form the TADB database (Xie et al., 2018) showed
that these toxin families are more abundant in proteobacteria and the members are not grouped by
phylum. ParD1 (SPyParD1) clustered with typical ParD-like antitoxins such as EcParD3 and
MtbParE2. B. Phylogenetic analysis of the ParD family cluster from A showed that SPyParE1 (blue)
group with an hypothetical protein from other S. pyogenes specie as well as the second ParD-like
proteins SPyParE2 (black bold) located in other cluster. The plasmidic ParD from E. coli is highlighted
with a yellow circle. The previously characterized ParD-like copies are also depicted in bold letters.
The blue circles represent the bootstrap support bigger than 70% (raxml). C. Killing assays as
described in 1.4B showed that EcParD3 (dark green) and MtbParD2 (light green) did not have an
effect in growth when express in E. coli in comparison with SPyParD1 (blue), implying that its toxicity
is exclusive. The principal component and phylogenetic analysis were performed in collaboration with
Dr. Eric JC. Galvez from the Max Planck Unit for the Science of Pathogens.
 As previously described in Figure 1.3A and 1.3B ParD1-ParF1 expression prevented
growth in the natural host S. pyogenes. To determine if this was the case in E. coli we co-
expressed parD1-parF1 and performed killing assay. The results showed the same trend of
killing when compared with single ParD1 expression (Figure 1.6A), confirming that ParF1
does not counteract the toxicity of ParD1 in E. coli.
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Given that ParD1 was toxic when produced from a high copy plasmid in E. coli, we
speculated that the toxic effect could be due to the amount of protein produced. In order to
validate that the phenotype is a direct consequence of ParD1 and is also detectable at low
levels of expression, titration experiments were performed with E. coli harboring the same high
copy vector, in which different concentrations of the inducer rhamnose (from 0% to 0.2%) were
used. When a small quantity of inducer (0.001%) was added, the number of CFU ml-1
increased or was maintained over time, which meant that cells were growing normally (Figure
1.6B). However, as higher concentrations of the inducer were added, there was a progressive
reduction of CFU ml-1 after two hours (Figure 1.6B and 1.6C). These results confirmed that
the observed phenotype is a direct consequence of ParD1 and its ability to cause an effect
even at small quantities.
Figure 1.6: The ParD1 effect is not prevented by ParF1 and is dose dependent.
A. Killing assays as described in 1.4B of E. coli cells harboring parD1-parF1 under Prha control
showed a CFU ml-1 reduction upon expression implying that ParF1 does not prevent the ParD1 toxic
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effect. B. Killing assays in E. coli where induction of the parD1 wild type expression was done in
subcultures at different concentration of the inductor rhamnose (0, 0.01, 0.005, 0.01, 0.05 and 0.2
%). The reduction of CFU ml-1 is ParD1 dose dependent since increasing concentration of the
inductor led to stronger killing in comparison with the non-induced conditions. Experiments were
performed in triplicates. C. SDS-PAGE gel from experiment described in B, total cell lysates,
confirmed the expression of the ParD1 protein. B.S Leticia Rodriguez-Montes contributed to the
analysis of the ParD1 phenotype in E. coli.
ParD1 is a toxin molecule that arrests cell division
Expression of ParD1 in S. pyogenes causes nucleoid condensation, cell elongation and
incomplete septum formation (Figure 1.3E). A similar phenotype has been reported for Gram-
positive bacteria in cells lacking proteins important for septum formation (Fleurie et al., 2014;
Stamsås et al., 2018). Since ParD1 expression also impacts E. coli growth, we speculated
that its target might be highly conserved between these two species. In order to better
characterize the ParD1 influence I assessed the phenotype of E. coli cells upon 2 hours of
ParD1 expression. Interestingly, ParD1 rendered the cells slightly larger, while the nucleus
was condensed in an uneven position (Figure 1.7A and 1.7B). I also quantified the DNA
content per cell and found that upon expression of ParE1, ParD1 and the more toxic variant
ParD1* G5A there were significant differences in DNA content in comparison with the non-
induced conditions, while the expression of the non-toxic variant ParD1* K3A did not lead to
statistically significant change (Figure 1.7B). Similarly, single DNA condensation and slight
cell elongation is evident when cells are treated with ciprofloxacin that arrest DNA replication
(will be described in section 3.3), suggesting that ParD1 could also potentially target this
process. However, the SOS response was not induced upon ParD1 overexpression implying
that the primary effect is not to disturb DNA topology (Figure 1.7C). Moreover, TEM showed
that the cells seemed to have replicated DNA and further decatenation appeared to have
started (Figure 1.7D); we observed defects on septum formation while the DNA tends to be
positioned at the pole of cell division (Figure 1.7D). Intriguingly, when ParD1 and ParF1 were
co-induced this phenotype is more obvious since daughter DNA molecules were more evident,
but still the septum is misallocated in the cell and some cells presented two condensed DNA
marks next to each other (Figure 1.7E). Finally, at lower concentration of the inducer, a single
DNA clump was evident and then resolved in two different clumps while inductor concentration
increased the septum was no longer visible (Figure 1.7F). These observations support the
hypothesis that ParD1 might have an effect at the level of cell division via a mechanism that
still needs to be understood.
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Figure 1.7: The ParD1 has an effect on cell division in E. coli.
A. Cells from the experiment described in 1.4B, 2 hours upon ParD1 expression were stained with
FM4-64 (membranes; red) and Hoechst (DNA; blue) and visualized by fluorescence and phase
contrast (Ph) microscopy. Expression of ParD1 led to mild cell elongation and DNA condensation. B.
The DNA content per cell was quantified from experiments described in 1.2A, 1.4B and 1.4D. ParE1
(red bar), ParD1 (dark blue bar), or ParD1 G5A expression (light blue bar) led to a significant
reduction (p £ 0.05) of DNA content in comparison with the non-induced conditions (black and grey
bars) while the less toxic ParD1* K3A variant presented statistically insignificant differences. C.
Exponentially growing E. coli cells (λatt::psulA-gfp) harboring either parD1 or parF1 under the Prha
control were grown as described in 1.4B and  expression was induced (green bar) or repressed (grey
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bar) for 2 hours, to measure the GFP signal. The SOS response was not induced by the proteins
tested. Ciprofloxacin (CPX) treated samples were used as controls. The data was normalized to the
OD600nm measurements and relative fluorescence units (RFU) were plotted in a log10 scale. Error bars
represent standard deviation of at least three biological replicates. D. E. coli cultures from 1.4B were
prepared for transmission electron microscopy (TEM). Expression of ParD1 led to nucleoid
condensation in the cell pole and cells are slightly elongated in comparison with the non-induced
conditions. TEM analysis was performed in collaboration with the Central Facility for Microscopy, at
The Helmholtz Centre for Infection Research, Braunschweig, Germany. E. E. coli cells from the
experiment described in 1.6A were prepared for fluorescence and Ph microscopy as described in A.
Co-expression of ParD1 and ParF1 led to the same phenotype observed in A, however two condense
DNA molecules were more prominently observed. F. Cells from the experiment described in 1.6B
were also observed by fluorescence microscopy and Ph and the DNA condensation pattern got
stronger as the concentration of the ParD1 inductor increased.
ParDE1 migth be a dual toxin-antitoxin system
The previous results indicated that both ParE1 and ParD1 are toxic for the cells (Figure
1.2A, 1.3 and 1.4B) and ParD1 efficiently counteracts ParE1 toxicity (Figure 1.2D). The
findings also revealed that in the natural host ParD1 toxicity is stronger in the absence of the
chromosomal ParE1 copy (Figure 1.3B).  Therefore, I speculated that ParE1 could also act
as an antitoxin of ParD1. In order to test this hypothesis, I have performed growth rescue
experiment in E. coli harboring two vectors; parE1 in the low copy vector pBAD33Para and
parD1 in the high copy vector pAH160Prha. This time, I grew the cells under repression
conditions until mid-exponential growth phase, and then split the culture in two and
independently induced either ParE1 or ParD1. A 102-fold reduction in CFU ml-1 was detected
upon 3 hours of only ParE1 expression (Figure 1.8A left panel, light red line). I assumed
that the smaller effect when only ParE1 is expressed could be due to the small quantities of
ParD1 coming from the leakiness of the promoter being enough to partially counter ParE1
toxicity (Figure 1.8B), or small amounts of glucose inside the cells that still partially repress
expression of Para. Conversely, when ParD1 was co-expressed after 1 hour of ParE1
expression there was a 106-fold reduction in CFU ml-1 (Figure 1.8A left panel dark red line).
These results suggested that the ParE1 effect plus overloaded quantities of ParD1 do not
rescue growth but kill E. coli faster, therefore a cumulative defect in growth was evident
(Figure 1.8A left panel). Interestingly, when only ParD1 was induced, there was a 107-fold
reduction in CFU ml-1 after 3 hours (Figure 1.8A right panel, dark blue line), but when ParE1
is co-expressed after 1 hour of ParD1 expression the cells resumed growth (Figure 1.8A right
panel, light blue line). We therefore conclude that ParE1 can counteract ParD1 toxicity. This
is further supported by another growth rescue experiment with the same strain wherein the
ParD1 molecule was expressed from the beginning of the experiment. Even though ParD1
disturbs the fitness of the cells, the leakiness of the vector that harbors the ParE1 molecule
resulted to be enough to reach 104 CFU ml-1 (Figure 1.8C). At this point, when ParE1 was
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expressed the cells tend to grow better (Figure 1.8C), and much better when the ParE1* L47A
non-toxic variant was induced (Figure 1.8D). In summary, these data suggest that ParD1-
ParE1 constitutes a dual toxin-antitoxin system where ParE1 prevents and reverses ParD1
toxicity, while ParD1 prevents but does not reverse ParE1 toxicity.
Figure 1.8: Expression of either ParD1 or ParE1 lead to effects in cell viability. ParE1 toxicity
is not rescued by co-expression of ParD1 while the ParD1 effect in growth is rescued by co-
expression of ParE1.
A. Exponentially growing E. coli cells harboring parE1 (TTG-SD6) under the Para control and parD1
under Prha control were grown under repression conditions (0.2% glucose), divided in two cultures
(time zero), washed twice and re-suspended in fresh LB media containing either 0.2% of arabinose
to induce the ParE1 expression (right figure) or 0.2% rhamnose to induce ParD1 (left figure). After
one hour, cells were washed again and re-suspended in fresh LB media containing the same (light
red or dark blue) or the opposite (dark red or light blue) sugar to co-express the second molecule.
ParD1 did not rescue the ParE1 effect on the cells (dark red line, right figure) and the CFU ml-1
decreased even more than when only ParE1 was expressed (light red line, right figure). Conversely,
ParE1 rescue ParD1 toxicity (light blue, left figure) while the CFU ml-1 continued decreasing when
only ParD1 was expressed (dark blue, left figure). B. Exponentially growing cells harboring the parE1
(TTG-SD6) under the Para control and parD1 under the Prha control were divided in two (time zero):
half of the culture served as a control (black line) while the second half was treated with 0.2%
arabinose (red line). ParE1 expression caused a CFU ml-1 reduction. C. E. coli cells from B were
grown under ParD1 expression conditions (0.2% rhamnose), until mid-exponential growth phase and
then divided in two: half of the culture served as a control (blue line) while the second half was
expressed with 0.2% arabinose (purple line). ParD1 had an effect in growth since cells only reached
104 CFU ml-1, co-expression of ParE1 rescued this effect. D. Exponentially growing E. coli cells
harboring the parE1* L47A (TTG-SD6) less toxic variant under the Para control and parD1 under the
Prha control, were grown and experiments were performed as C. ParD1 has an effect in growth while
the ParE1* L47A variant seemed to better rescue ParD1 toxicity in comparison with the wild type
ParE1 (C). M.Sc Frederik Kramer contributed to the death prevention experiments.
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3.2 The S. pyogenes parDE2 Operon Encodes a Bona-Fide Toxin-Antitoxin
System
Bacteria often encode several TA copies within the chromosome, yet the role of
redundant copies belonging to the same TA family is not well understood. S. pyogenes
encodes two ParDE-like TA systems and this section describes the characterization of the
bicistronic parDE2 operon. The results indicated that parDE2 is a bona-fide TA system that
does not cross talk with the parDEF1 module. Furthermore, ParE2 was less toxic than ParE1
in E. coli while it appeared to be more toxic in the absence of the antitoxin chromosomal copy
in S. pyogenes. Interestingly, ParD2 also displayed toxicity when solely expressed in S.
pyogenes, but this characteristic was not detected in E. coli where the potential native target
might be absent. The ParD2 non-canonical activity correlates with the ParD1 toxicity described
in the section 3.1. Overall, these findings provide more insights into the mechanism TA
systems use to modulate bacterial behavior. The questions addressed in this section also
highlight the importance of designing better molecular tools to understand the ParDE-like
mechanisms and their roles in the natural host S. pyogenes.
The parDE2 locus is an operon conserved among S. pyogenes serotypes
Two genes typically comprise the second ParDE-like TA system encoded in the
chromosome of S. pyogenes (Figure 2.1A) and RT-PCR analysis have confirmed their operon
architecture (Figure 2.1B); SPy_1926 is the first gene of the operon encoding the putative
ParD2 antitoxin protein and SPy_1927 the second gene encoding the putative toxin, named
ParE2. Eleven nucleotides of the end of the antitoxin gene overlap with the start of parE2 toxin
gene-encoding region. Analysis of previously reported transcriptome data of our model
organism (Le Rhun et al., 2017) showed low levels of parDE2 expression at mid-exponential
growth phase in rich media (Le Rhun et al., 2017), indicating that this TA system is active but
might not play a pivotal role under normal growth conditions (Figure 2.1A).
The parDE2 locus as well as its surrounding genomic context had high sequence
similarity among different S. pyogenes serotypes (> 82% of identity) (Figure 2.2C). Upstream
of the parDE2 operon are several genes involved in sugar metabolism, while downstream
putative genes implicated in transcription and a putative DNA integrase are encoded (Figure
2.2C). The presence of the hypothetical DNA integrase gene may imply the foreign origin of
this TA locus as an integrative element that has remained over the evolution of S. pyogenes
species.
Results
64
Figure 2.1: parDE2 is an operon conserved among S. pyogenes serotypes.
A. RNAseq analysis revealed that the parDE2 locus is co-transcribed in the S. pyogenes M1 GAS
(expression signal depicted in purple). The coverage of reads and the coverage of the 5’ and 3’ ends
are given into brackets (image captured from Integrative Genomics Viewer) (Robinson et al., 2011;
Thorvaldsdottir et al., 2013). The red box indicates the predicted Rho-independent terminator
(TransTermHP v2.07 prediction downloaded from Le Rhun et al., 2017). Analysis performed in
collaboration with Dr. Anaïs Le Rhun from the Max Planck Unit for the Science of Pathogens. B. The
parDE2 operon architecture was confirmed by RT-PCR analysis: parD2 antitoxin in blue, parE2 toxin
in red. 11 nucleotides overlap the antitoxin and toxin sequences. Gene sizes are shown above the
open reading frames (ORFs) and lines with arrows below the ORFs represent RT-PCRs performed.
The genes parD2 and parE2 formed a bicistronic operon (positive PCR line 2 and negative PCR line
1, 3 and 4 from cDNA). Positive (DNA) and negative (water) controls are also showed. C. The parDE2
operon is conserved among different S. pyogenes serotypes and the genomic context includes a
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putative DNA integrase and genes involved in sugar metabolism among others depicted in colors. A
BLAST-base analysis was performed using SyntTax web server (http://archaea.u-psud.fr/synttax).
ParDE2 is a bona fide TA system
In order to test whether the predicted TA system is functional, I made use of the same
strategy applied to characterize the parDEF1 TA operon (described in section 3.1). With the
aim to compare the toxic phenotype of ParE2 with ParE1, I maintained the same features
when cloning the parE2 gene in the low copy plasmid pBAD33Para, including 6 nucleotides left
between the ribosome binding side and the methionine-encoding triplet (SD6). However, due
to the less toxic phenotype observed with the parE2 TTG native start codon, the experiments
were instead performed with the ParE2 (ATG-SD6) variant, which was shown to be toxic when
induced in the heterologous host E. coli in comparison with the non-induced conditions
(Figure 2.2A). Interestingly, unlike the results of ParE1 expression, ParE2 expression did not
lead to a constant reduction in CFU ml-1, which might suggest a different mechanism by which
ParE2 acts in E. coli (Figure 1.2A). Moreover, the randomly acquired L48A mutation permitted
growth, suggesting the importance of the L48 residue for ParE2 toxicity or stability (Figure
2.2A). Next, I was interested on the characterization of the E. coli phenotype after two hours
of ParE2 expression, which resulted in a less prominent cell elongation phenotype in
comparison with ParE1 (Figure 1.2C), while the DNA appeared to be present over the whole
cell area (Figure 2.3B).
Next, I determined the antitoxin activity by cloning parD2 in the low copy vector
pZE12Plac. However, a complete depletion of ParE2 toxicity when co-expressed together with
the pZE12Plac empty vector was observed (data not shown), while the addition of only the
inductor IPTG did not reduce ParE2 toxicity. I hypothesized that the pZE12Plac effect on
rescuing the ParE2 toxicity might be due to the effect the toxin has on the cells, essentially
ParE2 toxin may interfere with plasmid replication/transcription. This might also explain why
ParE2 is less toxic than ParE1, since it could be affecting its own expression. Experiments
with the high copy pAH160Prha empty vector also showed depletion of the ParE2 toxicity
(Figure 2.2C) but to a lesser extent in comparison with pZE12Plac, allowing further studies.
Therefore, the putative antitoxin parD2 was cloned into pAH160Prha and co-transformed with
the toxin in the pBAD33Para vector. Cells were grown under antitoxin expression conditions
with rhamnose and at mid-exponential growth phase only half of the culture was induced with
arabinose to produce the toxin, while the second half served as a control. As expected, co-
expression of ParD2 efficiently counteracted the toxicity of its cognate toxin ParE2 (Figure
Results
66
2.2D) confirming its antitoxin capacity. Furthermore, in order to study the antitoxin-toxin
interaction I cloned and induced in S. pyogenes, the extra-chromosomally N-terminus FLAG-
tagged ParD2 variant that efficiently retained the antitoxin function (Figure 2.2E). ParD2 was
pulled-down and MS analysis confirmed that ParD2 interacts with ParE2 in vivo (data not
shown). Overall, the ParE2 toxicity, the ParD2 capacity to prevent ParE2 activity and the
ParD2-ParE2 interaction in vivo confirmed that ParDE2 is a bona-fide TA system.
Figure 2.2: parDE2 is a bona-fide TA system.
A. Exponentially growing E. coli cells harboring the toxin parE2 (ATG-SD6) under the Para control
were divided in two (time zero); half was treated with 0.2% D-glucose to repress Para (black) while
0.2% of arabinose was added to the second half (red) to induce toxin expression. The CFU ml-1 were
counted every 30 min during 2 hours. Expression of the ParE2 toxin for one hour resulted E. coli
abrogation of growth while after 2 hours of ParE1 expression the cells seemed to resume growth.
The toxin ParE2* L48A variant did not have a detrimental effect in the cells (red and black dotted
lines). Error bars represent the standard deviation of at least three biological replicates. B. Samples
from A 120 minutes after ParE2 (ATG-SD6) expression were stained with FM4-64 (membranes; red)
and Hoechst (DNA; blue) and observed by fluorescence and Ph microscopy. The toxin ParE2 led
mild cell elongation and nucleoid condensation indicating that DNA-topology and cell division were
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strongly affected. Representative images are shown. C. Exponentially growing E. coli cells in LB
media supplemented with 0.2% rhamnose harboring parE2 (ATG-SD6) under the Para control and
the pAH160 empty vector under the Prha control were divided in two (time zero): half of the culture
served as a control and the second half was induced with 0.2% arabinose. Induction of the ParE2
expression led to a reduction of CFU ml-1. D. The death prevention experiments in exponentially
growing E. coli cells harboring parE2 (ATG-SD6) under the Para control and parD2 under the Prha,
control were performed as described in C, pre-expression the ParD2 protein. ParD2 expression
efficiently prevents ParE2 toxicity. E. Death prevention experiment performed as described in C, pre-
expression the N-terminal FLAG-tag ParD2 protein showed that it prevented ParE1 toxicity. M.Sc.
Frederik Kramer contributed to the death prevention experiments.
ParDE2 does not cross talk with the ParDE1 TA system
TA cross talk has been reported for some TAs in different bacteria between modules
that belong to different families (Walling and Butler, 2016; Wessner et al., 2015). Moreover,
studies of TA paralogs in E. coli 0157:H7 have revealed cross talk between the chromosomal
CcdB toxin that is neutralized by the plasmidic CcdA antitoxin, while the plasmidic toxin is not
neutralized by the chromosomal antitoxin (Wilbaux et al., 2007). Conversely, evidence of cross
talk was neither detected in between the two chromosomal parDE loci from V. cholerae (Yuan
et al., 2011) nor among the three parDE loci encoded by distinct but paralogous TA loci in
Caulobacter crescentus (Fiebig et al., 2010). I aimed to study the putative cross talk that might
exist between the two ParDE-like TA systems from S. pyogenes. A certain level of antitoxin
and toxin similarity is required for the cross interaction to occur between two TA modules.
Protein sequence alignments have revealed that the TA molecules from both systems are not
homologs since ParE toxins share 26% identity while ParD antitoxins share only 21% identity
(Figure 2.3A and 2.3B). This observation implied that each antitoxin would be able to only
counteract the toxicity of its cognate toxin and not the ParE-like toxin belonging to the second
locus. To confirm our in silico predictions, mismatched pairs of toxin from the second locus
and antitoxin from the first locus and vice versa were introduced into E. coli and their effects
on growth and viability were assayed as described above in the death prevention experiments.
As shown before (Figure 1.4B) ParD1 is toxic in E. coli, therefore the starting point of this
experiment is 104 CFU ml-1, due to its deleterious effect. From this time point onwards, the
ParE2 toxic phenotype was not rescued by the previous presence of ParD1 in the cells (Figure
2.3C). Moreover, it was obvious that ParE2 did not rescue the ParD1 effect either (Figure
2.3C), in comparison with the cognate ParE1-ParD1 pair (Figure 1.9C). To further investigate
this phenomenon, the same experiment with the opposite set up was performed and ParD2
was not able to fully prevent the ParE1 toxicity either (Figure 2.3D). Finally, pull down
experiments in S. pyogenes and MS analysis did not detect ParE2 when ParD1 was induced
(Figure 1.2G), indicating that ParDE1 and ParDE2 do not interact in vivo.
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Figure 2.3: ParDE1 and ParDE2 do not cross talk in the heterologous host E. coli
A-B. Protein alignments highlighting the most conserved residues in colors. The proteins compared
A. ParD1 and ParD2, or B. ParE1 and ParE2 were not highly conserved. C. ParE2 growth prevention
experiments by the ParD1 non-cognate antitoxin. Two independent experiments are shown: i)
Control experiment performed as described in 2.2C, cell harboring parE2* (ATG-SD6) under the Para
control and the pAH160Prha empty vector showed one fold change CFU ml-1 reduction upon ParE2
expression. ii) Cell harboring parE2 (ATG-SD6) under the Para control and parD1 under the Prha
control were grown and experiment was performed as described in 2.2D. The growth effect of ParD1
pre-expression was again evident and there was CFU ml-1 reduction upon ParE2 expression, which
suggested non-cross interaction of ParD1 and ParE2. D. ParE1 growth prevention experiments by
the ParD2 non-cognate antitoxin. Two independent experiments are shown: i) Control experiment
performed as described in 2.2C, cell harboring parE1 (TTG-SD6) under the Para control and the
pAH160Prha empty vector showed 4 fold change CFU ml-1 reduction upon ParE1 expression. ii) Cell
harboring parE1 (TTG-SD6) under the Para control and parD2 under the Prha control were grown and
experiment was performed as described in 2.2D. ParD2 did not prevent ParE1 toxicity.
Overexpression of the antitoxin ParD2 causes cell division halt in S. pyogenes
As it has been previously described in section 3.1, I also aimed to assess the ParDE2
TA function in the natural host S. pyogenes. For this purpose, I studied the growth of the wild
type and ΔparDE2 mutant strain upon extra-chromosomal expression of each TA component
from the low copy vector pEC85Ptet under the control of the tetracycline promoter. As for
ParE1, cloning the wild type ParE2 led to random mutations. The ParE2* L48A variant with
the native start codon (TTG) did not show toxicity in wild type liquid cultures (Figure 2.4A).
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Conversely, ParE2* L48A (start codon ATG) variant leads to a non-toxic phenotype in E. coli
(Figure 2.2A), but reduced growth in liquid S. pyogenes wild type strain cultures (Figure
2.4B). This phenotype did not hold when the experiment was performed in solid media in the
wild type strain (Figure 2.4C); namely, expression of ParE2* L48A (start codon ATG) did not
reduce CFU ml-1. Conversely, expression of the same ParE2* L48A (ATG) variant led to non-
viable cells when transformed in the ΔparDE2 mutant strain (Figure 2.4D). These findings
could suggest that ParE2 needs the chromosomal antitoxin molecule to prevent its effect and
that the toxicity can be rescued in the wild type background.
Moreover, I assessed the antitoxin phenotype in S. pyogenes by following the same
methodology. Surprisingly, expression of N-terminal FLAG-tagged ParD2 that retained its
antitoxin activity (Figure 2.2E) also led to a toxic phenotype in both the wild type strain and
the ΔparDE2 mutant strain (Figure 2.4C and 2.4D) that was not preliminary observed when
performing the experiments in E. coli (Figure 2.2). As for ParD1 (Figure 1.3A and 1.3B), it is
expected that the chromosomal copy of the toxin could rescue the detrimental effect of the
antitoxin in the wild type strain. However, the putative capacity of ParD proteins to block the
transcription from its own operon should be taken into consideration when expressing this
molecule. High quantities of ParD2 could potentially reduce the transcription of parD2 but also
parE2 toxin from the chromosome. This could explain why the ParD2 expression from the
plasmid quickly kills the wild type strain.
Unexpectedly, plasmidic expression of the whole parDE2 operon also led to a
detrimental effect on growth in both the wild type and in the ΔparDE2 mutant strain (Figure
2.4C and 2.4D). Largely, these data do not conclude the canonical TA function ParDE2 should
have; instead, these findings highlight an unknown missing piece that we have not considered
in the natural host.  In addition, these findings support the idea that equal plasmidic amounts
of toxin- antitoxin molecules will not be sufficient to lead to growth rescue, highlighting the
importance of validating the TA bona-fide function by varying the different levels of molecule
expression in the natural host.
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Figure 2.4: Both ParE2 and ParD2 have a deleterious effect in S. pyogenes.
A-B. S. pyogenes overnight cultures of cells harboring the pEC85Ptet empty vector or harboring either
parE2* (TTG L48A) (A) or parE2* (ATG L48A) (B) were normalized to the same optical density
(OD620nm 0.2), and 1/100 dilution was inoculated in fresh THY media without or with the inducer AHT
(12 or 25 ng ml-1). The parE2* (ATG L48A) expression showed to be more toxic than the parE2*
(TTG L48A) variant. C-D. S. pyogenes overnight cultures of either wild type cells (C) or ΔparDE2
mutant background (D), harboring the pEC85Ptet empty vector or either parE2* (ATG L48A), N-
terminal FLAG-tagged parD2 or N-terminal FLAG-tagged parD2-parE2 under the control of the
tetracycline promoter, were normalized to the same optical density (OD620nm 0.2), and serial dilutions
(10-1 to 10-5) were spotted in TSA-blood with and without the inductor (AHT 50 ng ml-1). Induction of
the FLAG-tagged ParD1 expression and the whole ParDE2 operon led to reduce CFU ml-1 in both
strains, while transformation of parE2* (ATG L48A) led to not viable clones in the parDE2 mutant
background.
The non-canonical ParD2 toxicity does not affect E. coli
In order to further characterize ParD2, I investigated the ParD2 protein features and
confirmed that ParD2 is similar to ParD1 in terms of the two main domains typical of ParD-like
proteins (Figure 2.5A). As ParD1, ParD2 harbors the RHH fold in the N-terminal, which is
hypothesized to bind DNA (Oberer et al., 2002); it also contains the putative toxin-
neutralization domain in the C-terminus with a rather structured conformation composed by
two well-defined α-helical shapes (Figure 2.5A). This feature shared with ParD1 could lead to
a more stable protein as it has been previously described for other antitoxins (Dalton and
Crosson, 2010). Similar to ParD1, ParD2 has no special features that could explain its toxic
influence. Finally, phylogenetic studies grouped ParD2 in a cluster composed by hypothetical
proteins belonging to other S. pyogenes strains, (Figure 1.5B).
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Next, the detrimental effect of the antitoxin was assessed in E. coli by growth arrest
experiments. For this purpose, I used the high copy vector pAH160Prha previously used for the
death prevention experiments. As depicted in Figure 2.5B, expression of ParD2 did not lead
to a decrease in CFU ml-1 in comparison with the non-induced conditions. I have also tested
the toxicity of the N-terminal FLAG-tagged ParD2 variant that displayed detrimental effects in
S. pyogenes, and did not observe toxicity upon expression in E. coli (Figure 2.5C). Taken
together this information implied that ParD2 only has a negative effect in its natural host when
overexpressed ectopically. Further experiments are needed to confirm that the ParD1 and
ParD2 phenotypes are not an artifact due to the artificial expression from a plasmid in the
natural host. Expression of the TA molecules from the S. pyogenes chromosome should be
considered, especially to study the native ParD target.
Figure 2.5: ParD2 is not toxic in E. coli
A. The ParD1 secondary structure prediction obtained from the SWISS-MODEL tool (Waterhouse et
al., 2018), showed a b-sheet (b1: orange arrow) and two a-helix (a1, a2: orange spirals) on the
hypothetical DNA-binding (DNA-BD) domain located at the N-terminus while two a-helix (a3, a4:
orange spirals) on the putative toxin neutralization domain (TND) at the C-terminus of the protein. B-
C. Killing assays performed as described in 1.4B, E. coli exponentially growing cultures harboring
either parD2 (B) or N-terminal FLAG-tagged parD2 (C) under the Prha control of promoter, indicated
that ParD2 and FLAG-tagged ParD2 expression did not have any impact in E. coli growth.
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3.3 ParE1 and ParE2 Arrest DNA Replication by Targeting Gyrase and
Topoisomerase IV
Typical ParE toxins affect DNA topology by interacting with the DNA gyrase leading to
double strand breaks that will induce cell elongation and eventually lead to cell death. The
phenotypes observed upon ParE1 (section 3.1) and ParE2 (section 3.2) expression in E. coli
- mainly cell elongation and nucleoid condensation - correlate with this hypothesis. In this
section, I described the characterization of the ParE1 and ParE2 targets by in vivo studies in
E. coli and in vitro assays. Assuming that multiple copies of the putative target will prevent
killing by ParE1 or ParE2, we co-expressed each toxin together with either gyrase, its homolog
topo IV or each of their subunits, to evaluate death prevention. We observed prevention of
ParE1 and ParE2 toxic effect in the cells when co-expressed with topo IV E. These results
implied that the ParE toxins could potentially interact and inhibit topo IV, a characteristic that
has not been characterized yet for this toxin family. Moreover, I provided evidence that all
ParE-like toxins tested indeed abrogate topoisomerase IV activity in vitro. On the other hand,
co-expression of gyrase together with either ParE1 or ParE2 toxins caused stronger killing
implying a gyrase poisoning effect by the toxin, which was a characteristic shared with the
ParE3 toxin from E. coli. Interestingly, in vitro studies showed that ParE1, ParE2 and ParE3
from E. coli, indeed poison gyrase similar to a typical CcdB toxin. Furthermore, different
phenotypes and killing ratios observed upon expression of S. pyogenes ParE proteins and
ParE-like homologs from other organisms in E. coli, prompted us to hypothesize that their
target affinities towards gyrase and/or topo IV might vary. Collectively, this chapter expand the
view and diversity of mechanism employed by TA modules to control bacterial behavior.
The ParE1 and ParE2 toxicity is modulated upon co-expression of topoisomerases
The DNA condensation and cell elongation phenotype that we observed upon ParE1
and ParE2 expression in E. coli (Figure 1.2C and 2.2C) is in agreement with the phenotype
observed in the coccoid S. pyogenes when ParE1 is expressed (Figure 1.3D). This phenotype
generally observed is typical when cells experience DNA damage (Fiebig et al., 2010; Harms
et al., 2015). A similar phenotype is common for other ParE-like proteins that influence DNA
replication, stability and topology by targeting DNA gyrase (Gupta et al., 2016; Hallez et al.,
2010; Jiang et al., 2002; Yuan et al., 2010). We speculated that multiple copies of the putative
target in the cell could potentially rescue cell growth upon ParE expression by capturing and
thereby inactivating the toxin and thereby allowing the free molecules of the target to fulfill
their physiological function. We explored this hypothesis by growth rescue experiments, co-
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expressing the S. pyogenes ParE toxins from the Para inducible promoter located on one vector
and from a second vector under the Prha control either the whole gyrase protein or its subunits:
gyrase A or gyrase B (Harms et al., 2015).  Co-expression of either ParE1 or ParE2 toxins
with only one of the two-gyrase subunits had no effect on cell survival (Figure 3.1A and 3.1B).
Conversely, co-expression of the full complex of gyrase AB with either ParE1 (Figure 3.1A)
or ParE2 (Figure 3.1B) exhibited an additive effect, which resulted in a stronger phenotype
instead of rescuing the growth, namely cells died faster than cells in which only ParE1 or
ParE2 was expressed. This result suggest that the gyrase function is poisoned by ParE1 and
ParE2, which results in unrepaired double stand breaks and thus cell killing.
The topoisomerase IV (topo IV) shares sequence, folding and function similarity with
gyrase (Sissi and Palumbo, 2010). In fact, other toxins such as FicT have been shown to
target both enzymes: gyrase and topo IV (Harms et al., 2015). Only one report correlated the
topo IV and gyrase inhibition activity with different E. coli ParE synthetic peptides in vitro
(Barbosa et al., 2012). Thus, I decided to test whether co-expression of topo IV and its
subunits topo IV E or topo IV C will modulate the ParE1 and ParE2 effect on cell growth
(Figure 3.1A and 3.1B). Expression of the whole topo IV enzyme and topo IV C did not have
an effect on ParE1 (Figure 3.1A) neither on ParE2 (Figure 3.1B) toxicity. Nevertheless,
expression of the topo IV subunit E rescued growth upon expression of both toxins in
comparison with the control conditions where expression of either of the two ParE-like proteins
resulted in cell death (Figure 3.1A and 3.1B). This observation suggests that the ParE toxins
from S. pyogenes also target topo IV and that an excess of the topo IV E subunit prevents
ParE1 and ParE2 toxicity, implying a putative toxin-topo IV E protein interaction.
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Fi g ur e 3. 1: C o- e x pr e s si o n of P ar E-li k e t o xi n s wit h eit h er t o p o I V E or g yr a s e m o d ul at e P ar E 1
a n d P ar E 2 t o xi cit y.
A- B.  T w o i n d e p e n d e nt e x p eri m e nt s ar e s h o w n i n e a c h p a n el: i) T o a c c o u nt f or gr o wt h d ef e ct s d u e
t o  t ar g et  e x pr e s si o n,  e x p o n e nti all y  gr o wi n g  str ai n s  c arr yi n g  p A H 1 6 0 Pr h a wit h  e a c h  t ar g et  a n d  t h e
p B A D 3 3 P ar a   e m pt y  v e ct or  w er e  gr o w n  u n d er  t ar g et  e x pr e s si o n  c o n diti o n s  u ntil  mi d- e x p o n e nti al
gr o wt h p h a s e (ti m e- z er o): h alf of t h e c ult ur e s er v e d a s a c o ntr ol ( bl a c k li n e) w hil e t h e s e c o n d h alf
w a s tr e at e d wit h ar a bi n o s e 0. 2 % ( gr e y li n e) a n d t h e C F U ml - 1 w er e f oll o w e d f or 2 h o ur s. T h e t o p o
s u b u nit C h a s  a n  eff e ct  i n  gr o wt h i n c o m p ari s o n  wit h  t h e  c o ntr ol c o n diti o n s  w h er e n o n-t ar g et  w a s
t e st e d.  ii) E. c oli  c ell s h ar b ori n g t h e t o xi n p ar E 1  ( T T G- S D 6) ( A) or p ar E 2  ( A T G- S D 6) ( B) u n d er t h e
P ar a  c o ntr ol a n d e a c h of t h e p ot e nti al t o xi n t ar g et s u n d er t h e Pr h a c o ntr ol i n t h e p A H 1 6 0 v e ct or w er e
gr o w n u n d er t ar g et e x pr e s si o n c o n diti o n s u ntil mi d- e x p o n e nti al gr o wt h p h a s e (ti m e z er o). H alf of t h e
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ParE-like toxins have similar effects in E. coli
The effect of ParE-like proteins have on the topo IV activity has not been characterized,
yet. To test whether S. pyogenes ParE proteins are unique in their ability to target topo IV and
gyrase or whether this is a general characteristic of ParE-like toxins, we compared the ParE1
(SPyParE1) and ParE2 (SPyParE2) with closely related homologs. To select ParE-like
candidates we performed protein sequence-base comparisons, retrieving all the toxin
sequences belonging to the RelE/ParE superfamily from the TABD database (Xie et al., 2018).
Principal component analysis branded the toxins in two different clusters: ParE and RelE
(Figure 3.2A). The differences between the two clusters are independent of the taxonomical
assignment. We confirmed that SPyParE1 and SPyParE2 belong to the ParE superfamily
(Figure 3.2A), wherein some of its most similar counterparts previously characterized are
ParE3 from E. coli (EcParE3) (Hallez et al., 2010), ParE2 from M. tuberculosis H37Rv
(MtbParE2) (Gupta et al., 2016) ) and ParE1 and ParE2 from Vibrio cholerae (VcParE1 and
VcParE2) (Yuan et al., 2010). Earlier reports suggest that MtbParE2 has a bacteriostatic effect
since it damages the ATPase activity of the gyrase subunit B (Gupta et al., 2016), while
EcParE3 and VcParE2 are bactericidal due to their putative interaction with the gyrase DNA
binding side, subunit A (Hallez et al., 2010, Yuan et al., 2010), which leads to unrepaired
double strand breaks.
To obtain a better insight on the toxicity of the ParE-like molecules in E. coli, I
performed killing experiments and DNA damage assessment upon expression of each toxin
protein. For this purpose, I also included the well characterized CcdB protein from V. fisheri
(VfCcdB) that strongly effects gyrase as a control (Yuan et al., 2010). In general, SPyParE1
and VfCcdB presented similar killing rates upon expression, while EcParE3 reduces viable
cells less prominently (Figure 3.2B). Strikingly, MtbParE2 did not kill the standard strain E.
coli MG1655; instead MtbParE2 only kills TOP10 cells at a similar ratio when compared with
EcParE3. Moreover, SPyParE2 and VcParE2 had a weaker effect on growth, while VcParE1
had almost no effect. Next, I evaluated the DNA damage upon toxin expression. A typical
ParE-like toxin will activate the SOS-response, a cascade of genes whose expression is
triggered in order to respond to DNA breaks and allow correct DNA replication (Baharoglu and
Mazel, 2014). SulA is one of the proteins strongly expressed upon DNA-damage who stops
cell division by binding to FtsZ monomers, the initiating protein in this process (Justice et al.,
2000; Mukherjee et al., 1998). The strain E. coli MG1655 AT15 (λatt::PsulA-gfp) wherein the
promoter of the gene sulA has been fused to the GFP-encoding gene was used to evaluate
the SOS-response. In addition, Ciprofloxacin (CPX), which is an antibiotic that arrest DNA
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r e pli c ati o n a n d tri g g er s S O S r e s p o n s e, w a s u s e d a s a c o ntr ol f or t hi s e x p eri m e nt.  A s s h o w n
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to high nucleoid condensation and an effect on topo IV mainly to cell elongation and
unsegregated DNA (Harms et al., 2015; Kato et al., 1990). In order to explore the phenotype,
I compared cells under the microscope after two hours of each toxin expression (Figure 3.3).
The control conditions have shown normal cell size of around 2 µm while the DNA molecule
was spread over the cell area, similar to the VcParE1 expression conditions, which did not
display toxicity, consistent with the SOS response and growth arrest results (Figure 3.2B and
3.2C). SpyParE1 seemed to have the greatest effect as the cells showed stronger cell
elongation and a highly compact nucleus while SPyParE2 and EcoParE3 led to milder cell
elongation and a different DNA pattern (Figure 3.3). The nucleoid condensation was a
consistent phenotype also observed in cells treated with CPX and upon VfCcdB expression,
wherein cell elongation was not as prominent as when SPyParE1 was expressed (Figure 3.3).
Moreover, expression of VcParE2 and MtbParE2 (TOP10 E. coli cells) led to less cell
elongation while the DNA pattern looked normal (Figure 3.3). These data indicate that ParE-
like toxins could potentially harbor different affinities or dissimilar targets.
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Figure 3.3: Expression of ParE1-likes proteins lead to strong phenotypes in E. coli.
Fluorescence microscopy of samples from 3.2B, 120 minutes upon toxin induction showed cell
elongation and nucleoid condensation upon induction of each toxin and in a less extent under CPX,
MtbParE2, VcParE1 and VcParE2 treated conditions. Sample preparation was performed as
described for 1.2C. Representative pictures are shown.
Other ParE-like toxins are counteracted by Topo IV subunit E
In order to further investigate whether the toxicity of SPyParE1 and SPyParE2 is an
exclusive characteristic modulated upon co- expression of gyrase and topo IV E, I performed
growth rescue experiments under putative target expression in comparison with the homolog
EcParE3 and the unrelated toxin VfCcdB. Co-expression of EcParE3 and either the full gyrase
complex or each of the gyrase subunits led to similar killing as for SPyParE1 and SPyParE1
(Figure 3.4). It is well known that VfCcdB poisons the gyrase and has a high affinity to gyrase
VcParE2
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s u b u nit  A  t h e  D N A  i nt er a cti n g  d o m ai n  i n v ol v e d  i n  cl e a v a g e  a n d  s e ali n g;  a s  e x p e ct e d,  c o-
e x pr e s si o n of g yr a s e A r e s c u e d gr o wt h u p o n Vf C c d B e x pr e s si o n ( Fi g ur e 3. 4). T h e gr o wt h
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Growth prevention experiments of E. coli cells harboring each toxin under the Para control and each
of the putative toxin targets under the Prha control, (as described in 3.1). Data below “0” represented
killing, and around “0” or above represented growth. Co-expression of gyrase and SPyParE1,
SPyParE2 or EcParE3 led to stronger killing while co-expression of gyrase A and CcdB led to growth.
Topo IV E expression prevents the growth effect by SPyParE1, SPyParE2 and EcParE3 expression.
Experiments were performed as previously described in Figure 3.3, and the plot represented the CFU
ml-1 count normalized to time zero (log10 scale) upon expression of each toxin for 1 hour. Error bars
denote standard error of at least three biological replicates. Pairwise comparison using t-test was
performed to determine the significance between the toxin-expression conditions with and without
the target (control).
The SPyParE1, SPyParE2 and EcParE3 toxins poison Gyrase and inhibit
Topoisomerase IV
SPyParE1, SPyParE2 and EcParE3 might target the gyrase with a putative different
mechanism to what have been typically described for CcdB (Bahassi et al., 1999; Bernard and
Couturier, 1992; De Jonge et al., 2010), since they appeared to act on the whole gyrase
complex. I observed that SPyParE1, SPyParE2 and EcParE3 targeted and potentially can
interact with the topo IV subunit E, resulting in inhibition of topo IV. To confirm these in vivo
findings I performed biochemical assays to analyze the effect of the ParE toxins on the E. coli
recombinant DNA gyrases and topo IV proteins. I aimed to express SPyParE1 in E. coli for
protein purification and repetitively acquired random mutations, possible due to the detrimental
effect on cell growth. Therefore, I decided to use an in vitro translation system to produce the
toxin proteins of interest. First, the E. coli gyrase supercoiling activity was assessed incubating
the recombinant enzyme with a relaxed plasmid substrate in the presence of each toxin. In
addition, the topoisomerase interfacial poison CPX that stimulates the formation of DNA
cleavage complexes and the catalytic inhibitor novobiocin (NOV), which inhibits the
topoisomerase activity were also included. As expected, gyrase alone was able to supercoil a
relaxed plasmid, whereas the presence of CPX blocked the gyrase resealing capacity
resulting in accumulation of topoisomers of the plasmid while NOV abrogated the gyrase
function leading to absence of supercoiled plasmid (Figure 3.5A). Finally, the supercoiled
fraction of the substrate was significantly reduced in the presence of SPyParE1, SPyParE2
and EcParE3 similar to what we observed with VfCcdB confirming that all these toxins inhibit
the gyrase function.
As mentioned above, topo IV has not been reported as a potential ParE target thus,
the effect of the different toxins on the topo IV relaxation activity was tested (Figure 3.5B). In
the absence of any drug the expected topoisomers were formed, which indicates normal topo
IV activity while in the presence of CPX the linear form accumulates due to the inhibition of
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DNA-breaks sealing by topo IV (Figure 3.5B). In contrast, NOV abrogated topo IV activity and
the supercoiled form of the plasmid accumulated. The presence of SPyParE1, SPyParE2 and
EcParE3 also resulted in the accumulation of supercoiled plasmid, while VfCcdB did not have
an effect on the relaxation activity (Figure 3.5B), suggesting that the ParE toxins inhibit topo
IV like NOV, which is in concordance with our in vivo results (Figure 3.4).
Figure 3.5: SPyParE1, SPyParE2 and EcParE3 target E. coli gyrase and topoisomerase IV
recombinant proteins
A. The drugs CPX, NOV and the toxins SPyParE1, SPyParE2, EcParE3 or VfCcdB (in vitro translated
proteins) affected the gyrase capacity to supercoil a relaxed plasmid. B. CPX poisoned topo IV when
relaxing a supercoiled vector leading to a linear form while NOV, SPyParE1, SPyParE2 and EcParE3
abrogated the topo VI relaxation activity leading to the accumulation of the supercoiled form. VfCcdB
did not impair topo IV activity. Representative pictures of at least three biological replicates are
shown.
The effect of the more toxic SPyParE1 molecule versus the homolog EcParE3 was
also tested with the recombinant gyrase and topo IV proteins from the closely related organism
Streptococcus pneumonia (Spn). I have also included to these experiments the MtbParE2
molecule that was toxic only in top10 E. coli cells (Figure 3.2 and 3.3) and is known to be
specific towards gyrase subunit B (Gupta et al., 2016). The results indicated that the Spn
gyrase partially supercoiled the template in the presence of EcParE3 or MtbParE2, but only
SPyParE1 led to the formation of a linear product, which is a typical attribute of a poison that
impairs the re-resealing activity of the gyrase (Figure 3.6A). This observation also indicates
that SPyParE1 might have more affinity to the Spn gyrase than ParE3 from E. coli. Equally,
the relaxation experiments revealed the same results obtained with the recombinant topo IV
from E. coli (Figure 3.6B). Importantly, topo IV also has the ability to decatenate DNA
molecules, a process that plays an important role in the separation of daughter DNA molecules
during cell division (Vos et al., 2011). Therefore, we also studied the decatenation activity of
Supercoiling assay
Relaxed plasmid + supercoiled
Gyrase
linear
supercoiled
drug
gyrase
plasmid
relaxed
Relaxation assay
Supercoiled
plasmid +
Topo IV
coiled
nicked
linear
linear
supercoiled
drug
topo IV
plasmid
relaxed
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- CPX NOV SPyParE1 SPyParE2EcParE3 VfCcdB
+
-
- +
-
-
+
+
+
+
+
+
+
+
+
+
+
+
+
+
- CPX NOV SPyParE1 SPyParE2EcParE3 VfCcdB
+
-
- +
-
-
Results
82
Spn topo IV on kinetoplast DNA (kDNA) as a substrate. In the absence of drugs, Spn topo IV
decatenates kDNA into monomers while CPX, NOV and high concentrations of SPyParE1,
EcParE3 or MtbParE2 completely abrogate the decatenation activity, which confirmed that
these toxins can inhibit topo IV (Figure 3.6C). The results showed that the ParE-like toxins
tested can target both gyrase and topo IV, however, their specificity might vary leading to the
different phenotypes observed in vivo.
Figure 3.6: SPyParE1 strongly poisons S. pneumonia gyrase when compared with ParE
counterparts while all ParE-like toxins tested inhibit topo IV activities in vitro.
A. The drugs CPX, NOV and two different quantities of EcParE3, MtbParE2 and SPyParE1 (in vitro
translated toxins) affected the gyrase capacity to supercoil a relaxed plasmid. SPyParE1 strongly
poison gyrase leading to the linear from of the vector B. CPX poisoned topo IV when relaxing a
supercoiled vector leading to a linear form of the vector, while NOV or high concentrations of
EcParE3, MtbParE2 or SPyParE1 abrogated the topo VI relaxation activity leading to the
accumulation of the supercoiled form of the vector. C. In the absence of drugs topo IV decatenates
kDNA into monomers while CPX, NOV or high concentrations of EcParE3, MtbParE2 or SPyParE1
abrogated the topo VI decatenation activity leading to the accumulation of the kDNA substrate on the
gel wells. Representative pictures of at least three biological replicates are shown.
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3.4 The TA Operons parDEF1 and parDE2 are Stress Response Elements in
S. pyogenes
Toxin-Antitoxin systems can provide certain advantages to bacteria, for e.g. biofilm
formation, post-segregational killing, abortive infection, and expression of persistence stage
have been related to these modules. In this section, I present insights into the role of the two
chromosomally encoded ParDE-like TA systems in S. pyogenes. First, I assessed the
phenotypical characteristics of the ΔparDE1 and ΔparDE2 mutants in comparison with the
wild type strain and did not find a difference neither in growth nor in biofilm formation, leading
to the conclusion that the absence of single TA modules does not impair S. pyogenes fitness
under these conditions. TA systems are also well defined as stress-response elements.
Namely, upon stress, the antitoxin degradation will not only liberate the toxin to inhibit growth,
but will also loosen the repression of the TA promoter. Thus, we assessed the TA transcript
levels in wild type strain upon exposure to different stress conditions. The findings suggest
that both parDEF1 and parDE2 are stress response elements up-regulated upon treatment
with the multiple factorial inducer ethanol (EtOH) and serine hydroxamate (SHX) that mimics
amino acid starvation. In both cases the parDEF1 mRNA was more abundant than the parDE2
mRNA. Surprisingly, additional mRNA transcripts below the expected size of the parDE2
mRNA, were evident upon SHX treatment and absent in the control conditions. We
hypothesize that a post-transcriptional regulation of the parDE2 mRNA might occur upon
stress in S. pyogenes.
The absence of parDE1 and parDE2 does not impair S. pyogenes fitness
Redundant TA copies can be found in the chromosome of some bacteria, yet their role
is not well understood. Single or multiple deletions of TA modules might not lead to a reduction
in fitness when compared with the wild type strain (Shan et al., 2017). However, I wanted to
assess this possibility by phenotypical comparisons between the single TA mutants and the
wild type strain. First, I studied the fitness of S. pyogenes by counting CFU ml-1 during the
exponential phase of growth. As depicted in Figure 4.1A the TA mutants and the wild type
strain presented the same growth trend indicating that the lack of each TA module does not
affect growth. Moreover, no phenotypically differences were observed by microscopy analysis
(data not shown).
The direct correlation of TAs with biofilm formation has been debated due to the
multifactorial reasons that lead to the same phenotype in bacteria (Kim et al., 2009; Kolodkin-
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Gal et al., 2009). Mutations in the yafQ/dinJ TA system, or interruption of the hipA toxin gene
was reported to result in a prominent decrease in biofilm formation, as well as mazEF deletion.
In order to assess whether parDEF1 and parDE2 affect biofilm formation I grew the cells in
polystyrene coated plates at two different temperatures (25°C or 37°C) and quantified the
bilayer formed after 24 hours of incubation by coomassie blue staining. No statistical
differences were observed when comparing the TA mutants with the wild type strain (Figure
4.1B and 4.1C). Nevertheless, at 25°C the biofilm formation of the ΔparDE2 mutant tends to
be higher implying that ParDE could act as a biofilm repressor (Figure 4.1C). Further
experiments are required to confirm this phenotype and test whether the lack of parDE2 favors
biofilm formation of S. pyogenes.
Figure 4.1: The absence of parDE1 and parDE2 do not affect S. pyogenes growth nor biofilm
formation.
A. S. pyogenes wild type, ΔparDE1 and ΔparDE2 growth curves in THY media showed that the
absence of each TA operon did not impair growth. B-C. S. pyogenes wild type, ΔparDE1 and
ΔparDE2 biofilm formation experiments were done by growing the cells in polystyrene 96 well plates
and quantifying the bio layer (crystal violet) on the bottom after 24 hours of incubation at either 25°C
(B) or 37°C (C). The absence of the TA operons did not impair biofilm formation.
ParDEF1 and ParDE2 are stress response elements
As TA systems are also known to be involved in stress response, I aimed to study the
parDEF1 and parDE2 regulation upon different stress conditions that mimic the conditions S.
pyogenes might potentially face in vivo, e.g. oxidative, osmotic, heat-shock stress and
antibiotic treatments. The different stress inducers of these conditions were tested at the
selected compound concentrations that did not lead to death but growth arrest (Figure 4.2A).
We then added the chosen concentration of each inducer to S. pyogenes wild type cultures at
early exponential phase of growth, and collected RNA samples at different time points to follow
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the TA transcript abundance by performing qRT-PCR of the antitoxin mRNA molecule,
assuming that both the antitoxin and the toxin are equally co-transcribed. Conditions such as
oxidative and osmotic stress did not trigger parD1 neither parD2 mRNA antitoxin expression
(Figure 4.2B and 4.2C), unlike the general stress inducer ethanol that caused an increase in
abundance of antitoxin mRNA transcripts (Figure 4.2B and 4.2C).
Figure 4.2: The general stress inductor ethanol triggers the S. pyogenes TAs transcription.
A. Early exponentially growing cells treated with different stress inducers for one hour, showed to
arrest S. pyogenes growth (OD620nm followed for one hour). Error bars represent the standard
deviation of at least three biological replicates B-C. RNA samples were taken from S. pyogenes
cultures grown until early exponential phase, treated with different stress inducers as described in A.
qRT-PCR analysis (using cDNA as template) showed to trigger the parD1 mRNA (B) and in less
extent parD2 mRNA (C) transcription upon 8% ethanol treatment. The relative fold change was
calculated by using the trfA housekeeping gene and normalized to the control conditions. Error bars
represent the standard deviation of at least three biological replicates. M.Sc. Cristian Aparicio
contributed to the qRT-PCR analysis.
We wondered whether the concentration of ethanol used was indeed arresting the
growth but not killing the cells. Therefore, we added 8% or 10% of ethanol to S. pyogenes wild
type cultures at early exponential phase and followed growth by measuring the optical density
(Figure 4.3A) and by counting the CFU ml-1 (Figure 4.3B). Results confirmed that 8% ethanol
was indeed arresting the growth but not leading to cell death. We next quantified the TA mRNA
levels, but this time we assessed the antitoxin and toxin mRNA transcripts and found that
parDE1 and to a lesser extent parDE2 operons are indeed induced by ethanol treatment
(Figure 4.3C). In general, the transcriptional induction of TA loci is probably due to the
antitoxin degradation by the proteases triggered by stress (reviewed by Harms et al., 2018).
We also assessed the expression of the gene encoding the ClpP protease possibly involved
in antitoxin degradation in S. pyogenes and observed an up regulation under ethanol
treatment with the highest expression 5 minutes upon stress induction (Figure 4.3C). Finally,
we confirmed our previous observation by Northern blot assays targeting the parE1 or parE2
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toxin mRNA and observed that the parE1 and parE2 transcripts were evident 15 and 45
minutes upon ethanol addition, respectively (Figure 4.3D). The effect that ethanol might have
in the cells is rather general and although this stress is not a physiological condition that S.
pyogenes is likely to encounter in vivo, the results imply that the TAs from S. pyogenes might
be stress response elements.
Figure 4.3: The general stress inductor ethanol triggers parDEF1 and parDE2 transcription.
A-B. Growth curve by measuring OD620nm (A) and CFU ml-1 counting (B) upon stress induction as
described in 4.2, with ethanol at two different concentrations, revealed that the 8% did not impair
growth while 10% killed the cells (B). C. RNA samples of cultures treated with 8% ethanol were taken
from experiments performed as described in 4.2B-C, and qRT-PCR analysis (using cDNA as
template) showed to trigger parD1, parE1 and in less extent parD2, parE2, as well as the controls
clpP and in a less extent htrA transcription. Error bars represent the standard deviation of at least
three biological replicates. M.Sc. Cristian Aparicio contributed to the qRT-PCR analysis. D. The
parDEF1 and in less extent parDE2 operon are up regulated upon ethanol stress conditions. RNA
samples were taken from S. pyogenes cultures grown until early exponential phase, treated with 8%
ethanol for 1 hour. Northern blot analyses were performed using a probe targeting the 16S rRNA as
a loading control and a probe targeting the parE1 and parE2 gene, respectably to detect the toxin-
antitoxin (TA) mRNAs. A representative picture is shown.
The parDEF1 and parDE2 operons are triggered upon amino acid starvation
Next, I decided to separately test each of the cellular consequences potentially caused
by high concentrations of ethanol, starting with amino acid starvation, which is the most
common condition that triggers TA systems (reviewed by Harms et al., 2018). Serine
hydroxamate (SHX) was shown to induce amino acid starvation and has been used to test TA
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expression in other bacteria (Christensen et al., 2001b). SHX is an analogue of L-serine that
inhibits charging of Seryl-tRNA synthetase and therefore induces the synthesis of ppGpp
(guanosine tetraphosphate), which is the master regulator of the stringent response in E. coli
(Traxler et al., 2008). Different concentrations of SHX were tested to select a quantity that
might cause stress without killing the cells (Figure 4.4A). Interestingly, all tested
concentrations below 15 mg ml-1 arrested growth but did not lead to death (Figure 4.4A).  We
selected 5 mg ml-1 to further evaluate the TA influence at the transcriptional level (Figure
4.4B). In agreement with our previous findings, our preliminary Northern blot analysis using a
probe specific for the toxin mRNA demonstrated up-regulation of both S. pyogenes TA loci
under amino acid starvation (Figure 4.4B). Surprisingly, additional bands below the expected
size of the parDE2 operon were evident 10, 20 and 30 minutes upon SHX addition, but were
absent in the control conditions. The mRNA encoding the toxin that is being detected by the
probe increased over the time, which might suggest a putative processing of the mRNA.
Figure 4.4: The parDEF1 and parDE2 operon expression is up regulated upon amino acid
starvation.
A. S. pyogenes wild type growth curve by measuring OD620nm upon stress induction with SHX at
different concentrations revealed that none of the concentration tested impaired growth. B. The
parDEF1 and in less extent parDE2 operon were up regulated upon SHX stress conditions. The
parDE2 mRNA transcript seemed to be processed since several bands below the mRNA TA
transcript size were detected.  RNA samples were taken from S. pyogenes cultures grown until early
exponential phase, treated with SHX 5mg ml-1 for 30 minutes. Northern blot analysis were performed
using a probe targeting the 16S rRNA for loading control and a probe targeting the parE1 and parE2
gene, respectably to detect the toxin-antitoxin (TA) mRNAs. A representative picture of three
replicates is shown.
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3.5 ClpXP is Responsible for the ParD1 and ParD2 Antitoxin Degradation
In a conventional TA type II system, the antitoxin is a less stable protein prone to
degradation by the bacterial proteolytic machinery. This might be the main mechanism by
which the toxin is freed to cause an influence bacterial physiology. In this section, I describe
the characterization of the ParDEF1 and ParDE2 post-translational regulation through
antitoxin degradation. ParD1 and ParD2 proteins were unstable in the wild type strain while
stable in the ΔclpP and ΔclpX mutant backgrounds, suggesting that the ClpXP proteolytic
machinery is implicated in the antitoxin degradation. Moreover, both antitoxins displayed
different half-life in the wild type strain. Although the secondary structure prediction
hypothesizes rather structured C-terminal domains, the conformation and ClpXP accessibility
of certain residues may differ between the antitoxins. Additional factors for antitoxin
degradation may be involved; ParF1 could decrease ParD1 stability, since the protein was not
detectable when co-induced with ParF1. Finally, the long half-life of the wild type ParD2 was
significantly reduced when 15 of the C-terminal residues were removed, indicating the
importance of this domain for its stability. Further experiments in different stress conditions
and in the presence of the cognate toxin will give us more insights into the activation of these
ParDE-like modules.
ParD1 is an unstable protein degraded by ClpXP
To further characterize ParD1 I analyzed the in silico protein features that might give
an idea of the domain/region which is less stable or prone to degradation by bacterial
proteases. As already shown in Figure 1.4A, the C-terminal domain of ParD1 is predicted to
be structured with a well-defined α-helical shape. This characteristic could lead to a more
stable protein structure when comparing it with other antitoxins that typically have intrinsically
disordered C-terminal domains (Madl et al., 2006; Oberer et al., 2007). To confirm our
bioinformatic predictions, I expressed the N-terminal FLAG tagged ParD1 variant that was
previously shown to be an active antitoxin (Figure 1.2F) and followed the protein levels in the
wild type strain by Western blot analysis after protein synthesis was stopped. As shown in
Figure 5.1A the antitoxin ParD1 was unstable with a half-life of approximately 20 minutes
(Figure 1.5B). In addition to ClpP protease, the Gram-positive bacterium S. pyogenes harbors
the ClpX, ClpE and ClpC ATPases. In order to identify the protease complexes responsible
for the degradation of ParD1, different clp mutant backgrounds were constructed. ParD1
showed stability in the in the ΔclpP and ΔclpX mutants in comparison with the wild type and
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ΔclpC and ΔclpE mutant strains, suggesting that ClpXP is the protease complex responsible
for ParD1 degradation (Figure 5.1A).
Structural flexibility of an antitoxin may not completely explain its susceptibility to
proteolysis; specific C-terminal residues may also be implicated in the recognition for
degradation. Some reports have identified the presence of ClpX degradation tags in many
ClpX substrates, such as: SsrA-tag in streptococci (Tao and Biswas, 2015), the LPF C-
terminal domain in Streptococcus mutants (Jana et al., 2016) and other ClpXP consensus
recognition-signals (reviewed by Baker and Sauer, 2012). The ParD1 antitoxin does not
contain any of the known C-terminal ClpXP recognition residues. However, hydrophobic or
solvent-exposed regions of the protein may be recognized for degradation too. In order to
identify the residues that might be involved in the ParD1 recognition, I performed protein
stability experiments by testing a ParD1 antitoxin variant lacking the last 5 residues at the C-
terminus. Results revealed that the last 5 C-terminal residues of ParD1 were not implicated in
antitoxin recognition, since this antitoxin variant had an equal rate of degradation as the wild
type antitoxin (Figure 5.1C).
Finally, I wanted to assess the ParD1 stability in the presence of ParF1 that did not display
toxin or antitoxin function in the cell (Figure 1.2E). For this purpose I ectopically co-expressed
the two molecules from the same promoter and followed ParD1 stability over time. Since no
signal was detected from ParD1-ParF1 expressed cultures in comparison with the solely
ParD1 expression, I next aimed to detect ParD1 by Western blot after pull down of ParD1.
Interestingly, less ParD1 protein was visible only when ParF1 was co-expressed suggesting
that ParF1 might be implicated in the ParD1 stability (Figure 5.1D). However, the ParD1 and
ParF1 interaction might be transient or weak, since ParF1 was not detected from the ParD1
pull down experiments and MS analysis previously described in the section 3.1. Additional
efforts are needed to further characterize the role ParF1 might play in S. pyogenes.
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Figure 5.1: ParD1 degradation is ClpXP dependent and possibly mediated by ParF1.
A. The in vivo ParD1 stability was assessed in S. pyogenes wild type and ΔclpP, ΔclpX ΔclpC and
ΔclpE deletion mutant strains harboring the plasmid pEC85PtetΩFLAGtag-SPy_parD1. Western blots
were performed from samples taken at mid-exponential phase of growth upon translation arrest every
20 minutes for 2 hours and the protein HtrA was detected as loading control. The ParD1 antitoxin
was unstable in the wild type strain while stable in the ΔclpP and ΔclpX mutants. B. A half-life of
approximately 20 minutes was determined for the ParD1 protein by measuring the western blot signal
by Image J C. The in vivo ParD1 Δ5 C-terminus variant stability assays in S. pyogenes wild type
strain (as described in A), showed the same degradation ratio as the wild type ParD1 protein (A). D.
In vivo N-terminus FLAG-tagged ParD1 pull downs as described in 1.2G revealed a weaker signal
upon co-expression with ParF1.
ParD2 is a more stable protein and also degraded by ClpXP
Next, I was interested in characterizing the degradation rate of ParD2. As it has been
previously described (Figure 2.5A) the protein features determined in silico correlate with
what was observed for ParD1. Namely, ParD2 also harbors a well-defined α-helical structure
in the C-terminal implying that ParD2 might be a stable protein. I also followed the protein
levels by Western blot analysis upon expression of the N-terminal FLAG-tagged ParD2 variant
that was functional as an antitoxin (Figure 2.2E). ParD2 appeared to be less prompt for
degradation when compared with ParD1, with a half-life of roughly 47 minutes (Figure 5.2A
and 5.2B). In agreement with the ParD1 results, ParD2 was completely stable in the ΔclpP
mutant, suggesting that ClpP is the protease responsible for ParD2 degradation. Moreover,
ParD2 exhibited stability in the ΔclpX mutant when compared with the ΔclpC and ΔclpE mutant
backgrounds, which suggest that ClpX might be the main chaperone involved in ParD2
degradation. Interestingly, the ParD2 protein tends to be also stable in the ΔclpC mutant strain
but in a less extent in comparison with ΔclpX, therefore I cannot completely rule out whether
only ClpX or both ClpX and ClpC chaperons are involved in ParD2 degradation. Additional
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experiments will confirm this finding; ClpXP or ClpCP might be responsible for the ParD2
degradation under distinct conditions.
As for ParD1, ParD2 did not contain any SsrA-tag (Tao and Biswas, 2015),  LPF C-
terminal domain (Jana et al., 2016) or any other ClpXP consensus recognition-signal
previously reported (reviewed by Baker and Sauer, 2012). However, the C-terminus might
contain important features since the deletion of the last 15 C-terminal residues of ParD2
appeared to influence the stability of the protein. This variant had a half-life of less than 20
minutes compared to the half-life in the wild type strain (Figure 5.2C). Association of the last
C-terminus residues with a yet unknown stabilizing interaction partner might explain the
greater stability of ParD2 in the wild type strain. Nevertheless, the deleted 15 C-terminal
residues could also lead to changes in the protein structure that make the molecule more
susceptible to proteolytic degradation.
Figure 5.2: ParD2 degradation is ClpXP dependent.
A. The in vivo ParD2 stability assays were assessed in S. pyogenes wild type and clpP, clpX, clpC
and clpE deletion mutant strains harboring the plasmid pEC85PtetΩFLAGtag-SPy_parD2. Western
blots were performed from samples taken at mid-exponential phase of growth upon translation arrest
every 20 minutes for 2 hours and the protein HtrA was detected as loading control. The ParD2
antitoxin was unstable in the wild type strain while more stable in the ΔclpP and ΔclpX mutants. B. A
half-life of approximately 47 minutes was determined for the ParD2 protein. C. The in vivo ParD2
Δ15 C-terminal variant stability assays in S. pyogenes wild type strain (as described in A), showed a
faster degradation ratio in comparison with the ParD2 native protein (A).
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4 DISCUSSION
The role of many chromosomally encoded TA copies is not well understood and
strikingly their diversity in Gram-positive bacteria cocci is not fully appreciated. This work
describes the functional characterization of two chromosomal parDE-like TA homologs in the
human pathogen S. pyogenes: the tri-party TA system parDEF1 and the bicistronic parDE2
operon. S pyogenes is characterized by its remarkable ability to endure diverse host
conditions by mechanisms that are still unraveled. To date, this is the first report about
chromosomally encoded TA systems in S. pyogenes and in this section, the features that
provide the basis to understand their molecular mechanism for controlling bacterial growth will
be discussed.
4.1 The TA genomic context might correlate with its role
The biological roles of chromosomally encoded TA systems have been a matter of
discussion and controversy in the last years and two main roles have been related to them:
DNA-stabilization or stress response. TAs related with DNA stabilization were first described
in plasmids where typical ParDE-like TA systems are predicted to be addiction molecules that
need to be maintained so that the vector remains in the offspring, a concept known as PSK
(Roberts et al., 1994b). Presumably, ParDE systems encoded within bacterial chromosomes
are important for stabilization of DNA-regions that need to be kept during infection. As a matter
of fact, a previous report suggests that parDE modules encoded in the chromosome II of Vibrio
cholerae could potentially stabilize DNA regions that might be needed for bacteria (Yuan et
al., 2011). Moreover, the CopAso-ParEso TA operon has been recently shown to stabilize a
conjugative and integrative element within the chromosome of Shewanella oneidensis (Yao
et al., 2018). Thus, the analysis of the TA genomic context could give us potential clues for
their cellular function; in S. pyogenes the genomic contexts of the parDEF1 operon shows
putative prophage and antibiotic-resistant genes conserved among different serotypes
(Figure 1.1C), suggesting that this region could be under positive selection during the
evolution of this species. I speculate that this genomic area somehow gives to S. pyogenes a
selective advantage and that the parDEF1 operon might be involved in its maintenance. The
findings also suggest that this TA module might be originated from a phage since genomic
composition revealed that parDEF1 is present in a region with low GC content compare to the
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chromosomal GC composition in S. pyogenes. Additional effort is needed to test whether the
putative prophage region gets lost upon deletion of the parDEF1 TA element.
On the other hand, the parDE2 locus is also highly conserved among S. pyogenes
serotypes and its genomic context contains hypothetical genes implicated in diverse functions
(Figure 2.1C). A putative integrase homolog of the bacteriophage MM1 from S. pneumonia is
the only sign of a foreign DNA incorporation event, however, in our strain this gene seems to
be non-functional since it is truncated (Figure 2.1C). Furthermore, the GC content analysis
showed in average the same value compare to the genomic content. Due to the lack of
evidence we cannot hypothesize that the parDE2 locus is involved in PSK, instead, it might
be for instance a foreign selfish element or an altruistic programmed cell death system that
gets triggered to sacrifices part of its host population in adverse conditions.
4.2 ParDEF1 and ParDE2 TA modules are stress response elements in
S. pyogenes
Beside DNA-stabilization another important function of chromosomal TA systems is
cellular stress response, providing to the bacterial population an advantage to survive when
facing adverse conditions (reviewed by Gerdes et al., 2005). The basal expression of TA
systems in S. pyogenes is low. Conversely, among many stress conditions tested, the
parDEF1 and in a less extent the parDE2 operon responded to a non-lethal concentration of
ethanol that has a rather general cellular effect (Figure 4.2 and 4.3). Ethanol can decrease
pH, induce protein damage and aggregation, disrupt the fatty acid composition and function
of the membrane, and has profound effects on nutrient transport and metabolism, especially
the catabolism of amino acids (Chatterjee et al., 2006). The ethanol stress induction might
trigger TA-unrelated pathways that lead to a disruption of many functions, including
destabilization of protein structures. It has been reported that the stimulation of TA
transcriptions occurs due to the lack of TA promoter repression by the unstable antitoxin
(Christensen et al., 2001b). Therefore, TA levels of expression under ethanol conditions
indicated that the repression from the TA operon was released due to either a compromised
antitoxin structure or acceleration of the antitoxin proteolysis. It will be interesting to determine
whether the degradation of the antitoxin protein upon stress could result in a faster induction
of the system and thus can prompt toxin release.
It has been reported that many chromosomal TAs are overexpressed during amino
acid starvation in E. coli (reviewed by Gerdes et al., 2005). Since this is one of the cellular
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effects of ethanol, we assessed TA expression under SHX treatment in S. pyogenes, which is
a structural analog of L-serine that inhibits charging of seryl-tRNA and thereby induces amino
acid starvation (Christensen et al., 2001b). We observed an increasing abundance of the TA
mRNA upon SHX addition, suggesting that parDEF1 and parDE2 are stress response
elements which are activated under amino acid starvation conditions and the thereby induced
stringent response (Figure 4.4B).
Interestingly, the mRNA encoding the parE2 toxin that is being detected by the probe
in the NB analysis has shown the appearance of multiple bands below the expected TA operon
size which might suggest a putative transcript processing (Figure 4.4B). Upregulation of the
relBE TA systems has been observed upon SHX challenge in E. coli (Christensen et al.,
2001b). The same study observed multiple bands corresponding to the TA mRNA detected
that do not correspond to the expected TA operon size, but the authors did not comment on
that. Recent reports have suggested an additional layer of TA regulation at the post-
transcriptional level that involved mRNAses, where specific cleavages in the antitoxin mRNA
were found but interestingly also in the toxin transcripts (Altuvia et al., 2018; Lybecker et al.,
2014). I hypothesize that RNases may be involved in the regulation of TA transcripts upon
stress; this may represent a potential novel mechanism of TA post-transcriptional regulation.
However, induction of the second massager ppGpp upon amino acid starvation could also
inhibit or disrupt transcription of stable RNA operons by direct interaction with the RNA
polymerase during stringent response (reviewed by Chatterji and Kumar Ojha, 2001; Syal and
Chatterji, 2015). This process might lead to a drop-off of the RNA polymerase that leads to
different sizes of the same mRNA transcript. If the expression of the TAs is fast and tightly
regulated, it would be plausible to have a system where the antitoxin mRNA is degraded to
deplete production of the antitoxin protein - on top of its proteolytic regulation - under stress
conditions. Additional experiments will be important to validate this hypothesis assessing the
stability of the antitoxin mRNA or its disappearance over the time upon stress. This, together
with the fact that the toxin mRNA and protein are predicted to be more stable than the antitoxin
mRNA and protein molecules, would suggest a tight control of the TA systems at multiple
levels.
Furthermore, some reports have suggested the involvement of TA modules in other
cellular functions such as biofilm formation; however, their direct correlation has been
debated. As an example, MqsR is a particular type II toxin from E. coli b3022 that cross talk
with the quorum sensing molecule AI-2, while its MqsA antitoxin represses general stress
response regulators leading to reduce amount of the second messenger c-di-GMP and overall
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reduction of biofilm formation (Sun et al., 2017; Yamaguchi et al., 2009). Other reports showed
that mutations of yafQ/dinJ or mazEF TA systems or interruption of the HipA toxin gene
resulted in a prominent decrease in biofilm formation (Kolodkin-Gal et al., 2009). Our results
showed that parDE1 and parDE2 are not implicated in this process in S. pyogenes, since the
single TA mutant backgrounds did not show an impaired biofilm formation capacity (Figure
4.1B and 4.1C). Nevertheless, cumulative TA mutants that I did not test might have clearer
phenotypic outcomes (Kim et al., 2009).
Finally, It is important to note that a recent report claimed a new role of a ParDE module
from Pseudomonas aeruginosa (Pa) (Muthuramalingam et al., 2018). Muthuramalingam and
co-workers identified a protective function of the PaParE toxin against quinolones antibiotic
treatment, since both the toxin and this type of antibiotics outcompete for binding the same
target. This is an effect that relies on the amount of toxin that in high quantities might lead to
cell death (Muthuramalingam et al., 2018). Will be interesting to test this hypothesis in S.
pyogenes.
4.3 The ParD-like molecules from S. pyogenes are toxic
We have collected strong evidence to propose ParD1 as a new type of antitoxin that
has a deleterious effect in the cell: 1) ParD1 reversibly decreased viability when
overexpressed, 2) ParD1 induced nucleoid condensation, mild cell elongation and aberrant
cell septum, 3) its toxicity is exclusive since ParD homologs did not show the same effect in
E. coli and 4) its phylogenetic origin is not shared with proteins belonging to the ParD cluster.
We stress that the ParD1 target must be highly conserved among Gram-negative and Gram-
positive bacteria, since ParD1 is toxic in both the heterologous host E. coli and in S. pyogenes.
The remarkable nucleoid localization in the cells overexpressing ParD1 in comparison
with the non-induced conditions prompted me to consider that ParD1 might be targeting a
DNA-related function important during cell division or chromosomal segregation (Figure 1.3E
and 1.7). In addition, the ParD1 phenotype in E. coli looks similar to the CPX treated conditions
suggesting a potential DNA topological effect thereby possibly inducing the SOS response
(Figure 3.3 and 1.7A). Nevertheless, the SOS response was not triggered upon ParD1
expression in E. coli (Figure 1.7C), suggesting that DNA strand breaks are not a consequence
of ParD1 toxicity. DNA replication and chromosomal segregation are processes that occur
simultaneously with cell division (Reviewed by Surovtsev and Jacobs-Wagner, 2018); DNA
replication or segregation arrest will lead to an ongoing cell division that will eventually halt,
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which is evident by the cell elongation phenotype in E. coli (Figure 1.7A and 1.7D) and cell
swelling in S. pyogenes (Figure 1.3E). Furthermore, ParD1 might also affect RNA or protein
synthesis, since those are main processes that influence the cells at different levels; however,
transcription and translation arrest do not normally cause the observed nucleoid localization
upon ParD1 expression.
Interestingly, the cell septum was not visible upon ParD1 expression in E. coli
elongated cells (Figure 1.7A and 1.7D) while in S. pyogenes it appears to be abnormal
(Figure 1.3E). This phenotype is typical in Gram-positive bacteria lacking proteins important
for septum formation (Fleurie et al., 2014; Stamsås et al., 2018). In S. pneumoniae the deletion
of mid-cell anchored protein Z (MapZ) resulted in delocalization of the septum formation
protein FtsZ, which subsequently leads to abnormal cell morphogenesis, asymmetric division
and aberrant chromosomes (Fleurie et al., 2014). It has been shown that a deletion of ftsZ
inhibits cell division in Bacillus subtilis and Staphylococcus aureus (Arjes et al., 2014). Indeed,
inhibited cell division lead to an arrest in the initiation of new rounds of DNA replication, which
might lead to cell growth halt but not to the strong killing observed upon ParD1 expression.
Yet, FtsZ constitutes a good ParD1 target since it is well conserved among bacteria; however,
toxins that impair the FtsZ ring formation will induce a lemon-like morphology that we did not
observe in E. coli (Heller et al., 2017). Effects in other genes involved in septum formation
might also lead to the phenotype observed in S. pyogenes upon ParD1 expression. In S.
pneumoniae and Staphylococcus aureus, the coordinator of zonal elongation CozE mediates
control of cell division by interacting with the division protein EzrA, and the mutation of the
cozE gene leads to a similar outcome (Stamsås et al., 2018). For now, I cannot rule out
whether ParD1 is directly or indirectly affecting septum formation in the cell. Further antitoxin
pull down experiments could potentially elucidate whether ParD1 has a proteinaceous target
in the cell.
ParD1 does not share a high level of similarity with ParD2 (Figure 2.3A) and in fact,
phylogenetic analysis predicted that ParD2 belongs to the same family but clusters with a
different group of hypothetical antitoxins predicted in other S. pyogenes strains (Figure 1.5B).
The N-terminal FLAG-tagged ParD2 variant was toxic in S. pyogenes (Figure 2.4C and 2.4D),
having a detrimental effect similar to the one observed with the N-terminal tagged ParD1
protein. Interestingly neither of both, the FLAG-tagged ParD2 variant nor the wild-type ParD2
were toxic in E. coli (Figure 2.5B and 2.5C). These findings imply that both S. pyogenes ParD-
like molecules target an important function that leads to killing but does not necessarily mean
that they both share the same target. In addition, the lack of toxicity by ParD2 in E. coli could
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be due to either less specificity or the absence of the cellular target in this heterologous
system.
Remarkably, studies in E. coli with functional ParD1 variants (Figure 1.4C); have
revealed that the N-terminal naturally acquired suppressor mutations (N8I and K3A) that led
to non-toxic phenotypes, in addition, a mutation (G5A) intentionally planned resulted in a more
toxic outcome (Figure 1.4D). Moreover, ParD2 harbors the same predicted secondary
structure and the RHH fold found in the ParD1 N-terminal side that potentially interacts with
DNA and might be involved in the target recognition. Intriguingly, among some of the amino
acids that both share the residue K and N at the N-terminus that showed to be important for
ParD1 toxicity are conserved in ParD2. The N-terminus similarity between the two S.
pyogenes ParD proteins could highlight important features that support the involvement of this
region in the non-canonical antitoxin target recognition. Therefore, I do not exclude that the S.
pyogenes ParD-like antitoxins have a DNA related target.
Even though they are not reports about deleterious effects upon antitoxin
overexpression in bacteria, some reports shown that antitoxins can also act as transcriptional
regulators (Brown et al., 2009; Hu et al., 2012; Wang et al., 2011). The MqsA (from the MqsAR
TA system) and DinJ (from the DinJ-YafQ TA system) antitoxins, influence the general stress
response by transcriptionally regulating the rpoS gene encoding the sigma-S factor, which is
the master regulator of stress response (Brown et al., 2009; Hu et al., 2012; Wang et al.,
2011). In addition, MqsA is a stable antitoxin that also binds the promoter DNA-regions of
some genes important for E. coli cell physiology e.g. mcbR and spy, via its C-terminus domain
(Brown et al., 2009; Wang et al., 2011). Thus, we speculate that S. pyogenes ParD-like
antitoxins are potential transcriptional regulators and that their N-terminal side plays an
important role in the bacterial DNA-promoter recognition. Antitoxins are more diverse than
previously recognized and are perhaps vital in mediating bacteria stress responses, their
implications as transcriptional regulators need to be explored in detail.
4.4 ParD1-ParE1 migth constitute a dual toxin-antitoxin system
The findings presented in this work suggest that parDEF1 is a non-canonical TA
system: 1) the antitoxin-toxin genes are typically co-transcribed in the natural host and up-
regulated under stress conditions, 2) in S. pyogenes and in the heterologous host E. coli,
ParD1 and ParE1 reduce viable cells when overexpressed ectopically, 3) ParD1 prevents but
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not reverses the ParE1 toxicity while ParE1 rescues the ParD1 deleterious effect and 4) The
ParD1 antitoxin is typically degraded by ClpXP, which might have an implication in the
regulation of TA activity. I speculate that the parDEF1 operon migth work as a dual-TA system
where two of its molecules need to co-exist in the host to allow growth. Regarding the parDE2
operon that is indeed a bona fide TA system, more evidence is needed to elucidate its putative
TA dual function.
In typical ParDE-like TA systems, the prevention versus reversion of toxicity has been
investigated. Prevention of toxicity by the antitoxin implies that both molecules interact before
the toxin can reach its target. Reversion of toxicity denotes that the antitoxin is able to
sequester the toxin even after it has reached the target. As an example, the well-characterized
ParD antitoxin encoded in the RK2 plasmid has shown to be able to prevent and reverse ParE
toxicity in vitro (Jiang et al., 2002). Conversely, in vitro studies showed that ParD2 from V.
cholerae is able to prevent ParE2 toxicity, but is unable to rescue an already poisoned gyrase
by the toxin (Yuan et al., 2010). CcdB is a gyrase poison from the ccdAB TA system and
constitutes an example of a toxin that causes cell filamentation and nucleoid condensation
when expressed in E. coli. It has been described that the CcdB effect on gyrase can be
prevented and reversed by the antidote CcdA, (Bahassi et al., 1999; Kampranis et al., 1999).
Our data showed that ParD1 did not reverse ParE1 toxicity in the heterologous system E. coli,
instead, we observed a cumulative effect that led to stronger killing (Figure 1.8A). Conversely,
ParE1 efficiently reversed the ParD1 effect leading to cell growth (Figure 1.8A). These
findings could have important implications; if one molecule (ParE1) is able to compete with
the target of the second molecule (ParD1) for binding, it will counteract the toxic effect leading
to growth rescue. Conversely, if one molecule (ParD1) does not sequester the second
molecule (ParE1) within the toxin-target complex, the toxicity will lead to irreversible decreace
in cell-viability. We suggest that ParE1 is a toxin that irreversibly kills, while ParD1 is a toxin
that reversibly kills its host when released from the TA complex.
4.5 The ParDE1 and ParDE2 TA paralogs do not cross talk
TA cross talk has been reported in some bacteria, as an example TA paralogous in E.
coli 0157:H7 showed a cross talk interaction in between the chromosomal CcdB toxin that is
neutralized by the plasmidic CcdA antitoxin while the plasmidic toxin is not neutralized by the
chromosomal antitoxin (Wilbaux et al., 2007). Since ParDEF1 and ParDE2 constitute
paralogous TA systems it is tempting to expect cross-functionality, however, the low protein
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similarity among them suggest the absence of an interaction (Figure 2.3A). Mismatched pairs
of toxin and antitoxins were introduced into E. coli and their effects on growth and viability
were assayed. I observed that ParD1 did not protect cells from ParE2 toxicity and vice versa,
taking into account that ParD1 also has a detrimental effect on cell growth (Figure 2.3C).
Conversely, ParD2 did not fully protect the cells from ParE1 toxicity. Nevertheless, a slide
reduction of killing by ParE1 was observed in comparison with the control conditions where
ParE1 (the only molecule induced) seemed to have a stronger effect (Figure 2.3D). This
phenomenon is attributed to the to the dilution effect of the E. coli machinery needed to
translate and transcribe two molecules in parallel leading to fewer toxin copies. The absence
of the non-cognate ParE toxin molecules in both of the in vivo N-terminus FLAG-tagged ParD
pull-down assays (Figure 1.2G), further confirmed that ParDEF1 and ParDE2 do not cross
talk in S. pyogenes. Studies of chromosomal paralogous TA loci in other organisms including
the two ParDE copies from V. cholerae and the three ParDE modules in C. crescentus, also
failed to detect evidence of cross talk between antitoxin and toxins encoded by distinct TA loci
(Fiebig et al., 2010; Yuan et al., 2011). Nevertheless, another recent report showed that a
single mutation in the VapB1 antitoxin allows it to counteract the toxicity of both, its cognate
toxin VapC1 and its non-cognate toxin VapC2 from Haemophilus influenza (Walling and
Butler, 2016). Moreover, Wessner and coworkers have described the crosstalk between
chromosomally encoded type I and type II TA systems (Wessner et al., 2015). For now, there
is not enough evidence to exclude these possibilities in S. pyogenes.
4.6 ParE-like toxins are gyrase poisons and topo IV inhibitors
I provided evidence that ParE1 and ParE2 are toxic for the cell upon expression in S.
pyogenes (Figure 1.3 and 2.4) and in the heterologous host E. coli (Figure 1.2A and 2.2A).
The observed phenotype in E. coli (Figure 1.2C and 2.2B) was associated with impaired DNA
topology and DNA replication that eventually affect cell division, which is consistent with the
existing literature (Harms et al., 2015; Kato et al., 1990). The importance of topoisomerases
for the successful completion of DNA replication by preventing the buildup of torsional stress
is well established (Postow et al., 2001). The gyrase is essential; mainly important during
initiation, elongation, and termination of the DNA replication and has been reported to be the
target of typical ParE-like toxins (Gupta et al., 2016; Hallez et al., 2010; Jiang et al., 2002;
Yuan et al., 2010). This work confirmed that gyrase is one of the ParE1 and ParE2 cellular
targets since co-expression of each of the toxins and gyrase modulated the toxicity leading to
stronger killing (Figure 3.1). These results suggest that both ParE toxins interact with the
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gyrase and thereby transform it into a cellular poison that introduces DNA double-strand
breaks that lead to SOS response. As a comparison, CcdB is a well know molecule with a
particular way of harming the gyrase; it has a lethal effect when poisoning the gyrase-DNA
complex, but could also prevent cell death through the formation of a CcdB-GyrA subunit
complex that sequesters the toxin away from the gyrase complex (Bahassi et al., 1999;
Kampranis et al., 1999) (Figure 3.4). Conversely, ParE-like toxins might interact only with the
whole gyrase complex when bound to the DNA molecule inducing double strand breaks; which
would explain why co-expression of the ParE toxins with either the gyrase or its subunits did
not rescue growth (Figure 3.1). In addition, I demonstrated in vitro that SPyParE1, SPyParE2
and EcParE3 are indeed gyrase poisons, rather than inhibitors similar to VfCcdB, since they
equally damage the supercoiling activity of the gyrase complex (Figure 3.5A). Moreover, the
most toxic SPyParE1 displayed stronger effects than EcParE3 and MtbParE2 on the gyrase
recombinant protein from S. pneumonia, which is closer related to S. pyogenes validating the
prominent specificity to its natural target (Figure 3.6A).
Gyrase and topo IV are highly similar topoisomerases. However, unlike gyrase, topo
IV mainly influences chromosomal stabilization during cell division, thus interfering with the
separation of newly replicated DNA molecules (Reviewed by Sissi and Palumbo, 2010). It has
been described that the nucleoid condensation is likely a consequence of DNA gyrase
inhibition, while inactivation of topo IV is known to result in DNA catenation and knotting which
induces the so call “partition” phenotype namely cell filamentation and sequestration of
unsegregated DNA (Harms et al., 2015; Kato et al., 1990). The SPyParE1 and to a lesser
extent the SPyParE2 and EcParE3 phenotypes seem to be a cumulative effect on both the
gyrase and topo IV activity (Figure 3.3). Toxins that target gyrase and their cross-interaction
with Topo IV could be expected since these two enzymes are similar; in fact synthetic peptides
based on the plasmidic ParE from E. coli have shown to inhibit both enzymes in vitro (Barbosa
et al., 2012). This work provided the first in vivo and in vitro experimental evidence that the
chromosomal SPyParE1, SPyParE2, EcParE3, and MtbParE2 toxins indeed target topo IV,
highlighting the broader functional spectrum of ParE toxins.
The results displayed a remarkable growth rescue effect of the topo IV subunit E upon
either SPyParE1, SPyParE2 or EcParE3 toxin co-expression, unlike the opposite
phenomenon when the topo IV E homolog the gyrase subunit B is co-expressed with each
ParE toxin (Figure 3.1 and 3.4). Furthermore, topo IV E harbors the ATPase activity; ParE
interaction with this subunit would lead to complete inhibition of the topo IV relaxation and/or
decatenation activity. Alike, in vitro results demonstrated that the ParE-like toxins tested
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inhibiting topo IV like NOV, a catalytic inhibitor that abrogates the ATP activity of
topoisomerases (Figure 3.5B, 3.6B, and 3.6C). In addition, these data correlated with the
SPyParE1, EcParE3 and MtbParE2 effect on the recombinant protein from S. pneumonia,
validating the broad spectrum of these toxins on topoisomerases (Figure 3.6B and 3.6C).
These findings suggest that the ParE-like mechanism of targeting either gyrase or topo IV
might vary due to putative different specificities toward these enzymes and their subunits; this
would explain why SPyParE1 and EcParE3 poison gyrase but inhibit topo IV. Finally, our
findings indicate that ParE activity on topo IV might be an exclusive feature of this kind of
toxins as VfCcdB does not harm the topo IV enzyme as previously reported (Smith et al.,
2012) (Figure 3.4 and 3.5B).
Overall, our findings stress the functional diversity of ParE-like toxins ability to target
two essential bacterial enzymes. Gyrase and to a lesser extent topo IV are found in nearly all
bacteria but are absent in humans, this characteristic makes them interesting antibiotic targets
(reviewed by Vos et al., 2011). Fluoroquinolones are antibiotics that target topoisomerases;
their misusage has raised bacterial resistance, underlining the importance of finding new
compounds with a novel mode of action. A major challenge in designing quinolone-like drugs
that overcome target-mediated resistance relies on the ability to identify substituents that
mediate strong interaction with bacterial topoisomerases, and do not interact with the human
topo type II enzymes (Aldred et al., 2013; Mayer and Janin, 2014). In addition, topoisomerase
poisons such as CcdB and ParE or FtsZ-MrB inhibitors such as CbtA act by direct
stoichiometric interaction with their targets so that strong effects are achieved without
enzymatic activity (Heller et al., 2017). This characteristic makes them attractive drugs due to
the lack of cofactors or special conditions that enzymes need to function. Nevertheless, it will
be interesting to elucidate the nature and real requirements of ParE-like toxins interaction with
their targets.
4.7 The ParD antitoxins are subjected to degradation by the ClpXP protease
This work also showed that the antitoxins ParD1 and ParD2 are intrinsically unstable
in the wild type strain (Figure 5.1A and 5.2A). ParD1 presented a half-life of 20 minutes while
ParD2 showed a relatively long half-life of 47 minutes under normal growth conditions (Figure
5.1B and 5.2B). The half-lives of unstructured antitoxins such as RelB, HipB or ParD range
from 15 to 18 minutes (Reviewed by Gerdes et al., 2005), whereas more structured antitoxins,
such as YefM (Cherny and Gazit, 2004) or DinJ (Prysak et al., 2009) display a half-life of
almost an hour. The antitoxin degradation rates might change upon stress; this will potentially
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lead to a controlled toxin release. The MqsA antitoxin, for instance, has a structured C-
terminus, however, presents a short half-life of around 1.25 min during oxidative stress, in
comparison with the half-live of almost an hour under normal growth conditions (Brown et al.,
2009). It will be interesting to test this hypothesis for ParD1 and ParD2 under amino acid
starvation that appeared to trigger both TA systems in vivo.
ParD-like proteins are predicted to exist as dimers in solution and exhibit high thermal
stability and excellent refolding properties after heat-induced denaturation (Oberer et al 1999,
2002). The in vivo pull-down revealed three putative conformations for the N-terminal FLAG-
tagged ParD1: prominently a monomer and in a less extent a dimer and a hypothetical
degradation product below the expected size of the native ParD1 protein (Figure 1.2G). In the
in vivo stability experiments the monomeric band is the only one detected and followed over
the course of the experiment by WB, as it is the more prominent (Figure 5.1A). These findings
might suggest that there is another uncharacterized post-translational event occurring that
leads to the short version of ParD1, which might have important regulatory roles.
It has been recently described that the ClpAP protease is a universal factor that
degrades the ParD antitoxin from the RK2 plasmid and that ClpXP plays a minimal role in this
process in the Gram-negative bacteria E. coli, C. crecentus and Pseudominas putida (Dubiel
et al., 2018). In S. pyogenes, both ParD1 and ParD2 are degraded by the ClpXP protease in
vivo. Similar to our findings, the only S. pyogenes antitoxin characterized up to date, ε (epsilon)
from the native pSM19035 vector is also degraded by ClpXPB.s. protease in vitro and in vivo
in the Gram-positive bacterium Bacillus subtilis (Brzozowska and Zielenkiewicz, 2014),
suggesting a similar post-translational regulation path of chromosomally encoded antitoxins
in our model organism. This information highlight that the machinery responsible for ParD-like
antitoxin degradation varies depending on the organism. Interestingly, regulated protein
degradation often depends on additional factors such as the toxin that protects the antitoxin
from proteolysis (Dubiel et al., 2018). Moreover, previous reports have shown that the ClpAP
protease is able to bind DNA regardless of the sequence or DNA form, which increases the
ClpA ATPase activity and the ParD proteolysis efficiency (Dubiel et al., 2018; Kubik et al.,
2012). It would be interesting to investigate whether the ParE1 and ParE2 are more stable
than ParD1 and ParD2, and whether it stabilizes the antitoxin and/or protects it from
degradation as well as whether a DNA molecule plays a role in the process in S. pyogenes.
Although ParD1 and ParD2 did not show high sequence identity with any typical
antitoxin prone to degradation, some hydrophobic residues that could be protease recognition
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sites in the C-terminus are similar to the ones present in the DinJ antitoxin, which is typically
structured and degraded by ClpXP and Lon proteases in E. coli (Ruangprasert et al., 2017).
It was recently reported that a C-terminal loop predicted next to the last α-helix of DinJ is
solvent exposed and is a potent recognition site for proteolysis (Ruangprasert et al., 2017). I
attempted to evaluate the implication of the last residues of S. pyogenes ParD-like antitoxins
on its recognition for proteolysis and observed that 5 residues (after the last C-terminus α-
helix) of ParD1 did not have an implication for its stability (Figure 5.1C). Interestingly, deletion
of the last 15 residues of ParD2 led to a faster degradation rate (Figure 5.2C). This can be
due to defects on protein folding that provoke precipitation or due to the removal of a feature
that is needed for its stability or interaction with a potential protective partner.
Antitoxin degradation might also rely on adaptors (reviewed by Kirstein et al., 2009);
the adaptor molecule TrfA for instance (homolog to MecA from Bacillus subtilis) is involved in
antitoxin degradation by ClpCP in Staphylococcus aureus (Donegan et al., 2014). Additional
molecules might be involved in the recognition of ParD1 in S. pyogenes. The parF1 gene also
part of the parDEF1 operon in most of the S. pyogenes serotypes did not show toxic nor
antitoxin activity. Moreover, ParD1 pull down experiments displayed lower amounts of ParD1
detected by WB when co-induced with ParF1 (Figure 5.1D). Therefore, it is tempting to
speculate that ParF1 might somehow influence the stability of ParD1. Finally, the ParF1
function and potential interactions with the TA components and with other proteins could also
be related to a specific condition, such as stress-related conditions that have not been tested
yet.
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5 CONCLUSION AND FUTURE PERSPECTIVES
TA characterization provides new insights to tackle bacterial infections: on the one
hand, chromosomally encoded TA systems might constitute important antibiotic targets, on
the other hand, toxins might serve as drugs to treat infections since they modulate bacterial
growth. In this study, the characterization of two ParDE-like stress response TA systems
encoded within the chromosome of S. pyogenes was described. We provided a general
understandings regarding the mode of action of the ParE toxins, their broader target
recognition and TA regulation. The two systems contain ParE-like toxins that have a lethal
effect on DNA replication by poisoning the gyrase and inhibiting the topo IV, which is a feature
shared with other chromosomal ParE-like toxins from different organisms (Figure XIII and
XV). Both ParD1 and ParD2 proteins are typically degraded by the ClpXP protease, important
for the triggering of the system (Figure XIII and XV).
Figure XIII: The parDEF1 TA system in S. pyogenes:
The ParDEF1 TA system is triggered by amino acid starvation conditions. Upon antitoxin degradation
by ClpXP, the freed toxin accumulates and targets both gyrase and topo IV causing cell death. The
function of ParF1 is not known yet.
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The parDEF1 TA system may function as an addiction module that stabilized a putative
prophage region in the chromosome of S. pyogenes, It contains a third molecule ParF1, that
may play a role in the stability of ParD1 and which function is currently under study (Figure
XIII). We presented evidence of a dual TA function that in particular ParD1-ParE1 displayed
in both the heterologous host E. coli and in S. pyogenes. We hypothesize that the excess of
ParE1 leads to irreversible lose in cell-viability since co-expression of ParD1 did not result in
growth. Conversely, the excess of ParD1 reversible decrease cell-viability, which is aliviated
by co-expression of ParE1. The coexistence of both ParD1 and ParE1 in a yet unknown ratio
leads to cell growth (Figure XIV). We speculate that ParD1 migth have a target well conserved
among Gram-positive and Gram-negative bacterial species. Further experiments are needed
to elucidate the nature of the ParD1 target that could be a protein or a DNA molecule.
Moreover, we will attempt to test whether the ParD1 N-terminal region is involved in ParD1-
DNA interaction which might be the key element implicated in target recognition as a putative
transcriptional regulator.
Figure XIV: The ParDE1 migth constitute a dual TA system:
ParE1 accumulation leads to cell killing, in this condition DNA replication and chromosomal
decatenation are arrested due to toxin interaction with both gyrase and topo IV. The AT-T complex
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allows cell growth while freed ParD1 accumulation leads to non-viable cells, a state from which the
cells can be rescued by the presence of ParE1.
The ParDE2 TA module has commonly described bona fide TA characteristics (Figure
XV). Nevertheless, ParD2 showed to be toxic in S. pyogenes which may also suggest its TA-
dual function which needs to be further evaluated. Interestingly, we observed a putative
parDE2 post-transcriptional regulation via TA mRNA processing under amino acid starvation.
These data imply an additional layer of TA regulation upon stress exposure that has been
proposed for TA systems but never experimentally proven. Further studies analysing the
whole TA transcript will elucidate the nature of this putative mRNA cleavage and will provide
evidence of the potential mRNase involved in TA mRNA regulation in S. pyogenes.
Figure XV: The parDE2 TA system in S. pyogenes:
The parDE2 TA system is triggered by amino acid starvation, a condition in which a potential TA
mRNA post-transcriptional regulation occurs. Upon antitoxin degradation by ClpXP the freed toxin
accumulates and targets both gyrase and topo IV causing cell death.
The bases to understand the molecular mechanism by which chromosomal ParDE-
like TA systems function in the Gram-positive bacterium S. pyogenes were elucidated. Further
analysis will help us to understand the role of these modules during bacterial infection and the
generated knowledge should provide the foundation for the study of TA elements and their
use as either new antibiotic targets or molecular tools to kill bacterial pathogens.
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7 APPENDIX
Figure S1: Controls death prevention experiments
Death prevention experiments of exponentially growing E. coli cells harboring two vectors the
pBAD33Para empty or harboring the toxin parE1 (TTG-SD6) and the pAH160Prha empty or harboring
parF1, FLAG-tagged ParD1 or parD1-parF1. In all cases the cultures started in pAH160Prha
expression conditions (0.2% rhamnose), except for C (right panel). A. Induction of the empty
plasmids did not have an effect in growth. B. ParF1 did not prevented ParE1 toxicity (right panel) and
ParF1 is not toxic (left panel). C. The FLAG-parD1 variant prevented ParE1 toxicity (right panel) and
absence of FLAG-parD1 pre-expression led to killing by ParE1 (left panel). D. FLAG-parD1 pre-
expression led to less growth and this outcome is not modulated by co-expression of parF1 (right
panel) neither by the empty vector (left panel).
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Table 2: Strains and plasmids used in this study
Strain Relevant Characteristics Source
Escherichia coli
EC2618 E. coli K-12, MG1655, F-, λ; ilvG, rfb-50, rph-1 Kim Lewis lab
EC2620 E. coli MG1655 AT15, λatt::PsulA-gfp Kim Lewis lab
RDN204 Top10 (mcrA, Δ(mrr-hsdRMS-mcrBC), Phi80lacZ(del)M15, ΔlacX74,
deoR, recA1, araD139, Δ(ara-leu)7697, galU, galK, rpsL(SmR),
endA1, nupG)
Invitrogen (Host for cloning)
Streptococcus pyogenes
EC2514 Streptococcus pyogenes  M1 GAS SF370 ATCC 700294
EC2559 EC2514 ∆SPy_parDE1::lox72 This study
EC2568 EC2514 ∆SPy_parDE2::lox72 This study
EC2761 EC2514 ∆SPy_clpE::lox72 This study
EC2763 EC2514 ∆SPy_clpC::lox72 This study
EC1521 EC2514 ∆SPy_clpP::lox72 Laboratory collection
EC1376 EC2514 ∆SPy_clpX::lox72 Laboratory collection
Plasmid Relevant Characteristics Source
Killing assays
pEC1055 pBAD33Para (Guzman et al., 1995)
pEC1484 pBAD33ParaΩSPy_parE1(TTG-SD6) This study
pEC1601 pBAD33ParaΩSPy_parE1(TTG-SD6) L47A This study
pEC1315 pBAD33ParaΩSPy_parE2(ATG-SD6) This study
pEC1603 pBAD33ParaΩSPy_parE2(ATG-SD6) L48A This study
pEC2378 pBAD33ParaΩEcoO157:H7_parE3(ATG-SD6) This study
pEC2379 pBAD33ΩMtbH37Rv_parE2(ATG-SD6) This study
pEC2513 pBAD33ΩVc_parE1* L48P (ATG-SD6) This study
pEC2514 pBAD33ΩVc_parE2* I86T (ATG-SD6) This study
pEC2493 pBAD33ParaΩVfi_ccdB(TTG-SD6) This study
Growth rescue assays
pEC1057 pZE12Plac (Lutz and Bujard, 1997)
pEC2138 pZE12PlacΩSPy_parD1 This study
pEC1369 pZE12PlacΩSPy_parD1 F49L This study
pEC2141 pZE12PlacΩFLAGtag-SPy_parD1 This study
pEC2139 pZE12PlacΩSPy_parF1 This study
pEC1091 pZE12ΩSPy_1926 This study
Death prevention experiments
pEC2119 pAH160Prha (Harms et al., 2015a)
pEC2198 pAH160PrhaΩSPy_parD1 This study
pEC2199 pAH160PrhaΩFLAG-tag-SPy_parD1 This study
pEC2310 pAH160PrhaΩSPy_parD1- FLAG-tag This study
pEC2383 pAH160PrhaΩSPy_parD1 K3A This study
pEC2343 pAH160PrhaΩSPy_parD1 N8I This study
pEC2385 pAH160PrhaΩSPy_parD1 G6A This study
pEC2202 pAH160PrhaΩSPy_parF1 This study
pEC2205 pAH160PrhaΩSPy_parD1- parF1 This study
pEC2200 pAH160ΩSPy_parD2 This study
pEC2201 pAH160ΩFLAG-tag-SPy_ parD2 This study
pEC2120 pAH160PrhaΩgyrB (Harms et al., 2015)
pEC2121 pAH160PrhaΩparE (Harms et al., 2015)
pEC2122 pAH160PrhaΩgyrB-gyrA Christoph Dehio lab
pEC2123 pAH160PrhaΩparE-parC Christoph Dehio lab
pEC2160 pAH160PrhaΩparC This study
pEC2161 pAH160PrhaΩgyrA This study
S. pyogenes experiments
pEC85 repDEG-pAM β1, aphIII-Pjh1, ColE1 Laboratory collection
pEC1487 pEC85ΩPtetFLAGtag-SPy_parD1 This study
pEC2203 pEC85ΩPtetFLAGtag-SPy_parD1-parF1 This study
pEC1824 pEC85ΩPtetSPy_parE1 (ATG-L47A) This study
pEC1488 pEC85ΩPtetFLAGtag-SPy_parD2 This study
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pEC1820 pEC85ΩPtetFLAGtag-SPy_parE2 (TTG L48A) This study
pEC1821 pEC85ΩPtetFLAGtag-SPy_parE2 (ATG L48A) This study
pEC2162 pEC85ΩPtet FLAGtag-SPy_parD2-parE2 This study
pEC1072 pUC19ΩupSPy_0550-lox66-erm-lox71-dwSPy_0552 This study
pEC1071 pUC19ΩupSPy_1926-lox66-erm-lox71-dwSPy_1927 This study
pEC536 pEU8517ΩPtet (pCR-XL-TOPO (Invitrogen) back-bone) (Bugrysheva and Scott, 2010)
pEC454 pUC19Ωlox66-erm-lox71 Laboratory collection
pEC455 pEC85Ωßgal-PgyrAcre Laboratory collection
Table 3: Oligonucleotides used in this study
OLIGO Sequence 5´-3´ a F/Rb Target/ Purposec
RT-PCR and NB analysis
OLEC5128 AAACGTGATACAATGTCGTTA F RT-PCR 1: SPy_0549end -
SPy_0550startOLEC5129 CATTAACTCGTTGAGGCGC R
OLEC4693 TGAGTCAGGAGAAGTTTTATGATAAGC F RT-PCR 2: SPy_0550end -
SPy_552start, qRT-PCR and NBOLEC4694 GCTCAGCAAATCTGCTTTAGCATCATC R
OLEC4695 TCGCATTGTATATCATGTTCTGGAAG F RT-PCR3: SPy_0552end-
SPy_0553start and qRT-PCROLEC4696 TGCCAAATAGGTCAGGTATCGGAG R
OLEC5130 CAACTGATGGAACTTTGGTG F RT-PCR 4: SPy_0553end-
SPy_0555startOLEC5131 GCCCTCCTTATTTTGGGGTAC R
OLEC4699 TGAAAATCTGTCTCAATTACCGAGTC F RT-PCR 1: UPSpy_1926-
Spy_1926startOLEC4700 ACTGTCATTGCTTCGCTTACCA R
OLEC4701 TGAGGATGTTCGTCAAGGGAAGT F RT-PCR2: SPy_1926end-
SPy_1927start, qRT-PCR and NBOLEC4702 ACGCTGACCTGATGTTGAGG R
OLEC4703 ACTTGCTTCCTACTCAAAGCGACT F RT-PCR3: Spy_1927end-
DWSpy_1927OLEC4704 GCCTAGCTTCGTAGTCTTTGGCT R
OLEC4719 TACCATGTCTACTTAAGAGG F RT-PCR4: UPSpy_1926-
Spy_1926startOLEC4700 ACTGTCATTGCTTCGCTTACCA R
OLEC5923 CTACCTATATGTCAACACACCAG F qRT-PCR clpP
OLEC5924 CATTGGCTGGTGGATCATATAC R
OLEC5362 GATGGCAACTCCGCTTACGTTG F qRT-PCR htrA
OLEC5363 GTTCCTAGTGGGCTGCCGATAG R
OLEC6677 AAGCTCTTGAAGGCGACACT F qRT-PCR tufA
OLEC6678 TGACACGAACAGTACCACGG R
OliRN243 CGTTGTACCAACCATTGTAGC R 16S rRNA, NB
Sequencing
OLEC8101 GCTAGTTATTGCTCAGCGG F MCS pAH160
OLEC8102 GGAAATGCGGTGAGCATCAC R
OLEC4208 CTGTTTCTCCATACCCGTT F MCS pBAD33
OLEC4210 CACTTCTGAGTTCGGCAT R
OLEC4112 TGTCTCATGAGCGGATACATA F MCS pZE12
OLEC4114 GATCCTCATCCTGTCTCTTGA R
OliRN228 GGAACGAAAACTCACGTTAA F MCS pEC85
OLEC787 TGTGGTTACGTGGTTTTTAAC R
In-vitro translation
OLEC8194 aagctttaatacgactcactataggaacataaggagaaacaataATGAAA
GAATATCAGGTCACCATGT
F SPy_parE1
OLEC8195 caaaaaacccctcaagacccgtttagaggccccaaggggttatgctattttttTT
ACCAATTATTCATATGACG
R
OLEC8196 aagctttaatacgactcactataggaacataaggagaaacaataATGGAC
TATAAGAAATATCAGATTATCTAT
F SPy_parE2
OLEC8197 caaaaaacccctcaagacccgtttagaggccccaaggggttatgctattttttTT
ATTTGAATAACTTTATATAGTCGCT
R
OLEC8912 aagctttaatacgactcactataggaacataaggagaaacaataATGACG
CGCAGGCTGCGCGTCCATAAC
F Mtb_parE2 from genomic DNA
MtbH37Rv (Kaufmann lab)
OLEC8913 caaaaaacccctcaagacccgtttagaggccccaaggggttatgctattttttT
CACTCGAAGGTGCGGCCAGAGATCTC
R
OLEC9665 aagctttaatacgactcactataggaacataaggagaaacaataATGTAT
AAGCTTAGCGGAAAAGCTGT
F Ec_parE3 from E. coli O157:H7
DNA (DSM 17076)
Appendix
127
OLEC8911 caaaaaacccctcaagacccgtttagaggccccaaggggttatgctattttttTT
ACCAGTGACGGCGAGGTTCCATC
R
OLEC9670 aagctttaatacgactcactataggaacataaggagaaacaataATGTCT
CAATTTACGCTATATAAAAAC
F Vf_ccdB from pBAD33ccdBv.f.
(Yuan et al., 2010)
OLEC9671 caaaaaacccctcaagacccgtttagaggccccaaggggttatgctattttttTT
AAATGCCAGTGATTAAAAAATCAAT
R
Toxin cloning (restriction ligation mediated cloning)
OLEC4421 CCCCCTCTAGAGTCGACTAAAGGAAAAAAATTGAAGG
GAAATTGCTTATTGAAAGAA (XbaI)
F SPy_parE1
OLEC4077 TTCGCATGCTTACCAATTATTCATATGACGTGA (SphIR) R
OLEC8811 CCCCCTCTAGAGTCGACTAAAGGAAAAAAAATGACGC
GCAGGCTGCGCGTCCATAAC  (XbaI)
F Mtb_parE2 from genomic DNA
MtbH37Rv (Kaufmann lab)
OLEC8813 TTCGCATGCTCACTCGAAGGTGCGGCCAGAGATCTC
(SphIR)
R
OLEC9661 CCCCCTCTAGAGTCGACTAAAGGAAAAAAATTGAGCG
TTTACCTCAATATGCAAAAT (XbaI)
F Vc_parE1 from pBAD33parE1
(Yuan et al., 2011)
OLEC9662 TTCGCATGCTTAAGAAACAAAGCGTGACTGTTTGAG
(SphIR)
R
OLEC9659 CCCCCTCTAGAGTCGACTAAAGGAAAAAAATTGAAAC
CATTTAATCTTACCGTCGCC (XbaI)
F Vc_parE2 from pBAD33parE2
(Yuan et al., 2010)
OLEC9660 TTCGCATGCTTATGCGCCGAATATTGGGTTCACATC
(SphIR)
R
OLEC8846 CCCCCTCTAGAGTCGACTAAAGGAAAAAAAATGTATA
AGCTTAGCGGAAAAGCTGT (XbaI)
F Ec_parE3 from E. coli O157:H7
DNA (DSM 17076)
OLEC8847 TTCGCATGCTTACCAGTGACGGCGAGGTTCCATC
(SphIR)
R
OLEC9663 CCCCCTCTAGAGTCGACTAAAGGAAAAAAATTGTCTC
AATTTACGCTATATAAAAAC (XbaI)
F Vf_ccdB from pBAD33ccdBv.f.
(Yuan et al., 2010)
OLEC9664 TTCGCATGCTTAAATGCCAGTGATTAAAAAATCAAT(Sp
hIR)
R
Antitoxin cloning (restriction ligation mediated cloning for pZE12Plac and Gibson mediated cloning for pAH160Prha)
OLEC8231 AATGAAATTCCTGCAGATAGGAGGAACAATTTTATGGC
TAAAACGGGAACTTTGAAT
F SPy_parD1 to clone into pAH160
OLEC8232 GCCGGCCGATATCCAATTGAGATCTGCCATATGTTAA
GCATTTTCCTTCAATTGAAA
R
OLEC8237 AATGAAATTCCTGCAGATAGGAGGAACAATTTTATGGA
TTACAAGGATGACGATGACAAGGCTAAAACGGGAACT
TTGAAT
F FLAG-tagged SPy_parD1 to clone
into pAH160
OLEC8232 GCCGGCCGATATCCAATTGAGATCTGCCATATGTTAA
GCATTTTCCTTCAATTGAAA
R
OLEC8231 AATGAAATTCCTGCAGATAGGAGGAACAATTTTATGGC
TAAAACGGGAACTTTGAAT
F SPy_parD1 to construct pAH160
ΩSPy_parD1–parF1
OLEC7978 CATACATCACTCTCCCTTACTTTAAGCATTTTCCTTCAA
TTGAAA
R
OLEC7979 AGTAAGGGAGAGTGATGTATGGAACTCGTAAAGACGA
TACAAATT
F SPy_parF1 to construct pAH160
ΩSPy_parD1–parF1
OLEC8236 GCCGGCCGATATCCAATTGAGATCTGCCATATGTCAT
TCTGTCAATTCCTTAAATG
R
OLEC8233 AATGAAATTCCTGCAGATAGGAGGAACAATTTTATGAC
TACAGTAAAAAAAAACAGAGCG
F SPy_parD2 to clone into pAH160
OLEC8234 GCCGGCCGATATCCAATTGAGATCTGCCATATGTTATA
GTCCAAGTTCAGCCCTCAC
R
OLEC8238 AATGAAATTCCTGCAGATAGGAGGAACAATTTTATGGA
TTACAAGGATGACGATGACAAGACTACAGTAAAAAAAA
ACAGAGCG
F FLAG-tagged SPy_parD2 to clone
into pAH160
OLEC8234 GCCGGCCGATATCCAATTGAGATCTGCCATATGTTATA
GTCCAAGTTCAGCCCTCAC
R
OLEC7974 GCGGGTACCATGGCTAAAACGGGAACTTTGAAT (KpnI) F SPy_parD1 to clone into pZE12
OLEC7975 GCGGGATCCTTAAGCATTTTCCTTCAATTGAAA
(BamHI)
R
OLEC8017 GCGGGTACCATGGATTACAAGGATGACGATGACAAG
GCTAAAACGGGAACTTTGAAT (KpnI)
F FLAGtag-SPy_parD1 to clone into
pZE12
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OLEC7975 GCGGGATCCTTAAGCATTTTCCTTCAATTGAAA
(BamHI)
R
OLEC7976 GCGGGTACCATGGAACTCGTAAAGACGATACAAATT
(KpnI)
F SPy_parF1 to clone into pZE12
OLEC7977 GCGGGATCCTCATTCTGTCAATTCCTTAAATGC
(BamHI)
R
OLEC4415 GCGGGTACCATGACTACAGTAAAAAAAAACAGAGCG
(KpnI)
F SPy_parD2 to clone into pZE12
OLEC4100 GCGGGATCCTTATAGTCCAAGTTCAGCCCTCAC
(BamHI)
R
OLEC8018 GCGGGTACCATGGATTACAAGGATGACGATGACAAGA
CTACAGTAAAAAAAAACAGAGCG
F FLAGtag-SPy_parD2 to clone into
pZE12
OLEC8019 GCGGGATCCTTATAGTCCAAGTTCAGCCCTC (BamHI) R
pEC85 cloning (Gibson mediated cloning)
OLEC4839 GAATTCAGGCCGGCCAAAAAAGG F pEC85
OLEC4840 GGATCCTCTAGAGTCGACCTGCAG R
OLEC5258 CCGCTGCATGCCTGCAGGTCGACTCTAGAGGATCCTA
TGAGATAATGCCGACTGTAC
F Ptet from the pEC536
OLEC6249 CTTGTCATCGTCATCCTTGTAATCCATTCTAGATCACC
TCCTTAACTAG
R
OLEC6250 ATGGATTACAAGGATGACGATGACAAGGCTAAAACGG
GAACTTTGAAT
F FLAGtag-SPy_parD1
OLEC5261 CACTTTTGTGGGCCTTTTTTGGCCGGCCTGAATTC
CATTAAGCATTTTCCTTCAAT
R
OLEC6250 ATGGATTACAAGGATGACGATGACAAGGCTAAAACGG
GAACTTTGAAT
F FLAGtag-SPy_parD1, to construct
FLAGtag-SPy_parD1-parF1
OLEC7978 CATACATCACTCTCCCTTACTTTAAGCATTTTCCTTCAA
TTGAAA
R
OLEC7979 AGTAAGGGAGAGTGATGTATGGAACTCGTAAAGACGA
TACAAATT
F SPy_parF1, to construct FLAGtag-
SPy_parD1-parF1
OLEC7980 CACTTTTGTGGGCCTTTTTTGGCCGGCCTGAATTCTCA
TTCTGTCAATTCCTTAAATGC
R
OLEC6251 ATGGATTACAAGGATGACGATGACAAGACTACAGTAA
AAAAAAACAGAGCG
F FLAGtag-SPy_parD2
OLEC5263 CACTTTTGTGGGCCTTTTTTGGCCGGCCTGAATTCTTA
TAGTCCAAGTTCAGCCCTC
R
OLEC8515 TTTCAATTGAAGGAAAATGCTTATTGAAAGAATATCAG
GTCACCATGT
F SPy_parE1
OLEC7981 CACTTTTGTGGGCCTTTTTTGGCCGGCCTGAATTCTTA
CCAATTATTCATATGACG
R
OLEC5218 CTCGAATAGATCTTCGAGTCTAGTTAGAGGAAATTGGA
CTATAAGAAATATCAGATTATC
F SPy_parE2
OLEC5219 CTCGAATAGATCTTCGAGTCTAGTTAGAGGAAAATGG
ACTATAAGAAATATCAGATTATC
F
OLEC5220 CACTTTTGTGGGCCTTTTTTGGCCGGCCTGAATTCTTA
TTTGAATAACTTTATATAGTCGCT
R
OLEC6251 ATGGATTACAAGGATGACGATGACAAGACTACAGTAA
AAAAAAACAGAGCG
F FLAG-tag-SPy_parD2-parE2
OLEC7982 CACTTTTGTGGGCCTTTTTTGGCCGGCCTGAATTCTTA
TTTGAATAACTTTATATAGTCGCT
R
Toxin targets (Gibson mediated cloning)
OLEC8009 CATATGGCAGATCTCAATTGGATATCGGCCGGC F pAH160
OLEC8010 CATAAAATTGTTCCTCCTATCTGCAGGAATTTCATT R
OLEC8203 AATGAAATTCCTGCAGATAGGAGGAACAATTTTATGAG
CGACCTTGCGAGAGAAA
F Ec_gyrA from pEC2122
OLEC8204 GCCGGCCGATATCCAATTGAGATCTGCCATATGTTATT
CTTCTTCTGGCTCGTCG
R
OLEC8205 AATGAAATTCCTGCAGATAGGAGGAACAATTTTATGAG
CGATATGGCAGAGC
F Ec_parC from pEC2123
OLEC8206 GCCGGCCGATATCCAATTGAGATCTGCCATATGTTAC
TCTTCGCTATCACCGC
R
Mutants construction (TOPO XL cloning or restriction ligation mediated cloning for pUC19)
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OLEC1943 TACCGTTCGTATAGCATACATTATACGAAGTTATCCGT
AGCGGTTTTCAAAATTTGCAACC
F lox66-ermAM/B-lox71 cassette
from the pEC454 vector
OLEC1932 TACCGTTCGTATAATGTATGCTATACGAAGTTATTTATT
TCCTCCCGTTAAATAATAGATAACTATTAAA
R
OLEC4225 CGCGAATTCAAGTAAGAGACAATCATCTGA (EcoRI) F Upstream SPy_parD1
OLEC4228 TATAATGTATGCTATACGAACGGTATGTATCACGTTTT
TAGATTGAC
R
OLEC4232 ATAGCATACATTATACGAACGGTAAGTAAGGGAGAGT
GATGTATG
F Downstream SPy_parE1
OLEC4235 GCGGGATCCTCCTGGAATAACGACCTTATC (BamHI) R
OLEC4237 AGAAAATCTGTAGGATCATCC Up- Upstream SPy_parD1,
SEQ mutant
OLEC4241 GGAGTTAAAGAGATGGTTGTA Down- Downstream SPy_parE1,
SEQ mutant
OLEC4147 CGCGAATTCGTGGTGAATGTCGTGAAATTA (EcoRI) F Upstream SPy_parD2
OLEC4148 TATAATGTATGCTATACGAACGGTATTTATGTAACCCC
TTTATGTAACT
R
OLEC4185 ATAGCATACATTATACGAACGGTACACGTTAAAAGCCT
TAGCAGTCT
F Downstream SPy_parE2
OLEC4186 GCGGGATCCAGTCATTTGACTACTAGCATGTCC
(BamHI)
R
OLEC4155 AATTCTATTGCGACGTACAGT F Up- Upstream SPy_parD2,
SEQ mutant
OLRC4158 TTACAAGCATTTTGCAAGTCT Down- Downstream SPy_parE2,
SEQ mutant
OLEC5005 GGAAGTAGTCTTGAAAAGTCCAAG F Upstream SPy_clpE
OLEC5006 TATAATGTATGCTATACGAACGGTAAATATACCTCCGA
GGGTTTATCTA
R
OLEC5007 ATAGCATACATTATACGAACGGTACGTTAGCTAAGAGA
GTTTCTATAAG
F Downstream SPy_clpE
OLEC5008 TCTTTTAAGAAAATTGCTGGCTTC R
OLEC5005 CGCGAATTCGGTCAACGGCTTCACATGACTAC (EcoRI) F Nested PCR to mutate SPy_clpE
OLEC5206 GCGGGATCCGTCTGAATAGCTGGCTGCTG (BamHI) R
OLEC4997 GATGTGAGAGCGAGTAGAGTTGA F Upstream SPy_clpC
OLEC4998 TATAATGTATGCTATACGAACGGTATTTAATTGCTTCC
CTTTCTGTCAATTC
R
OLEC4999 ATAGCATACATTATACGAACGGTATTTCCATATAAAAG
GTGGATCATCC
F Downstream SPy_clpC
OLEC5000 CATCGTTGCCCACACGCTC R
OLEC5209 CGCGAATTCATGTGTTACTCTTAGTGAGT (EcoRI) F Nested PCR to mutate SPy_clpC
OLEC5210 GCGGGATCCTGGCTTTCAAGGCTTCAAC (BamHI) R
aitalic: sequence annealing to the template; underlined: restriction site; lowercase: t7
promoter/terminator; highlighted grey: FLAG-tag, sequence in bold; ribosome binding side or start
codon.
b F: forward primer; R: reverse primer. 
cRT-PCR: retro-transcription PCR; qRT-PCR: quantitative retro-transcription; NB: used for Northern blot
analysis; MCS: multiple cloning side; SEQ: sequencing; SPy: S. pyogenes; Ec: E. coli; Mtb:
Mycobacterium tuberculosis H37Rv; Vc: Vibrio Cholerae; Vf (v.f.): Vibrio Fischeri; SPy_0550: parD1;
SPy_0552: parE1; SPy_0553: parF1; SPy_1926: parD2; SPy_1927: parE2.
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